PMID
Article Title
Citation
Organization
Download
View Data
In vitro evaluation of potential bitterness-masking terpenoids from the Canada goldenrod (Solidago canadensis).
J Nat Prod 77: 1739-43 (2014)
The Ohio State University
A potent HDAC inhibitor, 1-alaninechlamydocin, from a Tolypocladium sp. induces G2/M cell cycle arrest and apoptosis in MIA PaCa-2 cells.
J Nat Prod 77: 1753-7 (2014)
University Of Oklahoma
Discovery of selective hexapeptide agonists to human neuromedin U receptors types 1 and 2.
J Med Chem 57: 6583-93 (2014)
Tokyo University Of Pharmacy And Life Sciences
Synthesis and biological evaluation of tetrahydro[1,4]diazepino[1,2-a]indol-1-ones as cyclin-dependent kinase inhibitors.
Eur J Med Chem 83: 617-29 (2014)
Universit£
Discovery of triazines as selective PDE4B versus PDE4D inhibitors.
Bioorg Med Chem Lett 24: 4031-4 (2014)
Northern Illinois University
Inhibition of the lymphoid tyrosine phosphatase: the effect of zinc(II) ions and chelating ligand fragments on enzymatic activity.
Bioorg Med Chem Lett 24: 4019-22 (2014)
University Of Utah
Synthesis and biological evaluation of 2,3'-diindolylmethanes as agonists of aryl hydrocarbon receptor.
Bioorg Med Chem Lett 24: 4023-5 (2014)
University Of Wisconsin
The discovery of indole full agonists of the neurotensin receptor 1 (NTSR1).
Bioorg Med Chem Lett 24: 3974-8 (2014)
The Scripps Research Institute
Design and synthesis of CHAP31, trapoxin B and HC-toxin based bicyclic tetrapeptides disulfide as potent histone deacetylase inhibitors.
Bioorg Med Chem 22: 3850-5 (2014)
University Of Rajshahi
Structure-based optimization and biological evaluation of trisubstituted pyrazole as a core structure of potent ROS1 kinase inhibitors.
Bioorg Med Chem 22: 3871-8 (2014)
Yonsei University
Pyridopyrimidinone inhibitors of HIV-1 RNase H.
Eur J Med Chem 83: 609-16 (2014)
Glaxosmithkline
Design, synthesis and structure-activity relationships of novel 4-phenoxyquinoline derivatives containing pyridazinone moiety as potential antitumor agents.
Eur J Med Chem 83: 581-93 (2014)
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Aryl-1,3,5-triazine derivatives as histamine H4 receptor ligands.
Eur J Med Chem 83: 534-46 (2014)
Jagiellonian University Medical College
Identification, pharmacological evaluation and binding mode analysis of novel chromene and chromane baseds1 receptor ligands.
Eur J Med Chem 83: 526-33 (2014)
University Of Trieste
Discovery of 9-(1-anilinoethyl)-2-morpholino-4-oxo-pyrido[1,2-a]pyrimidine-7-carboxamides as PI3Kß/d inhibitors for the treatment of PTEN-deficient tumours.
Bioorg Med Chem Lett 24: 3928-35 (2014)
Astrazeneca
Spongiapyridine and related spongians isolated from an Indonesian Spongia sp.
J Nat Prod 77: 1644-9 (2014)
University Of Hawaii At Manoa
Lead optimization of P5U and urantide: discovery of novel potent ligands at the urotensin-II receptor.
J Med Chem 57: 5965-74 (2014)
University Of Naples&Quot;Federico Ii&Quot
Design and synthesis of 6-oxo-1,4,5,6-tetrahydropyrimidine-5-carboxylate derivatives as neuraminidase inhibitors.
Eur J Med Chem 83: 466-73 (2014)
Wuhan University School Of Pharmaceutical Sciences
A new 9-alkyladenine-cyclic methylglyoxal diadduct activates wt- and F508del-cystic fibrosis transmembrane conductance regulator (CFTR) in vitro and in vivo.
Eur J Med Chem 83: 455-65 (2014)
Universit£
Benzimidazoles as new scaffold of sirtuin inhibitors: green synthesis, in vitro studies, molecular docking analysis and evaluation of their anti-cancer properties.
Eur J Med Chem 83: 448-54 (2014)
Universiti Sains Malaysia
High affinity ligands and potent antagonists for thea1D-adrenergic receptor. Novel 3,8-disubstituted [1]benzothieno[3,2-d]pyrimidine derivatives.
Eur J Med Chem 83: 419-32 (2014)
Universit£
Discovery of glycine sulfonamides as dual inhibitors of sn-1-diacylglycerol lipasea anda/ß-hydrolase domain 6.
J Med Chem 57: 6610-22 (2014)
Leiden University
Synthesis of some novel hydrazone and 2-pyrazoline derivatives: monoamine oxidase inhibitory activities and docking studies.
Bioorg Med Chem Lett 24: 3278-84 (2014)
Ministry Of Health Of Turkey
Benzoquinones as inhibitors of botulinum neurotoxin serotype A.
Bioorg Med Chem 22: 3971-81 (2014)
The Scripps Research Institute
Potential C-terminal-domain inhibitors of heat shock protein 90 derived from a C-terminal peptide helix.
Bioorg Med Chem 22: 3989-93 (2014)
Tufts University
Synthesis and biological evaluation of bivalent cannabinoid receptor ligands based on hCB2R selective benzimidazoles reveal unexpected intrinsic properties.
Bioorg Med Chem 22: 3938-46 (2014)
Julius-Maximilians-Universit£T W£Rzburg
Discovery and early clinical development of 2-{6-[2-(3,5-dichloro-4-pyridyl)acetyl]-2,3-dimethoxyphenoxy}-N-propylacetamide (LEO 29102), a soft-drug inhibitor of phosphodiesterase 4 for topical treatment of atopic dermatitis.
J Med Chem 57: 5893-903 (2014)
Leo Pharma
Development of first lead structures for phosphoinositide 3-kinase-C2¿ inhibitors.
J Med Chem 58: 212-21 (2015)
Eberhard Karls University Tuebingen
Novel 1-[4-(Aminosulfonyl)phenyl]-1H-1,2,4-triazole derivatives with remarkable selective COX-2 inhibition: design, synthesis, molecular docking, anti-inflammatory and ulcerogenicity studies.
Eur J Med Chem 83: 398-408 (2014)
Minia University
Toward fluorescent probes for G-protein-coupled receptors (GPCRs).
J Med Chem 57: 8187-203 (2014)
Shandong University
Fragment-based hit discovery and structure-based optimization of aminotriazoloquinazolines as novel Hsp90 inhibitors.
Bioorg Med Chem 22: 4135-50 (2014)
Nerviano Medical Sciences
Synthesis ofa,ß-unsaturated carbonyl based compounds as acetylcholinesterase and butyrylcholinesterase inhibitors: characterization, molecular modeling, QSAR studies and effect against amyloidß-induced cytotoxicity.
Eur J Med Chem 83: 355-65 (2014)
Universiti Kebangsaan Malaysia
Design and green synthesis of 2-(diarylalkyl)aminobenzothiazole derivatives and their dual activities as angiotensin converting enzyme inhibitors and calcium channel blockers.
Eur J Med Chem 83: 344-54 (2014)
Csir-Indian Institute Of Chemical Technology
Mode of interaction of 1,4-dioxane agonists at the M2 and M3 muscarinic receptor orthosteric sites.
Bioorg Med Chem Lett 24: 3255-9 (2014)
Universit£
Discovery of acylurea isosteres of 2-acylaminothiadiazole in the azaxanthene series of glucocorticoid receptor agonists.
Bioorg Med Chem Lett 24: 3268-73 (2014)
Bristol-Myers Squibb
Design, synthesis and pharmacological evaluation of novel polycyclic heteroarene ethers as PDE10A inhibitors: part II.
Bioorg Med Chem Lett 24: 3238-42 (2014)
Glenmark Pharmaceuticals
Broad-spectrum allosteric inhibition of herpesvirus proteases.
Biochemistry 53: 4648-60 (2014)
University Of California San Francisco
Design of symmetrical and nonsymmetrical
Medchemcomm 2013: 693-696 (2013)
Imperial College
Novel, potent and selective 17ß-hydroxysteroid dehydrogenase type 2 inhibitors as potential therapeutics for osteoporosis with dual human and mouse activities.
Eur J Med Chem 83: 317-37 (2014)
Saarland University
Prediction of anti-tumor chemical probes of a traditional Chinese medicine formula by HPLC fingerprinting combined with molecular docking.
Eur J Med Chem 83: 294-306 (2014)
The Second People'S Hospital Of Fujian Provinc
The discovery of potent, orally bioavailable pyrimidine-5-carbonitrile-6-alkyl CXCR2 receptor antagonists.
Bioorg Med Chem Lett 24: 3285-90 (2014)
Novartis Institutes For Biomedical Research
Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.
Bioorg Med Chem Lett 24: 3234-7 (2014)
Korea University
Pyrrolo- and pyridomorphinans: non-selective opioid antagonists and delta opioid agonists/mu opioid partial agonists.
Bioorg Med Chem 22: 4067-72 (2014)
University Of Bath
Targeting integrinsavß3 anda5ß1 with newß-lactam derivatives.
Eur J Med Chem 83: 284-93 (2014)
University Of Bologna
9- and 11-substituted 4-azapaullones are potent and selective inhibitors of African trypanosoma.
Eur J Med Chem 83: 274-83 (2014)
Technische Universit£T Braunschweig
Synthesis, biological evaluation and structure-activity relationship of new GABA uptake inhibitors, derivatives of 4-aminobutanamides.
Eur J Med Chem 83: 256-73 (2014)
Jagiellonian University Medical College
Synthesis and evaluation of iminocoumaryl and coumaryl derivatized glycosides as galectin antagonists.
Bioorg Med Chem Lett 24: 3516-20 (2014)
Lund University
Synthesis and biological evaluation ofa-1-C-4'-arylbutyl-L-arabinoiminofuranoses, a new class ofa-glucosidase inhibitors.
Bioorg Med Chem Lett 24: 3298-301 (2014)
Tohoku Pharmaceutical University
Effect of p-aminophenols on tyrosinase activity.
Bioorg Med Chem 22: 3994-4000 (2014)
Hoshi University
Influence of azide incorporation on binding affinity by small papain inhibitors.
Bioorg Med Chem 22: 5593-603 (2014)
Radboud University Nijmegen
Identification of endocannabinoid system-modulating N-alkylamides from Heliopsis helianthoides var. scabra and Lepidium meyenii.
J Nat Prod 77: 1663-9 (2014)
University Of Szeged
2-Hexylthio-ß,¿-CH2-ATP is an effective and selective NTPDase2 inhibitor.
J Med Chem 57: 5919-34 (2014)
Bar-Ilan University
Scaffold decoration at positions 5 and 8 of 1,2,4-triazolo[1,5-c]pyrimidines to explore the antagonist profiling on adenosine receptors: a preliminary structure-activity relationship study.
J Med Chem 57: 6210-25 (2014)
Universit£
1,3,4-Oxadiazole-containing histone deacetylase inhibitors: anticancer activities in cancer cells.
J Med Chem 57: 6259-65 (2014)
Sapienza University Of Rome
KDM4B as a target for prostate cancer: structural analysis and selective inhibition by a novel inhibitor.
J Med Chem 57: 5975-85 (2014)
National Tsing Hua University
Extended N(6) substitution of rigid C2-arylethynyl nucleosides for exploring the role of extracellular loops in ligand recognition at the A3 adenosine receptor.
Bioorg Med Chem Lett 24: 3302-6 (2014)
National Institute Of Diabetes And Digestive And Kidney Diseases
Discovery of VU0431316: a negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety.
Bioorg Med Chem Lett 24: 3307-14 (2014)
Vanderbilt University Medical Center
Diarylthiazole: an antimycobacterial scaffold potentially targeting PrrB-PrrA two-component system.
J Med Chem 57: 6572-82 (2014)
Astrazeneca
Identification, optimization, and pharmacology of acylurea GHS-R1a inverse agonists.
J Med Chem 57: 6128-40 (2014)
Astrazeneca
Chemical proteomics identifies heterogeneous nuclear ribonucleoprotein (hnRNP) A1 as the molecular target of quercetin in its anti-cancer effects in PC-3 cells.
J Biol Chem 289: 22078-89 (2014)
National Taiwan University
Discovery of novel inhibitors of vascular endothelial growth factor-A-Neuropilin-1 interaction by structure-based virtual screening.
Bioorg Med Chem 22: 4042-8 (2014)
Universit£
Discovery and SAR of a novel series of metabotropic glutamate receptor 5 positive allosteric modulators with high ligand efficiency.
Bioorg Med Chem Lett 24: 3641-6 (2014)
Vanderbilt University Medical Center
Ligand-based pharmacophore modeling and virtual screening for the discovery of novel 17ß-hydroxysteroid dehydrogenase 2 inhibitors.
J Med Chem 57: 5995-6007 (2014)
University Of Innsbruck
Calcitonin gene-related peptide receptor antagonists: new therapeutic agents for migraine.
J Med Chem 57: 7838-58 (2014)
Merck Research Laboratories
Lower homologues of ahpatinin, aspartic protease inhibitors, from a marine Streptomyces sp.
J Nat Prod 77: 1749-52 (2014)
The University Of Tokyo
Rexinoids isolated from Sophora tonkinensis with a gene expression profile distinct from the synthetic rexinoid bexarotene.
J Nat Prod 77: 1670-7 (2014)
Aichi Gakuin University
Optimization of pyrrolamide topoisomerase II inhibitors toward identification of an antibacterial clinical candidate (AZD5099).
J Med Chem 57: 6060-82 (2014)
Astrazeneca
Discovery of inter-domain stabilizers-a novel assay system for allosteric akt inhibitors.
ACS Chem Biol 10: 279-88 (2015)
Technische Universit??????T Dortmund
i-Motif DNA: structure, stability and targeting with ligands.
Bioorg Med Chem 22: 4407-18 (2014)
University Of East Anglia
Bioactive diterpenoids and flavonoids from the aerial parts of Scoparia dulcis.
J Nat Prod 77: 1594-600 (2014)
Institute Of Chinese Materia Medica
Indazole- and indole-5-carboxamides: selective and reversible monoamine oxidase B inhibitors with subnanomolar potency.
J Med Chem 57: 6679-703 (2014)
University Of Bonn
Rational design of urea-based glutamate carboxypeptidase II (GCPII) inhibitors as versatile tools for specific drug targeting and delivery.
Bioorg Med Chem 22: 4099-108 (2014)
Academy Of Sciences Of The Czech Republic
Synthesis and evaluation of salicylanilide derivatives as potential epidermal growth factor receptor inhibitors.
Chem Biol Drug Des 85: 280-9 (2015)
Anhui University Of Chinese Medicine
Benzene-1,3-dicarboxylic acid 2,5-dimethylpyrrole derivatives as multiple inhibitors of bacterial Mur ligases (MurC-MurF).
Bioorg Med Chem 22: 4124-34 (2014)
Freie Universit£T Berlin
Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
Bioorg Med Chem 22: 4223-32 (2014)
Birla Institute Of Technology & Science-Pilani
Synthesis and biological evaluation of 4-aza-2,3-dihydropyridophenanthrolines as tubulin polymerization inhibitors.
Bioorg Med Chem Lett 24: 3356-60 (2014)
Csir-Indian Institute Of Chemical Technology
Development of novel azabenzofuran TRPA1 antagonists as in vivo tools.
Bioorg Med Chem Lett 24: 3464-8 (2014)
Amgen
Synthesis of bi-/tricyclic azasugars fused thiazinan-4-one and their HIV-RT inhibitory activity.
Bioorg Med Chem Lett 24: 3426-9 (2014)
Hebei University
Design, synthesis and docking study of 5-(substituted benzylidene)thiazolidine-2,4-dione derivatives as inhibitors of protein tyrosine phosphatase 1B.
Bioorg Med Chem Lett 24: 3337-40 (2014)
Chonnam National University
Targeting the PPM1D phenotype; 2,4-bisarylthiazoles cause highly selective apoptosis in PPM1D amplified cell-lines.
Bioorg Med Chem Lett 24: 3469-74 (2014)
The Institute Of Cancer Research
A novel 2-oxoindolinylidene inhibitor of bacterial MurD ligase: Enzyme kinetics, protein-inhibitor binding by NMR and a molecular dynamics study.
Eur J Med Chem 83: 92-101 (2014)
Slovenia National Institute Of Chemistry
4,5-Di-substituted benzyl-imidazol-2-substituted amines as the structure template for the design and synthesis of reversal agents against P-gp-mediated multidrug resistance breast cancer cells.
Eur J Med Chem 83: 74-83 (2014)
Ocean University Of China
Design, synthesis and evaluation of highly selective pyridone-based class II MET inhibitors.
Bioorg Med Chem Lett 24: 3351-5 (2014)
Central China Normal University
Conformational analysis of an anti-androgenic, (E,E)-8-hydroxygermacrene B, using NOESY and dynamic NMR spectroscopy.
Bioorg Med Chem Lett 24: 3526-9 (2014)
Naresuan University
Syntheses, neural protective activities, and inhibition of glycogen synthase kinase-3ß of substituted quinolines.
Bioorg Med Chem Lett 24: 3392-7 (2014)
Kansas State University
Orally bioavailable factor Xa inhibitors containing alpha-substituted gem-dimethyl P4 moieties.
Bioorg Med Chem Lett 24: 3341-5 (2014)
Bristol-Myers Squibb
2',6'-Dihalostyrylanilines, pyridines, and pyrimidines for the inhibition of the catalytic subunit of methionine S-adenosyltransferase-2.
J Med Chem 57: 6083-91 (2014)
University Of Kentucky
Vascular L-type Ca²¿ channel blocking activity of sulfur-containing indole alkaloids from Glycosmis petelotii.
J Nat Prod 77: 1586-93 (2014)
Vietnam Academy Of Science And Technology
Rational improvement of the affinity and selectivity of integrin binding of grafted lasso peptides.
J Med Chem 57: 5829-34 (2014)
Philipps-Universit£T Marburg
2-Alkyl/alkenyl substituted pyridine C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as highly potent TRPV1 antagonists.
Bioorg Med Chem Lett 24: 4039-43 (2014)
Seoul National University
Base-dependent formation of cis and trans olefins and their application in the synthesis of 5-oxo-ETE receptor antagonists.
Bioorg Med Chem Lett 24: 3385-8 (2014)
Florida Institute Of Technology
Structural revision of kynapcin-12 by total synthesis, and inhibitory activities against prolyl oligopeptidase and cancer cells.
Bioorg Med Chem Lett 24: 3373-6 (2014)
Riken
Design and optimization of highly-selective fungal CYP51 inhibitors.
Bioorg Med Chem Lett 24: 3455-8 (2014)
Viamet Pharmaceuticals
Structure based virtual screening of MDPI database: discovery of structurally diverse and novel DPP-IV inhibitors.
Bioorg Med Chem Lett 24: 3447-51 (2014)
Jamia Hamdard
Flow synthesis and biological activity of aryl sulfonamides as selective carbonic anhydrase IX and XII inhibitors.
Bioorg Med Chem Lett 24: 3422-5 (2014)
University Of Perugia
Optimization of peptidomimetic boronates bearing a P3 bicyclic scaffold as proteasome inhibitors.
Eur J Med Chem 83: 1-14 (2014)
Universit£
Discovery of MK-4409, a Novel Oxazole FAAH Inhibitor for the Treatment of Inflammatory and Neuropathic Pain.
ACS Med Chem Lett 5: 717-21 (2014)
Merck Research Laboratories
Minimizing the Contribution of Enterohepatic Recirculation to Clearance in Rat for the NCINI Class of Inhibitors of HIV.
ACS Med Chem Lett 5: 711-6 (2014)
Boehringer Ingelheim (Canada)
Discovery of Novel Imidazo[4,5-b]pyridines as Potent and Selective Inhibitors of Phosphodiesterase 10A (PDE10A).
ACS Med Chem Lett 5: 700-5 (2014)
Amgen
Novel and high affinity fluorescent ligands for the serotonin transporter based on (s)-citalopram.
ACS Med Chem Lett 5: 696-9 (2014)
National Institute On Drug Abuse-Intramural Research Program
Diamine Derivatives as Novel Small-Molecule, Potent, and Subtype-Selective Somatostatin SST3 Receptor Agonists.
ACS Med Chem Lett 5: 690-5 (2014)
Merck Research Laboratories
Synthesis, Characterization, and in Vitro Evaluation of a New TSPO-Selective Bifunctional Chelate Ligand.
ACS Med Chem Lett 5: 685-9 (2014)
Universit£
Discovery and Synthesis of C-Nucleosides as Potential New Anti-HCV Agents.
ACS Med Chem Lett 5: 679-84 (2014)
Biota Scientific Management
Discovery of Anilinopyrimidines as Dual Inhibitors of c-Met and VEGFR-2: Synthesis, SAR, and Cellular Activity.
ACS Med Chem Lett 5: 673-8 (2014)
Shanghai Institute Of Materia Medica
Structure-Guided Rescaffolding of Selective Antagonists of BCL-XL.
ACS Med Chem Lett 5: 662-7 (2014)
Genentech
Chiral Resolution and Serendipitous Fluorination Reaction for the Selective Dopamine D3 Receptor Antagonist BAK2-66.
ACS Med Chem Lett 5: 647-51 (2014)
National Institute On Drug Abuse-Intramural Research Program
Potent and orally efficacious bisthiazole-based histone deacetylase inhibitors.
ACS Med Chem Lett 5: 628-33 (2014)
Chinese National Center For Drug Screening
Hybrid dopamine uptake blocker-serotonin releaser ligands: a new twist on transporter-focused therapeutics.
ACS Med Chem Lett 5: 623-7 (2014)
Rti International
Imidazo[2,1]thiazol-3-one Derivatives Useful as Diagnostic Agents for Alzheimer's Disease.
ACS Med Chem Lett 5: 619-20 (2014)
Temple University School Of Pharmacy
Structure-based design of new KSP-Eg5 inhibitors assisted by a targeted multicomponent reaction.
Chembiochem 15: 1471-80 (2014)
University Of Santiago De Compostela
Molecular basis of the selective binding of MDMA enantiomers to the alpha4beta2 nicotinic receptor subtype: synthesis, pharmacological evaluation and mechanistic studies.
Eur J Med Chem 81: 35-46 (2014)
University Of Barcelona
Easily accessible polycyclic amines that inhibit the wild-type and amantadine-resistant mutants of the M2 channel of influenza A virus.
J Med Chem 57: 5738-47 (2014)
Universitat De Barcelona
Synthesis and anti-cholinesterase activity of new 7-hydroxycoumarin derivatives.
Eur J Med Chem 82: 536-44 (2014)
Tehran University Of Medical Sciences
Discovery and structure-activity relationships of phenyl benzenesulfonylhydrazides as novel indoleamine 2,3-dioxygenase inhibitors.
Bioorg Med Chem Lett 24: 3403-6 (2014)
National Health Research Institutes
Strategies for the modulation of phase II metabolism in a series of PKCe inhibitors.
Bioorg Med Chem Lett 24: 3398-402 (2014)
Vertex Pharmaceuticals
2-(Hetero(aryl)methylene)hydrazine-1-carbothioamides as potent urease inhibitors.
Chem Biol Drug Des 85: 225-30 (2015)
Quaid-I-Azam University
Design and synthesis of 5-[(2-chloro-6-fluorophenyl)acetylamino]-3-(4-fluorophenyl)-4-(4-pyrimidinyl)isoxazole (AKP-001), a novel inhibitor of p38 MAP kinase with reduced side effects based on the antedrug concept.
Bioorg Med Chem 22: 4162-76 (2014)
Aska Pharmaceutical
Pharmacological evaluation and docking studies ofa,ß-unsaturated carbonyl based synthetic compounds as inhibitors of secretory phospholipase A2, cyclooxygenases, lipoxygenase and proinflammatory cytokines.
Bioorg Med Chem 22: 4151-61 (2014)
Universiti Kebangsaan Malaysia
Development of second generation EP2 antagonists with high selectivity.
Eur J Med Chem 82: 521-35 (2014)
Emory University
GPR103 antagonists demonstrating anorexigenic activity in vivo: design and development of pyrrolo[2,3-c]pyridines that mimic the C-terminal Arg-Phe motif of QRFP26.
J Med Chem 57: 5935-48 (2014)
Astrazeneca
Radioiodinated benzyloxybenzene derivatives: a class of flexible ligands target to ?-amyloid plaques in Alzheimer's brains.
J Med Chem 57: 6030-42 (2014)
Beijing Normal University
Discovery of tetrahydroisoquinoline-based CXCR4 antagonists.
ACS Med Chem Lett 4: 1025-30 (2013)
Emory University
Binding Model for the Interaction of Anticancer Arylsulfonamides with the p300 Transcription Cofactor.
ACS Med Chem Lett 3: 620-625 (2012)
TBA
The ?-Amyloid Hypothesis in Alzheimer's Disease: Seeing Is Believing.
ACS Med Chem Lett 3: 265-7 (2012)
University Of Pennsylvania
Synthesis and biological evaluation of a selective N- and p/q-type calcium channel agonist.
ACS Med Chem Lett 3: 985-990 (2012)
TBA
Discovery of Novel a4ß2 Neuronal Nicotinic Receptor Modulators through Structure-Based Virtual Screening.
ACS Med Chem Lett 2: 855-860 (2011)
TBA
Discovery of Potent Dual PPARa Agonists/CB1 Ligands.
ACS Med Chem Lett 2: 793-797 (2011)
TBA
The role of a novel auxiliary pocket in bacterial phenylalanyl-tRNA synthetase druggability.
J Biol Chem 289: 21651-62 (2014)
Astrazeneca R&D Boston
Coumarin hybrids as novel therapeutic agents.
Bioorg Med Chem 22: 3806-14 (2014)
Punjabi University
Novel pyrazoline derivatives as bi-inhibitor of COX-2 and B-Raf in treating cervical carcinoma.
Bioorg Med Chem 22: 4109-18 (2014)
Second Affiliated Hospital Of Southeast University
Diphenylpyrroles: Novel p53 activators.
Eur J Med Chem 82: 472-9 (2014)
Cairo University
Tyrosinase inhibitory activity of a glucosylated hydroxystilbene in mouse melan-a melanocytes.
J Nat Prod 77: 1270-4 (2014)
The Chinese University Of Hong Kong
Synthesis and evaluation of three structurally related¹8F-labeled orvinols of different intrinsic activities: 6-O-[¹8F]fluoroethyl-diprenorphine ([¹8F]FDPN), 6-O-[¹8F]fluoroethyl-buprenorphine ([¹8F]FBPN), and 6-O-[¹8F]fluoroethyl-phenethyl-orvinol ([¹8F]FPEO).
J Med Chem 57: 5464-9 (2014)
University Of Oslo
Discovery of 4-aryl-7-hydroxyindoline-based P2Y1 antagonists as novel antiplatelet agents.
J Med Chem 57: 6150-64 (2014)
Bristol-Myers Squibb Research
Synthesis and evaluation of N6-substituted apioadenosines as potential adenosine A3 receptor modulators.
Bioorg Med Chem 22: 4257-68 (2014)
Ghent University
Enzyme inhibition by hydroamination: design and mechanism of a hybrid carmaphycin-syringolin enone proteasome inhibitor.
Chem Biol 21: 782-91 (2014)
University Of California San Diego
Synthesis of new melatoninergic hexahydroindenopyridines.
Bioorg Med Chem Lett 24: 3534-6 (2014)
Universidad De Valencia
Synthesis and structure-activity relationships of 4-fluorophenyl-imidazole p38a MAPK, CK1d and JAK2 kinase inhibitors.
Bioorg Med Chem Lett 24: 3412-8 (2014)
Syncom
Design, synthesis and biological evaluation of hybrid bioisoster derivatives of N-acylhydrazone and furoxan groups with potential and selective anti-Trypanosoma cruzi activity.
Eur J Med Chem 82: 418-25 (2014)
Universidade De S£O Paulo (Usp)
Inhibition of 17ß-HSD1: SAR of bicyclic substituted hydroxyphenylmethanones and discovery of new potent inhibitors with thioether linker.
Eur J Med Chem 82: 394-406 (2014)
Saarland University
Design, synthesis and pharmacological evaluation of novel substituted quinoline-2-carboxamide derivatives as human dihydroorotate dehydrogenase (hDHODH) inhibitors and anticancer agents.
Eur J Med Chem 82: 385-93 (2014)
Nirma University
Structure-activity relationships of oxysterol-derived pharmacological chaperones for Niemann-Pick type C1 protein.
Bioorg Med Chem Lett 24: 3480-5 (2014)
The University Of Tokyo
New orally active dual enkephalinase inhibitors (DENKIs) for central and peripheral pain treatment.
J Med Chem 57: 5748-63 (2014)
Pharmaleads
Polyketides from the cultured lichen mycobiont of a Vietnamese Pyrenula sp.
J Nat Prod 77: 1404-12 (2014)
Kobe Pharmaceutical University
Synthesis and evaluation of a new series of 3,5-bis((5-bromo-6-methyl-2-t-aminopyrimidin-4-yl)thio)-4H-1,2,4-triazol-4-amines and their cyclized products 'pyrimidinylthio pyrimidotriazolothiadiazines' as 15- lipo-oxygenase inhibitors.
Chem Biol Drug Des 85: 216-24 (2015)
Ferdowsi University Of Mashhad
Inhibitory and mechanistic investigations of oxo-lipids with human lipoxygenase isozymes.
Bioorg Med Chem 22: 4293-7 (2014)
University Of California
Discovery and structure-activity relationship of novel 2,3-dihydrobenzofuran-7-carboxamide and 2,3-dihydrobenzofuran-3(2H)-one-7-carboxamide derivatives as poly(ADP-ribose)polymerase-1 inhibitors.
J Med Chem 57: 5579-601 (2014)
St. John'S University
Tricyclic pyrazoles. Part 6. Benzofuro[3,2-c]pyrazole: a versatile architecture for CB2 selective ligands.
Eur J Med Chem 82: 281-92 (2014)
Universit£
Design, synthesis and biological evaluation of type-II VEGFR-2 inhibitors based on quinoxaline scaffold.
Bioorg Chem 16-26 (2014)
Ain Shams University
Dose-dependent inhibition of BACE-1 by the monoterpenoid 2,3,4,4-tetramethyl-5-methylenecyclopent-2-enone in cellular and mouse models of Alzheimer's disease.
J Nat Prod 77: 1275-9 (2014)
University Of Coimbra
SAR studies on curcumin's pro-inflammatory targets: discovery of prenylated pyrazolocurcuminoids as potent and selective novel inhibitors of 5-lipoxygenase.
J Med Chem 57: 5638-48 (2014)
University Jena
Property- and structure-guided discovery of a tetrahydroindazole series of interleukin-2 inducible T-cell kinase inhibitors.
J Med Chem 57: 5714-27 (2014)
Genentech
Dual protonophore-chitinase inhibitors dramatically affect O. volvulus molting.
J Med Chem 57: 5792-9 (2014)
The Scripps Research Institute
Physicochemically and pharmacokinetically stable nonapeptide KISS1 receptor agonists with highly potent testosterone-suppressive activity.
J Med Chem 57: 6105-15 (2014)
Takeda Pharmaceutical
Digoxin derivatives with enhanced selectivity for the a2 isoform of Na,K-ATPase: effects on intraocular pressure in rabbits.
J Biol Chem 289: 21153-62 (2014)
Weizmann Institute Of Science
Synthesis and structure-activity relationships of new carbonyl guanidine derivatives as novel dual 5-HT2B and 5-HT7 receptor antagonists. Part 2.
Bioorg Med Chem 22: 4323-37 (2014)
Astellas Pharma
Design, synthesis and biological evaluation of (E)-3-(3,4-dihydroxyphenyl)acrylylpiperazine derivatives as a new class of tubulin polymerization inhibitors.
Bioorg Med Chem 22: 4285-92 (2014)
Nanjing University
Discovery of a series of 2,5-diaminopyrimidine covalent irreversible inhibitors of Bruton's tyrosine kinase with in vivo antitumor activity.
J Med Chem 57: 5112-28 (2014)
Peking University
Probing of primed and unprimed sites of calpains: Design, synthesis and evaluation of epoxysuccinyl-peptide derivatives as selective inhibitors.
Eur J Med Chem 82: 274-80 (2014)
E£Tv£S Lor£Nd University (Elte)
Aminoazabenzimidazoles, a novel class of orally active antimalarial agents.
J Med Chem 57: 5702-13 (2014)
Astrazeneca
Tetrahydronaphthyridine and dihydronaphthyridinone ethers as positive allosteric modulators of the metabotropic glutamate receptor 5 (mGlu5).
J Med Chem 57: 5620-37 (2014)
Vanderbilt University Medical Center
Maximizing diversity from a kinase screen: identification of novel and selective pan-Trk inhibitors for chronic pain.
J Med Chem 57: 5800-16 (2014)
Merck Research Laboratories
Development of CBAP-BPyne, a probe for ?-secretase and presenilinase.
Medchemcomm 5: 338-341 (2014)
Memorial Sloan-Kettering Cancer Center
SAR studies of differently functionalized chalcones based hydrazones and their cyclized derivatives as inhibitors of mammalian cathepsin B and cathepsin H.
Bioorg Med Chem 22: 4233-45 (2014)
Kurukshetra University
Pyridine analogues of spirocyclics1 receptor ligands.
Bioorg Med Chem 22: 4277-84 (2014)
Institut F£R Pharmazeutische Und Medizinische Chemie Der Westf£Lischen Wilhelms-Universit£T M£Nster
Discovery of a novel series of potent MK2 non-ATP competitive inhibitors using 1,2-substituted azoles as cis-amide isosteres.
Bioorg Med Chem Lett 24: 3609-13 (2014)
Merck Research Laboratories
Elements and modulation of functional dynamics.
J Med Chem 57: 7819-37 (2014)
Janssen Research And Development
Polyhydroxyanthraquinones as quorum sensing inhibitors from the guttates of Penicillium restrictum and their analysis by desorption electrospray ionization mass spectrometry.
J Nat Prod 77: 1351-8 (2014)
University Of North Carolina At Greensboro
Multistage screening reveals chameleon ligands of the human farnesyl pyrophosphate synthase: implications to drug discovery for neurodegenerative diseases.
J Med Chem 57: 5764-76 (2014)
Mcgill University
Synthesis and SAR studies of benzyl ether derivatives as potent orally active S1P1 agonists.
Bioorg Med Chem 22: 4246-56 (2014)
Daiichi Sankyo
Synthesis, biological evaluation and molecular modeling of 1,3,4-thiadiazol-2-amide derivatives as novel antitubulin agents.
Bioorg Med Chem 22: 4312-22 (2014)
Nanjing University
Lead identification of benzimidazolone and azabenzimidazolone arylsulfonamides as CC-chemokine receptor 4 (CCR4) antagonists.
Bioorg Med Chem 22: 4298-311 (2014)
Glaxosmithkline
Rational design of the first difluorostatone-based PfSUB1 inhibitors.
Bioorg Med Chem Lett 24: 3582-6 (2014)
University Of Siena
Synthesis and characterization of novel 1,2-oxazine-based small molecules that targets acetylcholinesterase.
Bioorg Med Chem Lett 24: 3618-21 (2014)
N.D. Zelinsky Institute Of Organic Chemistry
Guanidine-baseda2-adrenoceptor ligands: Towards selective antagonist activity.
Eur J Med Chem 82: 242-54 (2014)
Trinity College
Naphthyridinone (NTD) integrase inhibitors 4. Investigating N1 acetamide substituent effects with C3 amide groups.
Bioorg Med Chem Lett 24: 3104-7 (2014)
Glaxosmithkline
4-Quinolone-3-carboxylic acids as cell-permeable inhibitors of protein tyrosine phosphatase 1B.
Bioorg Med Chem 22: 3670-83 (2014)
Chinese Academy Of Sciences
Efficient modulation of ?-aminobutyric acid type A receptors by piperine derivatives.
J Med Chem 57: 5602-19 (2014)
University Of Vienna
Design ofa7 nicotinic acetylcholine receptor ligands in quinuclidine, tropane and quinazoline series. Chemistry, molecular modeling, radiochemistry, in vitro and in rats evaluations of a [(18)F] quinuclidine derivative.
Eur J Med Chem 82: 214-24 (2014)
Universit£
New insights into the biological properties of Crocus sativus L.: chemical modifications, human monoamine oxidases inhibition and molecular modeling studies.
Eur J Med Chem 82: 164-71 (2014)
Sapienza University Of Rome
Synthesis and in vivo SAR study of indolin-2-one-based multi-targeted inhibitors as potential anticancer agents.
Eur J Med Chem 82: 139-51 (2014)
Qilu Pharmaceutical
Structural basis for low-affinity binding of non-R2 carboxylate-substituted tricyclic quinoline analogs to CK2a: comparative molecular dynamics simulation studies.
Chem Biol Drug Des 85: 189-200 (2015)
Beijing University Of Technology
Discovery of novel 17-phenylethylaminegeldanamycin derivatives as potent Hsp90 inhibitors.
Chem Biol Drug Des 85: 181-8 (2015)
Shandong University
Endiandric acid analogues from Beilschmiedia ferruginea as dual inhibitors of Bcl-xL/Bak and Mcl-1/Bid interactions.
J Nat Prod 77: 1430-7 (2014)
Institut De Chimie Des Substances Naturelles (Icsn)
4-amino-1-hydroxy-2-oxo-1,8-naphthyridine-containing compounds having high potency against raltegravir-resistant integrase mutants of HIV-1.
J Med Chem 57: 5190-202 (2014)
National Institutes Of Health
Recent developments in novel antidepressants targetinga4ß2-nicotinic acetylcholine receptors.
J Med Chem 57: 8204-23 (2014)
University Of Illinois At Chicago
Oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad spectrum antibacterial agents.
ACS Med Chem Lett 5: 609-14 (2014)
Merck Research Laboratories
Discovery of a New Series of Naphthamides as Potent VEGFR-2 Kinase Inhibitors.
ACS Med Chem Lett 5: 592-7 (2014)
Chinese Academy Of Sciences
Late-Stage C-H Coupling Enables Rapid Identification of HDAC Inhibitors: Synthesis and Evaluation of NCH-31 Analogues.
ACS Med Chem Lett 5: 582-6 (2014)
Nagoya University
Chlorpheniramine Analogues Reverse Chloroquine Resistance in Plasmodium falciparum by Inhibiting PfCRT.
ACS Med Chem Lett 5: 576-81 (2014)
Australian National University
Pivotal Role of an Aliphatic Side Chain in the Development of an HDM2 Inhibitor.
ACS Med Chem Lett 5: 572-5 (2014)
Merck Research Laboratories
Himbacine-derived thrombin receptor antagonists: c7-spirocyclic analogues of vorapaxar.
ACS Med Chem Lett 5: 561-5 (2014)
Merck Research Laboratories
Design, Synthesis, and Optimization of Balanced Dual NK1/NK3 Receptor Antagonists.
ACS Med Chem Lett 5: 550-5 (2014)
Universit£
Development of novel benzomorpholine class of diacylglycerol acyltransferase I inhibitors.
ACS Med Chem Lett 5: 544-9 (2014)
Merck Research Laboratories
Discovery of the Fibrinolysis Inhibitor AZD6564, Acting via Interference of a Protein-Protein Interaction.
ACS Med Chem Lett 5: 538-43 (2014)
Astrazeneca
New Hits as Antagonists of GPR103 Identified by HTS.
ACS Med Chem Lett 5: 527-32 (2014)
Astrazeneca
Optimization of GPR40 Agonists for Type 2 Diabetes.
ACS Med Chem Lett 5: 517-21 (2014)
Amgen
2-(2-Arylphenyl)benzoxazole As a Novel Anti-Inflammatory Scaffold: Synthesis and Biological Evaluation.
ACS Med Chem Lett 5: 512-6 (2014)
National Institute Of Pharmaceutical Education And Research (Niper)
Novel carboline derivatives as potent antifungal lead compounds: design, synthesis, and biological evaluation.
ACS Med Chem Lett 5: 506-11 (2014)
Second Military Medical University
Biarylmethoxy Nicotinamides As Novel and Specific Inhibitors of Mycobacterium tuberculosis.
ACS Med Chem Lett 5: 491-5 (2014)
Alkem Laboratories
Discovery of antitubulin agents with antiangiogenic activity as single entities with multitarget chemotherapy potential.
ACS Med Chem Lett 5: 480-4 (2014)
Duquesne University
Discovery of PF-5190457, a Potent, Selective, and Orally Bioavailable Ghrelin Receptor Inverse Agonist Clinical Candidate.
ACS Med Chem Lett 5: 474-9 (2014)
Pfizer
Phenylalanine-Based Inactivator of AKT Kinase: Design, Synthesis, and Biological Evaluation.
ACS Med Chem Lett 5: 462-7 (2014)
Virginia Commonwealth University
Fused Thiazin-3-ones as KCa3.1 Inhibitors.
ACS Med Chem Lett 5: 460-1 (2014)
Temple University School Of Pharmacy
Treatment of Immunological or Inflammatory Disorders with ITK Kinase Inhibitors.
ACS Med Chem Lett 5: 456-7 (2014)
Therachem Research Medilab (India)
3-Amido-3-aryl-piperidines: A Novel Class of Potent, Selective, and Orally Active GlyT1 Inhibitors.
ACS Med Chem Lett 5: 428-33 (2014)
F. Hoffmann-La Roche
Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1.
ACS Med Chem Lett 5: 422-7 (2014)
Boehringer Ingelheim (Canada)
Discovery of AZD3199, An Inhaled Ultralong Acting?2 Receptor Agonist with Rapid Onset of Action.
ACS Med Chem Lett 5: 416-21 (2014)
Astrazeneca
Oxathiazolones Selectively Inhibit the Human Immunoproteasome over the Constitutive Proteasome.
ACS Med Chem Lett 5: 405-10 (2014)
Weill Cornell Medical College
C-ring cannabinoid lactones: a novel cannabinergic chemotype.
ACS Med Chem Lett 5: 400-4 (2014)
Northeastern University
Improving the Pharmacokinetics of GPR40/FFA1 Full Agonists.
ACS Med Chem Lett 5: 384-9 (2014)
Amgen
Discovery and Optimization of Tetramethylpiperidinyl Benzamides as Inhibitors of EZH2.
ACS Med Chem Lett 5: 378-83 (2014)
Constellation Pharmaceuticals
Plasmepsin inhibitory activity and structure-guided optimization of a potent hydroxyethylamine-based antimalarial hit.
ACS Med Chem Lett 5: 373-7 (2014)
Latvian Institute Of Organic Synthesis
Novel delta opioid receptor agonists with oxazatricyclodecane structure.
ACS Med Chem Lett 5: 368-72 (2014)
Kitasato University
Structure-Activity Relationship of Semicarbazone EGA Furnishes Photoaffinity Inhibitors of Anthrax Toxin Cellular Entry.
ACS Med Chem Lett 5: 363-7 (2014)
University Of California
Enhancing a CH-? Interaction to Increase the Affinity for 5-HT1A Receptors.
ACS Med Chem Lett 5: 358-62 (2014)
University Of Li£Ge
Interkingdom pharmacology of Angiotensin-I converting enzyme inhibitor phosphonates produced by actinomycetes.
ACS Med Chem Lett 5: 346-51 (2014)
Vanderbilt University Department Of Chemistry
Delayed and Prolonged Histone Hyperacetylation with a Selective HDAC1/HDAC2 Inhibitor.
ACS Med Chem Lett 5: 340-5 (2014)
Merck Research Laboratories
Development of [(3)H]2-Carboxy-4,6-dichloro-1H-indole-3-propionic Acid ([(3)H]PSB-12150): A Useful Tool for Studying GPR17.
ACS Med Chem Lett 5: 326-30 (2014)
University Of Bonn
Optimizing the Physicochemical Properties of Raf/MEK Inhibitors by Nitrogen Scanning.
ACS Med Chem Lett 5: 309-14 (2014)
Chugai Pharmaceutical
Novel 2,4-Diarylaminopyrimidine Analogues (DAAPalogues) Showing Potent c-Met/ALK Multikinase Inhibitory Activities.
ACS Med Chem Lett 5: 304-8 (2014)
State Key Laboratory Of Drug Research
Discovery and Biological Evaluation of Novel Dual EGFR/c-Met Inhibitors.
ACS Med Chem Lett 5: 298-303 (2014)
Vichem Chemie Research
Analogues of the Natural Product Sinefungin as Inhibitors of EHMT1 and EHMT2.
ACS Med Chem Lett 5: 293-7 (2014)
University Of Copenhagen
Inhibitors of Factor XIa and Plasma Kallikrein May Treat Thromboembolic Disorders and Many Diabetes Complications.
ACS Med Chem Lett 5: 286-7 (2014)
Therachem Research Medilab (India)
Selective 5-HT Receptor Modulators May Deliver Focused Targeting with Fewer Adverse Effects.
ACS Med Chem Lett 5: 284-5 (2014)
Therachem Research Medilab (India)
Triazolo[4,5-d]pyrimidine Derivatives as Inhibitors of GCN2.
ACS Med Chem Lett 5: 282-3 (2014)
Dart Neuroscience
Novel cycloalkenepyrazoles as inhibitors of bub1 kinase.
ACS Med Chem Lett 5: 280-1 (2014)
Dart Neuroscience
Phenyl carboxamide analogues as spleen tyrosine kinase (syk) inhibitors.
ACS Med Chem Lett 5: 278-9 (2014)
Dart Neuroscience
Thiazolocarboxamide Analogues as NAMPT Inhibitors.
ACS Med Chem Lett 5: 277-277 (2014)
Dart Neuroscience
Quinoline Derivatives as 5-HT6 Receptor PET Ligands.
ACS Med Chem Lett 5: 275-6 (2014)
Dart Neuroscience
Novel Quinoline-Based P2-P4 Macrocyclic Derivatives As Pan-Genotypic HCV NS3/4a Protease Inhibitors.
ACS Med Chem Lett 5: 264-9 (2014)
Merck Research Laboratories
Potent Hepatitis C Virus NS5A Inhibitors Containing a Benzidine Core.
ACS Med Chem Lett 5: 255-8 (2014)
Seoul National University
Novel Peptidomimetic Hepatitis C Virus NS3/4A Protease Inhibitors Spanning the P2-P1' Region.
ACS Med Chem Lett 5: 249-54 (2014)
Uppsala University
Discovery and development of potent and selective inhibitors of histone methyltransferase g9a.
ACS Med Chem Lett 5: 205-9 (2014)
Abbvie
Small Macrocycles As Highly Active Integrin?2?1 Antagonists.
ACS Med Chem Lett 5: 193-8 (2014)
Sanofi R & D
Inhibitors of factor d may provide a treatment for age-related macular degeneration.
ACS Med Chem Lett 5: 106-7 (2014)
Therachem Research Medilab (India)
Selective EP4 Antagonist May Be Useful in Treating Arthritis and Arthritic Pain.
ACS Med Chem Lett 5: 104-5 (2014)
Therachem Research Medilab (India)
Design and Synthesis of Phenylpyrrolidine Phenylglycinamides As Highly Potent and Selective TF-FVIIa Inhibitors.
ACS Med Chem Lett 5: 188-92 (2014)
Bristol-Myers Squibb R & D
Himbacine-derived thrombin receptor antagonists: c7-aminomethyl and c9a-hydroxy analogues of vorapaxar.
ACS Med Chem Lett 5: 183-7 (2014)
Merck Research Laboratories
Functionally Optimized Neuritogenic Farinosone C Analogs: SAR-Study and Investigations on Their Mode of Action.
ACS Med Chem Lett 5: 172-7 (2014)
University Of Basel
FGFR1 Kinase Inhibitors: Close Regioisomers Adopt Divergent Binding Modes and Display Distinct Biophysical Signatures.
ACS Med Chem Lett 5: 166-71 (2014)
Astrazeneca
Original Design of Fluorescent Ligands by Fusing BODIPY and Melatonin Neurohormone.
ACS Med Chem Lett 5: 158-61 (2014)
Universit£
Neutral ?-Lactams Inactivate High Molecular Mass Penicillin-Binding Proteins of Class B1, Including PBP2a of MRSA.
ACS Med Chem Lett 5: 154-7 (2014)
Wesleyan University
Crystal Structures of PI3K? Complexed with PI103 and Its Derivatives: New Directions for Inhibitors Design.
ACS Med Chem Lett 5: 138-42 (2014)
Shanghai Jiao Tong University
Isomannide-based peptidomimetics as inhibitors for human tissue kallikreins 5 and 7.
ACS Med Chem Lett 5: 128-32 (2014)
Universidade Federal Do Abc
Discovery of Potent and Orally Active p53-MDM2 Inhibitors RO5353 and RO2468 for Potential Clinical Development.
ACS Med Chem Lett 5: 124-7 (2014)
Roche Pharma Research
Qualification of LSP1-2111 as a Brain Penetrant Group III Metabotropic Glutamate Receptor Orthosteric Agonist.
ACS Med Chem Lett 5: 119-23 (2014)
Lundbeck Research Usa
(S)-N-Methyldihydroquinazolinones are the Active Enantiomers of Retro-2 Derived Compounds against Toxins.
ACS Med Chem Lett 5: 94-7 (2014)
Cea
Evaluation of aminohydantoins as a novel class of antimalarial agents.
ACS Med Chem Lett 5: 89-93 (2014)
Saint Louis University
Discovery of a Novel Class of Imidazo[1,2-a]Pyridines with Potent PDGFR Activity and Oral Bioavailability.
ACS Med Chem Lett 5: 78-83 (2014)
Array Biopharma
Discovery of Tertiary Amine and Indole Derivatives as Potent ROR?t Inverse Agonists.
ACS Med Chem Lett 5: 65-8 (2014)
Glaxosmithkline
Novel Indole-N-glucoside, TA-1887 As a Sodium Glucose Cotransporter 2 Inhibitor for Treatment of Type 2 Diabetes.
ACS Med Chem Lett 5: 51-5 (2014)
Mitsubishi Tanabe Pharma
Evaluation and Structural Basis for the Inhibition of Tankyrases by PARP Inhibitors.
ACS Med Chem Lett 5: 18-22 (2014)
University Of Oulu
Identification of ML251, a Potent Inhibitor of T. brucei and T. cruzi Phosphofructokinase.
ACS Med Chem Lett 5: 12-7 (2014)
National Center For Advancing Translational Sciences
Tankyrase inhibitors: potential treatment of hyperproliferative diseases.
ACS Med Chem Lett 5: 10-1 (2014)
Therachem Research Medilab (India)
Inhibitors of Tropomyosin-Receptor Kinases (Trk's): Potential Pain Therapy and More.
ACS Med Chem Lett 5: 8-9 (2014)
Therachem Research Medilab (India)
Exploring multitarget interactions to reduce opiate withdrawal syndrome and psychiatric comorbidity.
ACS Med Chem Lett 4: 875-9 (2013)
University Of Camerino
[(11)C]MK-4232: The First Positron Emission Tomography Tracer for the Calcitonin Gene-Related Peptide Receptor.
ACS Med Chem Lett 4: 863-8 (2013)
Merck Research Labortories
Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors.
ACS Med Chem Lett 4: 835-40 (2013)
Constellation Pharmaceuticals
Aminopyrazole-Phenylalanine Based GPR142 Agonists: Discovery of Tool Compound and in Vivo Efficacy Studies.
ACS Med Chem Lett 4: 829-34 (2013)
Amgen
Gamma secretase modulators.
ACS Med Chem Lett 4: (2013)
Montclair State University
Substituted Benzylspiroindolin-2-one Analogues as Positive Allosteric Modulators of the Muscarinic Acetylcholine Receptor M1.
ACS Med Chem Lett 4: (2013)
Montclair State University
Trisubstituted imidazoles as positive modulators of metabotropic glutamate receptor subtype 5.
ACS Med Chem Lett 4: 819-21 (2013)
Dart Neuroscience
Inhibitors of PI3K? as Potential Treatment for Cancer.
ACS Med Chem Lett 4: 815-6 (2013)
Therachem Research Medilab (India)
Aminopyridyl/Pyrazinyl Spiro[indoline-3,4'-piperidine]-2-ones As Highly Selective and Efficacious c-Met/ALK Inhibitors.
ACS Med Chem Lett 4: 806-10 (2013)
Southern Medical University
Structure and Property Based Design of Pyrazolo[1,5-a]pyrimidine Inhibitors of CK2 Kinase with Activity in Vivo.
ACS Med Chem Lett 4: 800-5 (2013)
Astrazeneca
Structural and biological exploration of phe(3)-phe(4)-modified endomorphin-2 peptidomimetics.
ACS Med Chem Lett 4: 795-9 (2013)
Universit£
Potent and Orally Bioavailable GPR142 Agonists as Novel Insulin Secretagogues for the Treatment of Type 2 Diabetes.
ACS Med Chem Lett 4: 790-4 (2013)
Daiichi Sankyo
Potent DGAT1 Inhibitors in the Benzimidazole Class with a Pyridyl-oxy-cyclohexanecarboxylic Acid Moiety.
ACS Med Chem Lett 4: 773-8 (2013)
Merck Research Laboratories
Integrated Synthesis and Testing of Substituted Xanthine Based DPP4 Inhibitors: Application to Drug Discovery.
ACS Med Chem Lett 4: 768-72 (2013)
Sanofi-Aventis
Tropolones as lead-like natural products: the development of potent and selective histone deacetylase inhibitors.
ACS Med Chem Lett 4: 757-61 (2013)
University Of Connecticut
Discovery of AZD8931, an Equipotent, Reversible Inhibitor of Signaling by EGFR, HER2, and HER3 Receptors.
ACS Med Chem Lett 4: 742-6 (2013)
Astrazeneca
Contribution of Cage-Shaped Structure of Physalins to Their Mode of Action in Inhibition of NF-kB Activation
ACS Med Chem Lett 4: 730-5 (2013)
Riken
Flow Synthesis and Biological Studies of an Analgesic Adamantane Derivative That Inhibits P2X7-Evoked Glutamate Release.
ACS Med Chem Lett 4: 704-9 (2013)
University Of Cambridge
Histone Deacetylase 4 (HDAC4) Inhibitors: A Promising Treatment for Huntington's Disease.
ACS Med Chem Lett 4: 692-3 (2013)
Therachem Research Medilab (India)
Inhibitors of ATR Kinase for Treatment of Cancer.
ACS Med Chem Lett 4: 688-9 (2013)
Therachem Research Medilab (India)
Synthesis of 2?-heteroarylalkyl active vitamin d3 with therapeutic effect on enhancing bone mineral density in vivo.
ACS Med Chem Lett 4: 671-4 (2013)
Teikyo University
Discovery of novel insulin-like growth factor-1 receptor inhibitors with unique time-dependent binding kinetics.
ACS Med Chem Lett 4: 627-31 (2013)
Osi Pharmaceuticals
Pyrazolo[3,4-d]pyrimidine Prodrugs: Strategic Optimization of the Aqueous Solubility of Dual Src/Abl Inhibitors.
ACS Med Chem Lett 4: 622-6 (2013)
Universit£
C-Glucopyranosyl-1,2,4-triazoles As New Potent Inhibitors of Glycogen Phosphorylase.
ACS Med Chem Lett 4: 612-5 (2013)
University Of Debrecen
4-Substituted 2-Hydroxyisoquinoline-1,3(2H,4H)-diones as a Novel Class of HIV-1 Integrase Inhibitors.
ACS Med Chem Lett 4: 606-11 (2013)
Universit£
Structure-Activity Relationships and in Vivo Evaluation of Quinoxaline Derivatives for PET Imaging of ?-Amyloid Plaques.
ACS Med Chem Lett 4: 596-600 (2013)
Kyoto University
Identification of a series of compounds with potent antiviral activity for the treatment of enterovirus infections.
ACS Med Chem Lett 4: 585-9 (2013)
Biofocus
?-Secretase Inhibitors for the Treatment of Alzheimer's Disease and Down's Syndrome.
ACS Med Chem Lett 4: 578-9 (2013)
Therachem Research Medilab (India)
ERK2 Inhibitors May Provide Treatment for Cancer.
ACS Med Chem Lett 4: 576-7 (2013)
Therachem Research Medilab (India)
FPRL-1 Receptor Modulators May Provide Treatment for Inflammation.
ACS Med Chem Lett 4: 574-5 (2013)
Therachem Research Medilab (India)
Discovery of a New Class of Potent MMP Inhibitors by Structure-Based Optimization of the Arylsulfonamide Scaffold.
ACS Med Chem Lett 4: 565-9 (2013)
University Of Florence
Discovery of a potent, dual serotonin and norepinephrine reuptake inhibitor.
ACS Med Chem Lett 4: 560-4 (2013)
Eli Lilly
Discovery and Optimization of Potent GPR40 Full Agonists Containing Tricyclic Spirocycles.
ACS Med Chem Lett 4: 551-5 (2013)
Amgen
Identification of Selective Nanomolar Inhibitors of the Human Neuraminidase, NEU4.
ACS Med Chem Lett 4: 532-7 (2013)
University Of Alberta
Development of Unsymmetrical Dyads As Potent Noncarbohydrate-Based Inhibitors against Human ?-N-Acetyl-d-hexosaminidase.
ACS Med Chem Lett 4: 527-31 (2013)
East China University Of Science And Technology
Metabolically Stable tert-Butyl Replacement.
ACS Med Chem Lett 4: 514-6 (2013)
Novartis Institutes For Biomedical Research
Discovery of MK-3168: A PET Tracer for Imaging Brain Fatty Acid Amide Hydrolase.
ACS Med Chem Lett 4: 509-13 (2013)
Merck Research Laboratories
Identification of New Nonsteroidal ROR? Ligands; Related Structure-Activity Relationships and Docking Studies.
ACS Med Chem Lett 4: 504-8 (2013)
Genfit
Tricyclic Pyrimidines As Inhibitors of DYRK1A/DYRK1B As Potential Treatment for Down's Syndrome or Alzheimer's Disease.
ACS Med Chem Lett 4: 502-3 (2013)
Dart Neuroscience
Negative allosteric modulators of metabotropic glutamate receptor subtype.
ACS Med Chem Lett 4: 500-1 (2013)
Dart Neuroscience
Imidazopyrazine Derivatives As Inhibitors of mTOR.
ACS Med Chem Lett 4: 498-9 (2013)
Dart Neuroscience
Selective Inhibitors of Fibroblast Activation Protein (FAP) with a (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine Scaffold.
ACS Med Chem Lett 4: 491-6 (2013)
University Of Antwerp (Ua)
Development of Novel Alkene Oxindole Derivatives As Orally Efficacious AMP-Activated Protein Kinase Activators.
ACS Med Chem Lett 4: 475-80 (2013)
Chinese Academy Of Sciences
Discovery of RG7112: A Small-Molecule MDM2 Inhibitor in Clinical Development.
ACS Med Chem Lett 4: 466-9 (2013)
Roche Research Center
Novel thiazolobenzodiazepines as inhibitors of histamine h3 receptor.
ACS Med Chem Lett 4: 435-435 (2013)
Dart Neuroscience
Dihydrooxazines As Inhibitors of BACE-1 or BACE-2.
ACS Med Chem Lett 4: 433-4 (2013)
Dart Neuroscience
PAK1: A Therapeutic Target for Cancer Treatment.
ACS Med Chem Lett 4: 431-2 (2013)
Therachem Research Medilab (India)
Synthesis and Pharmacological Characterization of Two Novel, Brain Penetrating P2X7 Antagonists.
ACS Med Chem Lett 4: 419-22 (2013)
Janssen Research And Development
Identification of RO4597014, a Glucokinase Activator Studied in the Clinic for the Treatment of Type 2 Diabetes.
ACS Med Chem Lett 4: 414-8 (2013)
Hoffmann-La Roche
Anthraquinone Derivatives as Potent Inhibitors of c-Met Kinase and the Extracellular Signaling Pathway.
ACS Med Chem Lett 4: 408-13 (2013)
Soochow University
Design, Synthesis, and Pharmacological Evaluation of Fluorescent and Biotinylated Antagonists of?1 GABAC Receptors.
ACS Med Chem Lett 4: 402-7 (2013)
The University Of Sydney
Benzanilide-Biphenyl Replacement: A Bioisosteric Approach to Quinoline Carboxamide-Type ABCG2 Modulators.
ACS Med Chem Lett 4: 393-6 (2013)
University Of Regensburg
Cyclopropyl-Fused 1,3-Thiazepines as BACE1 and BACE2 Inhibitors.
ACS Med Chem Lett 4: 379-80 (2013)
Temple University
Selective Cyp11B1 Inhibitors for the Treatment of Cortisol Dependent Diseases.
ACS Med Chem Lett 4: 377-8 (2013)
Temple University
Aldosterone synthase inhibitors.
ACS Med Chem Lett 4: 375-6 (2013)
Temple University
Targeting CCR2 Receptor To Treat Inflammation Diseases and Disorders.
ACS Med Chem Lett 4: 371-2 (2013)
Therachem Research Medilab (India)
Discovery of Dabrafenib: A Selective Inhibitor of Raf Kinases with Antitumor Activity against B-Raf-Driven Tumors.
ACS Med Chem Lett 4: 358-62 (2013)
Glaxosmithkline
Synthesis, Optimization, and Evaluation of Novel Small Molecules as Antagonists of WDR5-MLL Interaction.
ACS Med Chem Lett 4: 353-7 (2013)
Entremed
Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor Modulator.
ACS Med Chem Lett 4: 333-7 (2013)
Genomics Institute Of The Novartis Research Foundation
Inhibition of mTOR Kinase and Cancer Treatment.
ACS Med Chem Lett 4: 321-2 (2013)
Therachem Research Medilab (India)
Positive allosteric modulators of nicotinic acetylcholine receptor.
ACS Med Chem Lett 4: 319-20 (2013)
Dart Neuroscience
High-Throughput Selectivity Assays for Small-Molecule Inhibitors of ?-Catenin/T-Cell Factor Protein-Protein Interactions.
ACS Med Chem Lett 4: 306-11 (2013)
University Of Utah
Discovery of Indenopyrazoles as a New Class of Hypoxia Inducible Factor (HIF)-1 Inhibitors.
ACS Med Chem Lett 4: 297-301 (2013)
Gakushuin University
Optimization of a Novel Series of TRPV4 Antagonists with In Vivo Activity in a Model of Pulmonary Edema.
ACS Med Chem Lett 4: 293-6 (2013)
Glaxosmithkline
Discovery of a highly potent, orally active mitosis/angiogenesis inhibitor r1530 for the treatment of solid tumors.
ACS Med Chem Lett 4: 259-63 (2013)
Hoffmann-La Roche
Interrogation of the Active Sites of Protein Arginine Deiminases (PAD1, -2, and -4) Using Designer Probes.
ACS Med Chem Lett 4: 249-53 (2013)
University Health Network
Discovery of novel N-substituted oxindoles as selective m1 and m4 muscarinic acetylcholine receptors partial agonists.
ACS Med Chem Lett 4: 244-8 (2013)
Dainippon Sumitomo Pharma
[3a,4]-Dihydropyrazolo[1,5a]pyrimidines: Novel, Potent, and Selective Phosphatidylinositol-3-kinase ? Inhibitors.
ACS Med Chem Lett 4: 230-4 (2013)
Glaxosmithkline
Azaindole-Based Inhibitors of Cdc7 Kinase: Impact of the Pre-DFG Residue, Val 195.
ACS Med Chem Lett 4: 211-5 (2013)
Abbott Laboratories
The role of the acidity of N-heteroaryl sulfonamides as inhibitors of bcl-2 family protein-protein interactions.
ACS Med Chem Lett 4: 186-90 (2013)
Novartis Institutes For Biomedical Research
Irreversible inhibitors of cysteine proteases.
ACS Med Chem Lett 4: 163-4 (2013)
Dart Neuroscience
PDE10 Inhibitors as Potential Treatment for Schizophrenia.
ACS Med Chem Lett 4: 161-2 (2013)
Therachem Research Medilab (India)
TRPV4 Antagonists: Potential Treatment for Congestive Heart Failure, Bladder Dysfunctions, and Pain.
ACS Med Chem Lett 4: 159-60 (2013)
Therachem Research Medilab (India)
Aldosterone synthase inhibitors: targeting chronic kidney disease and diabetic nephropathy.
ACS Med Chem Lett 4: 157-8 (2013)
Therachem Research Medilab (India)
Bodilisant-a novel fluorescent, highly affine histamine h3 receptor ligand.
ACS Med Chem Lett 4: 269-73 (2013)
Goethe University
Synthesis and antimycobacterial activity of 2,1'-dihydropyridomycins.
ACS Med Chem Lett 4: 264-8 (2013)
Swiss Federal Institute Of Technology (Eth) Zurich
Structure-Based Approach for the Discovery of Pyrrolo[3,2-d]pyrimidine-Based EGFR T790M/L858R Mutant Inhibitors.
ACS Med Chem Lett 4: 201-5 (2013)
Takeda Pharmaceutical
Synthesis and antimalarial activity of 3,3-spiroanellated 5,6-disubstituted 1,2,4-trioxanes.
ACS Med Chem Lett 4: 165-9 (2013)
Division Of Medicinal & Process Chemistry, Division Of Parasitology, Division Of Pharmacokinetics And Metabolism, And Sophisticated Analytical Instrument Facility, Central Drug Research Institute
Discovery of Small Molecule RIP1 Kinase Inhibitors for the Treatment of Pathologies Associated with Necroptosis.
ACS Med Chem Lett 4: 1238-43 (2013)
Glaxosmithkline
Design and Synthesis of Peptide YY Analogues with C-terminal Backbone Amide-to-Ester Modifications.
ACS Med Chem Lett 4: 1228-32 (2013)
University Of Copenhagen
Structure-based design of 2-aminopyridine oxazolidinones as potent and selective tankyrase inhibitors.
ACS Med Chem Lett 4: 1218-23 (2013)
Amgen
Fragment-based discovery of 6-azaindazoles as inhibitors of bacterial DNA ligase.
ACS Med Chem Lett 4: 1208-12 (2013)
Astex Pharmaceuticals
Discovery and in Vivo Evaluation of Potent Dual CYP11B2 (Aldosterone Synthase) and CYP11B1 Inhibitors.
ACS Med Chem Lett 4: 1203-7 (2013)
Novartis Institutes For Biomedical Research
Synthesis and in vitro and in vivo pharmacological evaluation of new 4-aminoquinoline-based compounds.
ACS Med Chem Lett 4: 1198-202 (2013)
University Of Cape Town
Structure Guided Optimization, in Vitro Activity, and in Vivo Activity of Pan-PIM Kinase Inhibitors.
ACS Med Chem Lett 4: 1193-7 (2013)
Novartis Institutes For Biomedical Research
Design, Synthesis, and Antiviral Evaluation of Chimeric Inhibitors of HIV Reverse Transcriptase.
ACS Med Chem Lett 4: 1183-8 (2013)
Yale University
Multifunctional cholinesterase and amyloid Beta fibrillization modulators. Synthesis and biological investigation.
ACS Med Chem Lett 4: 1178-82 (2013)
University Of Siena
Design and Discovery of 2-Arylquinazolin-4-ones as Potent and Selective Inhibitors of Tankyrases.
ACS Med Chem Lett 4: 1173-7 (2013)
University Of Bath
Exploring the chemical space of multitarget ligands using aligned self-organizing maps.
ACS Med Chem Lett 4: 1169-72 (2013)
Goethe University
Stapled Vasoactive Intestinal Peptide (VIP) Derivatives Improve VPAC2 Agonism and Glucose-Dependent Insulin Secretion.
ACS Med Chem Lett 4: 1163-8 (2013)
Astrazeneca
Probing the Binding Site of Bile Acids in TGR5.
ACS Med Chem Lett 4: 1158-62 (2013)
Universit£
Discovery of Pyridyl Bis(oxy)dibenzimidamide Derivatives as Selective Matriptase Inhibitors.
ACS Med Chem Lett 4: 1152-7 (2013)
Aurigene Discovery Technologies
Diphenylpropane Derivatives as Agonist of PPAR Nuclear Receptors.
ACS Med Chem Lett 4: 1135-6 (2013)
Dart Neuroscience
Inhibition of CK2: An Attractive Therapeutic Target for Cancer Treatment.
ACS Med Chem Lett 4: 1131-2 (2013)
Therachem Research Medilab (India)
Potent Targeting of the STAT3 Protein in Brain Cancer Stem Cells: A Promising Route for Treating Glioblastoma.
ACS Med Chem Lett 4: 1102-7 (2013)
University Of Toronto At Mississauga
Structures of human acetylcholinesterase bound to dihydrotanshinone I and territrem B show peripheral site flexibility.
ACS Med Chem Lett 4: 1091-6 (2013)
New York Structural Biology Center
Chemical Probe Identification Platform for Orphan GPCRs Using Focused Compound Screening: GPR39 as a Case Example.
ACS Med Chem Lett 4: 1079-84 (2013)
Pfizer
Potent oxazolidinone antibacterials with heteroaromatic C-ring substructure.
ACS Med Chem Lett 4: 1074-8 (2013)
Research Foundation Itsuu Laboratory
Improved Cav2.2 Channel Inhibitors through a gem-Dimethylsulfone Bioisostere Replacement of a Labile Sulfonamide.
ACS Med Chem Lett 4: 1064-8 (2013)
Merck Research Laboratories
Fluorine Scanning by Nonselective Fluorination: Enhancing Raf/MEK Inhibition while Keeping Physicochemical Properties.
ACS Med Chem Lett 4: 1059-63 (2013)
Chugai Pharmaceutical
Discovery of Octahydroindenes as PAR1 Antagonists.
ACS Med Chem Lett 4: 1054-8 (2013)
Korea Research Institute Of Technology
Identification and optimization of an aminoalcohol-carbazole series with antimalarial properties.
ACS Med Chem Lett 4: 1037-41 (2013)
Merck Serono
Discovery of 3,4-Dihydropyrimidin-2(1H)-ones As a Novel Class of Potent and Selective A2B Adenosine Receptor Antagonists.
ACS Med Chem Lett 4: 1031-6 (2013)
University Of Santiago De Compostela
N-[4-(1H-Pyrazolo[3,4-B]pyrazin-6yl)-phenyl]-sulonamides and Their Use As Pharmaceuticals.
ACS Med Chem Lett 4: 1022-4 (2013)
Temple University School Of Pharmacy
Endothelial lipase inhibitors for the treatment of atherosclerosis and cardiovascular disorders.
ACS Med Chem Lett 4: 1016-7 (2013)
Therachem Research Medilab (India)
Sphingosine-1-phosphate (S1P) Receptor Modulators Provide Potential for Diverse Treatments.
ACS Med Chem Lett 4: 1014-5 (2013)
Therachem Research Medilab (India)
Design, Synthesis, and Biological Evaluation of Novel Conformationally Constrained Inhibitors Targeting EGFR.
ACS Med Chem Lett 4: 974-8 (2013)
Zhejiang University
Discovery of GSK2656157: An Optimized PERK Inhibitor Selected for Preclinical Development.
ACS Med Chem Lett 4: 964-8 (2013)
Glaxosmithkline
Identification of a Novel and Selective Series of Itk Inhibitors via a Template-Hopping Strategy.
ACS Med Chem Lett 4: 948-52 (2013)
Glaxosmithkline
Discovery of Clinical Candidate GSK1842799 As a Selective S1P1 Receptor Agonist (Prodrug) for Multiple Sclerosis.
ACS Med Chem Lett 4: 942-7 (2013)
Praecis Pharmaceuticals
Design and Synthesis of 4-(4-Benzoylaminophenoxy)phenol Derivatives As Androgen Receptor Antagonists.
ACS Med Chem Lett 4: 937-41 (2013)
Tokyo Medical And Dental University
Discovery of DF-461, a Potent Squalene Synthase Inhibitor.
ACS Med Chem Lett 4: 932-6 (2013)
Daiichi Sankyo
Anabaseine analogues as modulators of nicotinic acetylcholine receptor.
ACS Med Chem Lett 4: 902-3 (2013)
Dart Neuroscience
Fighting Obesity and Metabolic Disorders with MGAT-2 Inhibitors.
ACS Med Chem Lett 4: 898-9 (2013)
Therachem Research Medilab (India)
Solvent Selection for Insoluble Ligands, a Challenge for Biological Assay Development: A TNF-?/SPD304 Study.
ACS Med Chem Lett 4: 137-41 (2013)
The Centre For Research And Technology Of Thessaly (Ce.Re.Te.Th.)
Biological evaluation of new largazole analogues: alteration of macrocyclic scaffold with click chemistry.
ACS Med Chem Lett 4: 132-6 (2013)
Chinese Academy Of Sciences
Discovery of HSD-621 as a Potential Agent for the Treatment of Type 2 Diabetes.
ACS Med Chem Lett 4: 118-23 (2013)
Pfizer
Imidazopyridine-Based Fatty Acid Synthase Inhibitors That Show Anti-HCV Activity and in Vivo Target Modulation.
ACS Med Chem Lett 4: 113-7 (2013)
3-V Biosciences
Discovery and Biological Profiling of Potent and Selective mTOR Inhibitor GDC-0349.
ACS Med Chem Lett 4: 103-7 (2013)
Genentech
Discovery of the Highly Potent PI3K/mTOR Dual Inhibitor PF-04979064 through Structure-Based Drug Design.
ACS Med Chem Lett 4: 91-7 (2013)
Pfizer
Discovery of a Highly Selective, Brain-Penetrant Aminopyrazole LRRK2 Inhibitor.
ACS Med Chem Lett 4: 85-90 (2013)
Genentech
Identification of Tetrahydropyrido[4,3-d]pyrimidine Amides as a New Class of Orally Bioavailable TGR5 Agonists.
ACS Med Chem Lett 4: 63-8 (2013)
Pfizer
Azepines and piperidines with dual norepinephrine dopamine uptake inhibition and antidepressant activity.
ACS Med Chem Lett 4: 46-51 (2013)
Astrazeneca
Magnolia Extract, Magnolol, and Metabolites: Activation of Cannabinoid CB2 Receptors and Blockade of the Related GPR55.
ACS Med Chem Lett 4: 41-5 (2013)
University Of Bonn
Structure-Based Design of Irreversible Human KAT II Inhibitors: Discovery of New Potency-Enhancing Interactions.
ACS Med Chem Lett 4: 37-40 (2013)
Pfizer
Spleen Tyrosine Kinase Inhibitors (SYK) as Potential Treatment for Autoimmune and Inflammatory Disorders: Patent Highlight.
ACS Med Chem Lett 4: 18-9 (2013)
Therachem Research Medilab (India)
Treatment of Obesity and Related Disorders with Acetyl-CoA Carboxylase Inhibitors.
ACS Med Chem Lett 4: 16-7 (2013)
Therachem Research Medilab (India)
Modulators of the GPR119 Receptor for the Treatment of Metabolic Syndrome.
ACS Med Chem Lett 4: 8-9 (2013)
Dart Neuroscience
Metabolites of the pyrimidine amine preladenant as adenosine a2a receptor antagonists.
ACS Med Chem Lett 4: 5-6 (2013)
Dart Neuroscience
Fluorescent Human EP3 Receptor Antagonists.
ACS Med Chem Lett 3: 774-779 (2012)
TBA
Symmetric kv1.5 blockers discovered by focused screening.
ACS Med Chem Lett 3: 769-773 (2012)
TBA
Identification of an Adamantyl Azaquinolone JNK Selective Inhibitor.
ACS Med Chem Lett 3: 764-768 (2012)
TBA
Discovery of DS-8108b, a Novel Orally Bioavailable Renin Inhibitor.
ACS Med Chem Lett 3: 754-758 (2012)
TBA
Macrocyclic peptoid-Peptide hybrids as inhibitors of class I histone deacetylases.
ACS Med Chem Lett 3: 749-753 (2012)
TBA
Irreversible 4-Aminopiperidine Transglutaminase 2 Inhibitors for Huntington's Disease.
ACS Med Chem Lett 3: 731-735 (2012)
TBA
Discovery of AM-1638: A Potent and Orally Bioavailable GPR40/FFA1 Full Agonist.
ACS Med Chem Lett 3: 726-730 (2012)
TBA
Discovery of Disubstituted Imidazo[4,5-b]pyridines and Purines as Potent TrkA Inhibitors.
ACS Med Chem Lett 3: 705-709 (2012)
TBA
Prostaglandin e2 synthase-1 inhibitors as potential treatment for osteoarthritis: patent highlight.
ACS Med Chem Lett 3: 703-704 (2012)
TBA
Inhibitors of LRRK2 as Treatment for Parkinson's Disease: Patent Highlight.
ACS Med Chem Lett 3: 701-702 (2012)
TBA
Cyclopropyl-spiro-piperidines Useful as Sodium Channel Blockers: Patent Highlight.
ACS Med Chem Lett 3: 697-698 (2012)
TBA
Substituted pyridines as sodium channel blockers: patent highlight.
ACS Med Chem Lett 3: 695-696 (2012)
TBA
Bromodomains: are readers right for epigenetic therapy?
ACS Med Chem Lett 3: 691-694 (2012)
TBA
Discovery of Phenylaminopyridine Derivatives as Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors.
ACS Med Chem Lett 3: 678-682 (2012)
TBA
Target-Activated Prodrugs (TAPs) for the Autoregulated Inhibition of MMP12.
ACS Med Chem Lett 3: 653-657 (2012)
TBA
Identification of Hydroxybenzoic Acids as Selective Lactate Receptor (GPR81) Agonists with Antilipolytic Effects.
ACS Med Chem Lett 3: 637-639 (2012)
TBA
Substituted benzimidazole and imidazopyridine compounds useful as cyp17 modulators: patent highlight.
ACS Med Chem Lett 3: 614-615 (2012)
TBA
Fatty Acid synthase inhibitors as possible treatment for cancer: patent highlight.
ACS Med Chem Lett 3: 612-613 (2012)
TBA
Potassium channel modulators as possible treatment for pain: patent highlight.
ACS Med Chem Lett 3: 608-9 (2012)
Therachem Research Medilab (India)
Lipophilic Isosteres of a ?-? Stacking Interaction: New Inhibitors of the Bcl-2-Bak Protein-Protein Interaction.
ACS Med Chem Lett 3: 579-83 (2012)
Novartis Institutes For Biomedical Research
Diaminopyridine-based potent and selective mps1 kinase inhibitors binding to an unusual flipped-Peptide conformation.
ACS Med Chem Lett 3: 560-564 (2012)
TBA
Synthesis and Agonistic Activity at the GPR35 of 5,6-Dihydroxyindole-2-carboxylic Acid Analogues.
ACS Med Chem Lett 3: 550-554 (2012)
TBA
Identification of new snake venom metalloproteinase inhibitors using compound screening and rational Peptide design.
ACS Med Chem Lett 3: 540-543 (2012)
TBA
Low Doses of Allyphenyline and Cyclomethyline, Effective against Morphine Dependence, Elicit an Antidepressant-like Effect.
ACS Med Chem Lett 3: 535-539 (2012)
TBA
Design and synthesis of potent, selective inhibitors of matriptase.
ACS Med Chem Lett 3: 530-534 (2012)
TBA
Rational Design, Synthesis, and SAR of a Novel Thiazolopyrimidinone Series of Selective PI3K-beta Inhibitors.
ACS Med Chem Lett 3: 524-529 (2012)
TBA
Biotin analogues with antibacterial activity are potent inhibitors of biotin protein ligase.
ACS Med Chem Lett 3: 509-514 (2012)
TBA
Discovery of HDAC Inhibitors That Lack an Active Site Zn(2+)-Binding Functional Group.
ACS Med Chem Lett 3: 505-508 (2012)
TBA
The Discovery of MK-4256, a Potent SSTR3 Antagonist as a Potential Treatment of Type 2 Diabetes.
ACS Med Chem Lett 3: 484-489 (2012)
TBA
Synthesis and biochemical evaluation of thiochromanone thiosemicarbazone analogues as inhibitors of cathepsin L.
ACS Med Chem Lett 3: 450-453 (2012)
TBA
Fragment-Based Discovery of 7-Azabenzimidazoles as Potent, Highly Selective, and Orally Active CDK4/6 Inhibitors.
ACS Med Chem Lett 3: 445-449 (2012)
TBA
RXR Partial Agonist CBt-PMN Exerts Therapeutic Effects on Type 2 Diabetes without the Side Effects of RXR Full Agonists.
ACS Med Chem Lett 3: 427-432 (2012)
TBA
ß-Lactones Inhibit N-acylethanolamine Acid Amidase by S-Acylation of the Catalytic N-Terminal Cysteine.
ACS Med Chem Lett 3: 422-426 (2012)
TBA
Novel Carboxamide-Based Allosteric MEK Inhibitors: Discovery and Optimization Efforts toward XL518 (GDC-0973).
ACS Med Chem Lett 3: 416-421 (2012)
TBA
Intestinally Targeted Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitors Robustly Suppress Postprandial Triglycerides.
ACS Med Chem Lett 3: 411-415 (2012)
TBA
Design of a Potent CB1 Receptor Antagonist Series: Potential Scaffold for Peripherally-Targeted Agents.
ACS Med Chem Lett 3: 397-401 (2012)
TBA
Fungal bis-Naphthopyrones as Inhibitors of Botulinum Neurotoxin Serotype A.
ACS Med Chem Lett 3: 387-391 (2012)
TBA
Targeted kinase selectivity from kinase profiling data.
ACS Med Chem Lett 3: 383-386 (2012)
TBA
A Divergent SAR Study Allows Optimization of a Potent 5-HT2c Inhibitor to a Promising Antimalarial Scaffold.
ACS Med Chem Lett 3: 373-377 (2012)
TBA
Discovery of Selective Small Molecule ROMK Inhibitors as Potential New Mechanism Diuretics.
ACS Med Chem Lett 3: 367-372 (2012)
TBA
The Rhodadyns, a New Class of Small Molecule Inhibitors of Dynamin GTPase Activity.
ACS Med Chem Lett 3: 352-356 (2012)
TBA
A Back-to-Front Fragment-Based Drug Design Search Strategy Targeting the DFG-Out Pocket of Protein Tyrosine Kinases.
ACS Med Chem Lett 3: 342-346 (2012)
TBA
Discovery of BMS-846372, a Potent and Orally Active Human CGRP Receptor Antagonist for the Treatment of Migraine.
ACS Med Chem Lett 3: 337-341 (2012)
TBA
Discovery of MK-5172, a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor.
ACS Med Chem Lett 3: 332-6 (2012)
Merck Research Laboratories
Stimulation of Glucose-Dependent Insulin Secretion by a Potent, Selective sst3 Antagonist.
ACS Med Chem Lett 3: 289-293 (2012)
TBA
Potent and Selective Inhibitors of CK2 Kinase Identified through Structure-Guided Hybridization.
ACS Med Chem Lett 3: 278-283 (2012)
TBA
Avicholic Acid: A Lead Compound from Birds on the Route to Potent TGR5 Modulators.
ACS Med Chem Lett 3: 273-277 (2012)
TBA
Discovery of MK-7725, A Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Obesity.
ACS Med Chem Lett 3: 252-256 (2012)
TBA
NOpiates: Novel Dual Action Neuronal Nitric Oxide Synthase Inhibitors with µ-Opioid Agonist Activity.
ACS Med Chem Lett 3: 227-231 (2012)
TBA
Discovery of a Novel Class of Bicyclo[3.1.0]hexanylpiperazines as Noncompetitive Neuropeptide Y Y1 Antagonists.
ACS Med Chem Lett 3: 222-226 (2012)
TBA
Mitigating hERG Inhibition: Design of Orally Bioavailable CCR5 Antagonists as Potent Inhibitors of R5 HIV-1 Replication.
ACS Med Chem Lett 3: 216-221 (2012)
TBA
Discovery and Development of Potent LFA-1/ICAM-1 Antagonist SAR 1118 as an Ophthalmic Solution for Treating Dry Eye.
ACS Med Chem Lett 3: 203-206 (2012)
TBA
Discovery of Brain-Penetrant, Irreversible Kynurenine Aminotransferase II Inhibitors for Schizophrenia.
ACS Med Chem Lett 3: 187-192 (2012)
TBA
The First Dual ChE/FAAH Inhibitors: New Perspectives for Alzheimer's Disease?
ACS Med Chem Lett 3: 182-186 (2012)
TBA
Discovery of a potent thiadiazole class of histamine h3 receptor antagonist for the treatment of diabetes.
ACS Med Chem Lett 3: 198-202 (2012)
TBA
BACE1 Inhibitor Peptides: Can an Infinitely Small k cat Value Turn the Substrate of an Enzyme into Its Inhibitor?
ACS Med Chem Lett 3: 193-197 (2012)
TBA
Discovery of Natural Phenols as G Protein-Coupled Receptor-35 (GPR35) Agonists.
ACS Med Chem Lett 3: 165-169 (2012)
TBA
Virtual Screening and X-ray Crystallography for Human Kallikrein 6 Inhibitors with an Amidinothiophene P1 Group.
ACS Med Chem Lett 3: 159-164 (2012)
TBA
Dual-target virtual screening by pharmacophore elucidation and molecular shape filtering.
ACS Med Chem Lett 3: 155-158 (2012)
TBA
Discovery of GNF-5837, a Selective TRK Inhibitor with Efficacy in Rodent Cancer Tumor Models.
ACS Med Chem Lett 3: 140-145 (2012)
TBA
Discovery of a Novel Series of CHK1 Kinase Inhibitors with a Distinctive Hinge Binding Mode.
ACS Med Chem Lett 3: 123-128 (2012)
TBA
Application of MM-GB/SA and WaterMap to SRC Kinase Inhibitor Potency Prediction.
ACS Med Chem Lett 3: 94-99 (2012)
TBA
Synthesis and biological evaluation of cyclic sulfamide derivatives as 11ß-hydroxysteroid dehydrogenase 1 inhibitors.
ACS Med Chem Lett 3: 88-93 (2012)
TBA
Discovery of CX-6258. A Potent, Selective, and Orally Efficacious pan-Pim Kinases Inhibitor.
ACS Med Chem Lett 3: 135-139 (2012)
TBA
Discovery of PF-04449913, a Potent and Orally Bioavailable Inhibitor of Smoothened.
ACS Med Chem Lett 3: 106-111 (2012)
TBA
Discovery of a Potent Dihydrooxadiazole Series of Non-ATP-Competitive MK2 (MAPKAPK2) Inhibitors.
ACS Med Chem Lett 3: 100-105 (2012)
TBA
Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2.
ACS Med Chem Lett 3: 1091-1096 (2012)
TBA
Identification of amides as carboxylic Acid surrogates for quinolizidinone-based m1 positive allosteric modulators.
ACS Med Chem Lett 3: 1070-1074 (2012)
TBA
Structure-Based Design of Potent and Selective CK1¿ Inhibitors.
ACS Med Chem Lett 3: 1059-1064 (2012)
TBA
Inhibitors of the NAD(+)-Dependent Protein Desuccinylase and Demalonylase Sirt5.
ACS Med Chem Lett 3: 1050-1053 (2012)
TBA
A new approach to explore the binding space of polysaccharide-based ligands: selectin antagonists.
ACS Med Chem Lett 3: 1045-1049 (2012)
TBA
Discovery of a 4-Azetidinyl-1-thiazoyl-cyclohexane CCR2 Antagonist as a Development Candidate.
ACS Med Chem Lett 3: 1039-1044 (2012)
TBA
SAR Development of Lysine-Based Irreversible Inhibitors of Transglutaminase 2 for Huntington's Disease.
ACS Med Chem Lett 3: 1024-1028 (2012)
TBA
Discovery of AC710, a Globally Selective Inhibitor of Platelet-Derived Growth Factor Receptor-Family Kinases.
ACS Med Chem Lett 3: 997-1002 (2012)
TBA
Peptides and Pseudopeptides as SIRT6 Deacetylation Inhibitors.
ACS Med Chem Lett 3: 969-974 (2012)
TBA
Development of Synthetic Aminopeptidase N/CD13 Inhibitors to Overcome Cancer Metastasis and Angiogenesis.
ACS Med Chem Lett 3: 959-964 (2012)
TBA
GPR119 Modulators for the Treatment of Diabetes, Obesity, and Related Diseases: Patent Highlight.
ACS Med Chem Lett 3: 955-958 (2012)
TBA
Evaluation of [(11)C]N-Methyl Lansoprazole as a Radiopharmaceutical for PET Imaging of Tau Neurofibrillary Tangles.
ACS Med Chem Lett 3: 936-941 (2012)
TBA
Synthesis and SAR Studies of Fused Oxadiazines as ?-Secretase Modulators for Treatment of Alzheimer's Disease.
ACS Med Chem Lett 3: 931-5 (2012)
Merck Research Laboratory
Nonpeptidic lysosomal modulators derived from z-phe-ala-diazomethylketone for treating protein accumulation diseases.
ACS Med Chem Lett 3: 920-924 (2012)
TBA
Neuroprotective Tri- and Tetracyclic BChE Inhibitors Releasing Reversible Inhibitors upon Carbamate Transfer.
ACS Med Chem Lett 3: 914-919 (2012)
TBA
Initial Optimization of a New Series of ?-Secretase Modulators Derived from a Triterpene Glycoside.
ACS Med Chem Lett 3: 908-13 (2012)
Satori Pharmaceuticals
Discovery of SCH 900229, a Potent Presenilin 1 Selective ¿-Secretase Inhibitor for the Treatment of Alzheimer's Disease.
ACS Med Chem Lett 3: 892-896 (2012)
TBA
A Potent and Orally Efficacious, Hydroxyethylamine-Based Inhibitor of ß-Secretase.
ACS Med Chem Lett 3: 886-891 (2012)
TBA
Benzenesulfonyl and Benzenesulfonamide as Modulators of the 5-HT6 Receptor: Patent Highlight.
ACS Med Chem Lett 3: 881-2 (2012)
Dart Neuroscience
Novel and selective inhibitors of histone deacetylase: patent highlight.
ACS Med Chem Lett 3: 879-80 (2012)
Dart Neuroscience
Compounds and Their Use as BACE Inhibitors: Patent Highlight.
ACS Med Chem Lett 3: 875-876 (2012)
TBA
5-Amino-oxazepine and 5-Amino-thiazepine Compounds as ß-Secretase Antagonists and Methods of Use: Patent Highlight.
ACS Med Chem Lett 3: 873-874 (2012)
TBA
BACE-Inhibitors: Potential Treatment of Alzheimer Disease, Dementia, and Related Neurodegenerative Diseases. C. Spiro-Heterocyclic Derivatives: Patent Highlight.
ACS Med Chem Lett 3: 871-872 (2012)
TBA
BACE Inhibitors: Potential Treatment of Alzheimer's Disease, Dementia, and Related Neurodegenerative Disorders (B): 3-Amino-4-fluoro-1H-isoindol Derivatives: Patent Highlight.
ACS Med Chem Lett 3: 869-870 (2012)
TBA
BACE Inhibitors: Potential Treatment of Alzheimer's Disease, Dementia, and Related Neurodegenerative Disorders (A): 5,6-Dihydroimidazo[1,2-a]pyrazin-8-yl-amine Derivatives: Patent Highlight.
ACS Med Chem Lett 3: 867-868 (2012)
TBA
Discovery of the First Potent Inhibitors of Mutant IDH1 That Lower Tumor 2-HG in Vivo.
ACS Med Chem Lett 3: 850-855 (2012)
TBA
Discovery of a novel chemotype of tyrosine kinase inhibitors by fragment-based docking and molecular dynamics.
ACS Med Chem Lett 3: 834-838 (2012)
TBA
Aryl Piperazinyl Ureas as Inhibitors of Fatty Acid Amide Hydrolase (FAAH) in Rat, Dog, and Primate.
ACS Med Chem Lett 3: 823-827 (2012)
TBA
Discovery of 2-Alkyl-1-arylsulfonylprolinamides as 11ß-Hydroxysteroid Dehydrogenase Type 1 Inhibitors.
ACS Med Chem Lett 3: 793-798 (2012)
TBA
Selective Dual Inhibitors of the Cancer-Related Deubiquitylating Proteases USP7 and USP47.
ACS Med Chem Lett 3: 789-792 (2012)
TBA
Novel compounds for the treatment of neurodegenerative diseases: patent highlight.
ACS Med Chem Lett 3: 788-788 (2012)
TBA
Combatting Drug-Resistant Bacteria with Gyrase and Topoisomerase IV Inhibitors: Patent Highlight.
ACS Med Chem Lett 3: 783-784 (2012)
TBA
Factor D Inhibitors for the Treatment of AMD: Patent Highlight.
ACS Med Chem Lett 3: 781-782 (2012)
TBA
Optimization of a Potent, Orally Active S1P1 Agonist Containing a Quinolinone Core.
ACS Med Chem Lett 3: 74-78 (2012)
TBA
Discovery of SCH 900271, a Potent Nicotinic Acid Receptor Agonist for the Treatment of Dyslipidemia.
ACS Med Chem Lett 3: 63-68 (2012)
TBA
(18)F-labeled phenyldiazenyl benzothiazole for in vivo imaging of neurofibrillary tangles in Alzheimer's disease brains.
ACS Med Chem Lett 3: 58-62 (2012)
TBA
Proposed Bioactive Conformations of Opiorphin, an Endogenous Dual APN/NEP Inhibitor.
ACS Med Chem Lett 3: 20-24 (2012)
TBA
Prodrugs of a CXC Chemokine-12 (CXCL12) Neutraligand Prevent Inflammatory Reactions in an Asthma Model in Vivo.
ACS Med Chem Lett 3: 10-14 (2012)
TBA
Optimization of Potent Inhibitors of P. falciparum Dihydroorotate Dehydrogenase for the Treatment of Malaria.
ACS Med Chem Lett 2: 708-713 (2011)
TBA
A Novel (18)F-Labeled Imidazo[2,1-b]benzothiazole (IBT) for High-Contrast PET Imaging of ?-Amyloid Plaques.
ACS Med Chem Lett 2: 673-7 (2011)
Technische Universit£T M£Nchen
Exploring aigialomycin d and its analogues as protein kinase inhibitors for cancer targets.
ACS Med Chem Lett 2: 662-666 (2011)
TBA
Synthesis and Cardiac Imaging of (18)F-Ligands Selective for ß1-Adrenoreceptors.
ACS Med Chem Lett 2: 650-655 (2011)
TBA
Optimization of the Central Core of Indolinone-Acetic Acid-Based CRTH2 (DP2) Receptor Antagonists.
ACS Med Chem Lett 2: 644-649 (2011)
TBA
Discovery and Hit-to-Lead Optimization of Non-ATP Competitive MK2 (MAPKAPK2) Inhibitors.
ACS Med Chem Lett 2: 632-637 (2011)
TBA
The myo-1,2-Diaminocyclitol Scaffold Defines Potent Glucocerebrosidase Activators and Promising Pharmacological Chaperones for Gaucher Disease.
ACS Med Chem Lett 2: 614-619 (2011)
TBA
Combination of a Beta adrenoceptor modulator and a norepinephrine-serotonin uptake inhibitor for the treatment of obesity.
ACS Med Chem Lett 2: 583-586 (2011)
TBA
Bivalent Ligands for the Serotonin 5-HT3 Receptor.
ACS Med Chem Lett 2: 571-576 (2011)
TBA
Optimization of the First Selective Steroid-11ß-hydroxylase (CYP11B1) Inhibitors for the Treatment of Cortisol Dependent Diseases.
ACS Med Chem Lett 2: 559-564 (2011)
TBA
Inhibitors of Ketohexokinase: Discovery of Pyrimidinopyrimidines with Specific Substitution that Complements the ATP-Binding Site.
ACS Med Chem Lett 2: 538-543 (2011)
TBA
Structure-Activity Relationship Studies of HIV-1 Integrase Oligonucleotide Inhibitors.
ACS Med Chem Lett 2: 532-7 (2011)
Lomonosov Moscow State University
Assessment of partially deoxygenated deoxynojirimycin derivatives as glucosylceramide synthase inhibitors.
ACS Med Chem Lett 2: 519-522 (2011)
TBA
Benzodiazepinone Derivatives as CRTH2 Antagonists.
ACS Med Chem Lett 2: 515-518 (2011)
TBA
N-Methylated sst2 Selective Somatostatin Cyclic Peptide Analogue as a Potent Candidate for Treating Neurogenic Inflammation.
ACS Med Chem Lett 2: 509-514 (2011)
TBA
Synthesis and Evaluation of 5-Fluoro-2-aryloxazolo[5,4-b]pyridines as ?-Amyloid PET Ligands and Identification of MK-3328.
ACS Med Chem Lett 2: 498-502 (2011)
Merck Research Laboratories
Ranking high affinity ligands of low solubility by NMR spectroscopy.
ACS Med Chem Lett 2: 485-487 (2011)
TBA
N-Pyridyl and Pyrimidine Benzamides as KCNQ2/Q3 Potassium Channel Openers for the Treatment of Epilepsy.
ACS Med Chem Lett 2: 481-484 (2011)
TBA
Potent CXCR4 antagonists containing amidine type Peptide bond isosteres.
ACS Med Chem Lett 2: 477-480 (2011)
TBA
Disubstituted Bis-THF Moieties as New P2 Ligands in Nonpeptidal HIV-1 Protease Inhibitors.
ACS Med Chem Lett 2: 461-5 (2011)
University Of Southampton
The impact of ionization States of matrix metalloproteinase inhibitors on docking-based inhibitor design.
ACS Med Chem Lett 2: 455-460 (2011)
TBA
Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist.
ACS Med Chem Lett 2: 450-454 (2011)
TBA
Bisdionin C-a rationally designed, submicromolar inhibitor of family 18 chitinases.
ACS Med Chem Lett 2: 428-432 (2011)
TBA
Discovery of substituted biphenyl oxazolidinone inhibitors of cholesteryl ester transfer protein.
ACS Med Chem Lett 2: 424-427 (2011)
TBA
Discovery of PF-04620110, a Potent, Selective, and Orally Bioavailable Inhibitor of DGAT-1.
ACS Med Chem Lett 2: 407-412 (2011)
TBA
Discovery of s-nitrosoglutathione reductase inhibitors: potential agents for the treatment of asthma and other inflammatory diseases.
ACS Med Chem Lett 2: 402-406 (2011)
TBA
Discovery of CS-0777: A Potent, Selective, and Orally Active S1P1 Agonist.
ACS Med Chem Lett 2: 368-372 (2011)
TBA
Indomethacin Analogues that Enhance Doxorubicin Cytotoxicity in Multidrug Resistant Cells without Cox Inhibitory Activity.
ACS Med Chem Lett 2: 353-357 (2011)
TBA
Pyrazolopyridine Inhibitors of B-Raf(V600E). Part 1: The Development of Selective, Orally Bioavailable, and Efficacious Inhibitors.
ACS Med Chem Lett 2: 342-7 (2011)
Array Biopharma
Discovery of AMG 853, a CRTH2 and DP Dual Antagonist.
ACS Med Chem Lett 2: 326-330 (2011)
TBA
Structure Guided Development of Potent Reversibly Binding Penicillin Binding Protein Inhibitors
ACS Med Chem Lett 2: 219-223 (2011)
TBA
Hybrid Dual Aromatase-Steroid Sulfatase Inhibitors with Exquisite Picomolar Inhibitory Activity
ACS Med Chem Lett 2: 243-247 (2011)
TBA
Discovery of a Potent and Short−Acting Oral Calcilytic with a Pulsatile Secretion of Parathyroid Hormone
ACS Med Chem Lett 2: 238-242 (2011)
TBA
Discovery of LAS101057: A Potent, Selective, and Orally Efficacious A2B Adenosine Receptor Antagonist
ACS Med Chem Lett 2: 213-218 (2011)
TBA
Synthesis and SAR of Thiazolylmethylphenyl Glucoside as Novel C-Aryl Glucoside SGLT2 Inhibitors
ACS Med Chem Lett 2: 182-187 (2011)
TBA
Sulfonate-Containing Thiiranes as Selective Gelatinase Inhibitors
ACS Med Chem Lett 2: 177-181 (2011)
TBA
Discovery of a Potent Nicotinic Acid Receptor Agonist for the Treatment of Dyslipidemia
ACS Med Chem Lett 2: 171-176 (2011)
TBA
Novel 3-Aryl Indoles as Progesterone Receptor Antagonists for Uterine Fibroids
ACS Med Chem Lett 2: 148-153 (2011)
TBA
Discovery of novel cyanamide-based inhibitors of cathepsin C.
ACS Med Chem Lett 2: 142-147 (2011)
TBA
TSPO 18 kDa (PBR) Targeted Photosensitizers for Cancer Imaging (PET) and PDT.
ACS Med Chem Lett 2: 136-141 (2011)
TBA
Design, Synthesis, and Preclinical Characterization of the Selective Androgen Receptor Modulator (SARM) RAD140
ACS Med Chem Lett 2: 124-129 (2011)
TBA
Identification of Potent and Selective Glucosylceramide Synthase Inhibitors from a Library of N-Alkylated Iminosugars
ACS Med Chem Lett 2: 119-123 (2011)
TBA
Discovery of AMG 369, a Thiazolo[5,4-b]pyridine Agonist of S1P1 and S1P5
ACS Med Chem Lett 2: 107-112 (2011)
TBA
Discovery of a Potent, S1P3-Sparing Benzothiazole Agonist of Sphingosine-1-Phosphate Receptor 1 (S1P1)
ACS Med Chem Lett 2: 102-106 (2011)
TBA
Benzofuran Derivatives as Potent, Orally Active S1P1 Receptor Agonists: A Preclinical Lead Molecule for MS
ACS Med Chem Lett 2: 97-101 (2011)
TBA
Discovery of a Novel Series of CRTH2 (DP2) Receptor Antagonists Devoid of Carboxylic Acids.
ACS Med Chem Lett 2: 938-942 (2011)
TBA
Discovery of benzodiazepine sulfonamide-based bombesin receptor subtype 3 agonists and their unusual chirality.
ACS Med Chem Lett 2: 933-937 (2011)
TBA
Potent and Selective Inhibitors of Long Chain l-2-Hydroxy Acid Oxidase Reduced Blood Pressure in DOCA Salt-Treated Rats.
ACS Med Chem Lett 2: 919-923 (2011)
TBA
Discovery of INCB8761/PF-4136309, a Potent, Selective, and Orally Bioavailable CCR2 Antagonist.
ACS Med Chem Lett 2: 913-918 (2011)
TBA
Development of Polar Adenosine A2A Receptor Agonists for Inflammatory Bowel Disease: Synergism with A2B Antagonists.
ACS Med Chem Lett 2: 890-895 (2011)
TBA
Identification of a Potent and Selective Cannabinoid CB1 Receptor Antagonist from Auxarthron reticulatum.
ACS Med Chem Lett 2: 866-869 (2011)
TBA
Homology Model and Docking-Based Virtual Screening for Ligands of the s1 Receptor.
ACS Med Chem Lett 2: 834-839 (2011)
TBA
Synthesis and Evaluation of the Metabolites of AMG 221, a Clinical Candidate for the Treatment of Type 2 Diabetes.
ACS Med Chem Lett 2: 824-827 (2011)
TBA
Highly Selective and Potent Thiophenes as PI3K Inhibitors with Oral Antitumor Activity.
ACS Med Chem Lett 2: 809-813 (2011)
TBA
Mannitol Bis-phosphate Based Inhibitors of Fructose 1,6-Bisphosphate Aldolases.
ACS Med Chem Lett 2: 804-808 (2011)
TBA
Discovery of BIIB042, a Potent, Selective, and Orally Bioavailable ¿-Secretase Modulator.
ACS Med Chem Lett 2: 786-791 (2011)
TBA
Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating Cancer.
ACS Med Chem Lett 2: 774-779 (2011)
TBA
The Discovery of VX-745: A Novel and Selective p38a Kinase Inhibitor.
ACS Med Chem Lett 2: 758-763 (2011)
TBA
4-Methoxy-N-[2-(trifluoromethyl)biphenyl-4-ylcarbamoyl]nicotinamide: A Potent and Selective Agonist of S1P1.
ACS Med Chem Lett 2: 752-757 (2011)
TBA
Discovery of VTP-27999, an Alkyl Amine Renin Inhibitor with Potential for Clinical Utility.
ACS Med Chem Lett 2: 747-751 (2011)
TBA
3D Pharmacophore Model-Assisted Discovery of Novel CDC7 Inhibitors.
ACS Med Chem Lett 2: 720-723 (2011)
TBA
Development of Selective LH Receptor Agonists by Heterodimerization with a FSH Receptor Antagonist
ACS Med Chem Lett 2: 85-89 (2011)
TBA
Benzimidazoles as Potent and Orally Active mGlu5 Receptor Antagonists with an Improved PK Profile
ACS Med Chem Lett 2: 58-62 (2011)
TBA
Activation of Neuropeptide FF Receptors by Kisspeptin Receptor Ligands.
ACS Med Chem Lett 2: 53-57 (2011)
TBA
Discovery of MK-5046, a Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of Obesity
ACS Med Chem Lett 2: 43-47 (2011)
TBA
Synthesis and in Vitro and in Vivo Evaluation of Phosphoinositide-3-kinase Inhibitors
ACS Med Chem Lett 2: 34-38 (2011)
TBA
Kinase Inhibition by Deoxy Analogues of the Resorcylic Lactone L-783277
ACS Med Chem Lett 2: 22-27 (2011)
TBA
Novel Cyclic Phosphinic Acids as GABAC ρ Receptor Antagonists: Design, Synthesis, and Pharmacology
ACS Med Chem Lett 2: 11-16 (2011)
TBA
First Selective CYP11B1 Inhibitors for the Treatment of Cortisol-Dependent Diseases
ACS Med Chem Lett 2: 2-6 (2011)
TBA
Facile synthesis of a fluorescent cyclosporin a analogue to study cyclophilin 40 and cyclophilin 18 ligands.
ACS Med Chem Lett 1: 536-539 (2010)
TBA
Design, Synthesis, and in Vitro Evaluation of Novel Aminomethyl-pyridines as DPP-4 Inhibitors.
ACS Med Chem Lett 1: 530-535 (2010)
TBA
Benzimidazole-2-pyrazole HIF Prolyl 4-Hydroxylase Inhibitors as Oral Erythropoietin Secretagogues.
ACS Med Chem Lett 1: 526-529 (2010)
TBA
Modification at the Lipophilic Domain of RXR Agonists Differentially Influences Activation of RXR Heterodimers.
ACS Med Chem Lett 1: 521-525 (2010)
TBA
Discovery of an Orally Efficacious Imidazo[5,1-f][1,2,4]triazine Dual Inhibitor of IGF-1R and IR.
ACS Med Chem Lett 1: 510-515 (2010)
TBA
Short-acting T-type calcium channel antagonists significantly modify sleep architecture in rodents.
ACS Med Chem Lett 1: 504-509 (2010)
TBA
Discovery of a potent inhibitor of anaplastic lymphoma kinase with in vivo antitumor activity.
ACS Med Chem Lett 1: 493-498 (2010)
TBA
Discovery of Dual VEGFR-2 and Tubulin Inhibitors with in Vivo Efficacy.
ACS Med Chem Lett 1: 488-492 (2010)
TBA
Discovery of INCB9471, a Potent, Selective, and Orally Bioavailable CCR5 Antagonist with Potent Anti-HIV-1 Activity.
ACS Med Chem Lett 1: 483-487 (2010)
TBA
Discovery of omecamtiv mecarbil the first, selective, small molecule activator of cardiac Myosin.
ACS Med Chem Lett 1: 472-477 (2010)
TBA
Identification of Niclosamide as a New Small-Molecule Inhibitor of the STAT3 Signaling Pathway.
ACS Med Chem Lett 1: 454-459 (2010)
TBA
Aminoindazole PDK1 Inhibitors: A Case Study in Fragment-Based Drug Discovery.
ACS Med Chem Lett 1: 439-442 (2010)
TBA
Exploring a7-Nicotinic Receptor Ligand Diversity by Scaffold Enumeration from the Chemical Universe Database GDB.
ACS Med Chem Lett 1: 422-426 (2010)
TBA
From taxuspine x to structurally simplified taxanes with remarkable p-glycoprotein inhibitory activity.
ACS Med Chem Lett 1: 416-421 (2010)
TBA
Antiproliferative and differentiating activities of a novel series of histone deacetylase inhibitors.
ACS Med Chem Lett 1: 411-5 (2010)
Menarini Ricerche
Identification of a New Series of STAT3 Inhibitors by Virtual Screening.
ACS Med Chem Lett 1: 371-375 (2010)
TBA
Identification of an Orally Bioavailable, Potent, and Selective Inhibitor of GlyT1.
ACS Med Chem Lett 1: 350-354 (2010)
TBA
Structure-Activity Study of Dihydrocinnamic Acids and Discovery of the Potent FFA1 (GPR40) Agonist TUG-469.
ACS Med Chem Lett 1: 345-349 (2010)
TBA
Novel and Potent 5-Piperazinyl Methyl-N 1-aryl Sulfonyl Indole Derivatives as 5-HT6 Receptor Ligands.
ACS Med Chem Lett 1: 340-344 (2010)
TBA
Novel 3-Oxazolidinedione-6-aryl-pyridinones as Potent, Selective, and Orally Active EP3 Receptor Antagonists.
ACS Med Chem Lett 1: 316-320 (2010)
TBA
Discovery of TAK-875: A Potent, Selective, and Orally Bioavailable GPR40 Agonist.
ACS Med Chem Lett 1: 290-294 (2010)
TBA
Synthesis and Biochemical Testing of 3-(Carboxyphenylethyl)imidazo[2,1-f][1,2,4]triazines as Inhibitors of AMP Deaminase.
ACS Med Chem Lett 1: 286-289 (2010)
TBA
Quinolizidinone carboxylic acids as CNS penetrant, selective m1 allosteric muscarinic receptor modulators.
ACS Med Chem Lett 1: 263-267 (2010)
TBA
Synthesis and Biological Evaluation of Muraymycin Analogues Active against Anti-Drug-Resistant Bacteria.
ACS Med Chem Lett 1: 258-262 (2010)
TBA
Development of Fluorescent Ligands for the Human 5-HT1A Receptor.
ACS Med Chem Lett 1: 249-253 (2010)
TBA
Novel N-Substituted Benzimidazolones as Potent, Selective, CNS-Penetrant, and Orally Active M1 mAChR Agonists.
ACS Med Chem Lett 1: 244-248 (2010)
TBA
Novel pyridyl- or isoquinolinyl-substituted indolines and indoles as potent and selective aldosterone synthase inhibitors.
J Med Chem 57: 5179-89 (2014)
Saarland University
Discovery of novel 2-[2-(3-hydroxy-pyridin-2-yl)-thiazol-4-yl]-acetamide derivatives as HIF prolyl 4-hydroxylase inhibitors; SAR, synthesis and modeling evaluation.
Bioorg Med Chem Lett 24: 3142-5 (2014)
Sungkyunkwan University
Development of synthetic lethality anticancer therapeutics.
J Med Chem 57: 7859-73 (2014)
The University Of Texas M.D. Anderson Cancer Center
Two amino acid residues confer different binding affinities of Abelson family kinase SRC homology 2 domains for phosphorylated cortactin.
J Biol Chem 289: 19704-13 (2014)
Yale University
Catechol-rhodanine derivatives: Specific and promiscuous inhibitors of Escherichia coli deoxyxylulose phosphate reductoisomerase (DXR).
Bioorg Med Chem 22: 3713-9 (2014)
University Of Strasburg
The design and discovery of water soluble 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as multitargeted receptor tyrosine kinase inhibitors and microtubule targeting antitumor agents.
Bioorg Med Chem 22: 3753-72 (2014)
Duquesne University
Thiazolidine-2,4-diones derivatives as PPAR-¿ agonists: synthesis, molecular docking, in vitro and in vivo antidiabetic activity with hepatotoxicity risk evaluation and effect on PPAR-¿ gene expression.
Bioorg Med Chem Lett 24: 3034-42 (2014)
Jamia Hamdard (Hamdard University)
Identification of 1, 4-Dihydrothieno [3', 2':5, 6]thiopyrano[4, 3-c] pyrazole derivatives as human 5-Lipo-oxygenase inhibitors.
Chem Biol Drug Des 84: 642-7 (2014)
Peking University
Structure guided design and kinetic analysis of highly potent benzimidazole inhibitors targeting the PDEd prenyl binding site.
J Med Chem 57: 5435-48 (2014)
Max Planck Institute Of Molecular Physiology
Discovery, optimization, and biological evaluation of 5-(2-(trifluoromethyl)phenyl)indazoles as a novel class of transient receptor potential A1 (TRPA1) antagonists.
J Med Chem 57: 5129-40 (2014)
Genomics Institute Of The Novartis Research Foundation
Discovery of the first potent and orally available agonist of the orphan G-protein-coupled receptor 52.
J Med Chem 57: 5226-37 (2014)
Takeda Pharmaceutical
Synthesis and evaluation of novel cyclic Peptide inhibitors of lysine-specific demethylase 1.
ACS Med Chem Lett 5: 29-33 (2014)
Medical University Of South Carolina
Novel 3-arylfuran-2(5H)-one-fluoroquinolone hybrid: design, synthesis and evaluation as antibacterial agent.
Bioorg Med Chem 22: 3620-8 (2014)
Jishou University
Design, synthesis and biological evaluation of novel 6,7-disubstituted-4-phenoxyquinoline derivatives bearing 4-oxo-3,4-dihydrophthalazine-1-carboxamide moieties as c-Met kinase inhibitors.
Bioorg Med Chem 22: 3642-53 (2014)
Shenyang Pharmaceutical University
Towards the next generation of dual Bcl-2/Bcl-xL inhibitors.
Bioorg Med Chem Lett 24: 3026-33 (2014)
Astrazeneca
Identification of diarylsulfonamides as agonists of the free fatty acid receptor 4 (FFA4/GPR120).
Bioorg Med Chem Lett 24: 3100-3 (2014)
Glaxosmithkline
Design, synthesis and evaluation of phenethylaminoheterocycles as K(v)1.5 inhibitors.
Bioorg Med Chem Lett 24: 3018-22 (2014)
Bristol-Myers Squibb Research And Development
Discovery of a series of aryl-N-(3-(alkylamino)-5-(trifluoromethyl)phenyl)benzamides as TRPA1 antagonists.
Bioorg Med Chem Lett 24: 3204-6 (2014)
Astrazeneca
Structure-activity relationship and interaction studies of new SIRT1 inhibitors with the scaffold of 3-(furan-2-yl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole.
Bioorg Med Chem Lett 24: 3050-6 (2014)
Chinese Academy Of Sciences
Novel synthesis of dihydropyrimidines for a-glucosidase inhibition to treat type 2 diabetes: in vitro biological evaluation and in silico docking.
Bioorg Chem 54: 96-104 (2014)
Comsats Institute Of Information Technology
Inhibition of Enterococcus faecalis biofilm formation by highly active lactones and lactams analogues of rubrolides.
Eur J Med Chem 82: 127-38 (2014)
Federal University Of Vi£Osa
Thiosemicarbazide, a fragment with promising indolamine-2,3-dioxygenase (IDO) inhibition properties.
Eur J Med Chem 82: 96-105 (2014)
University Of Namur (Unamur)
Carbonic anhydrase inhibitors: Synthesis, molecular docking, cytotoxic and inhibition of the human carbonic anhydrase isoforms I, II, IX, XII with novel benzenesulfonamides incorporating pyrrole, pyrrolopyrimidine and fused pyrrolopyrimidine moieties.
Bioorg Med Chem 22: 3684-95 (2014)
King Saud University
Novel aza-analogous ergoline derived scaffolds as potent serotonin 5-HT6 and dopamine D2 receptor ligands.
J Med Chem 57: 5823-8 (2014)
University Of Copenhagen
Multiparameter optimization in CNS drug discovery: design of pyrimido[4,5-d]azepines as potent 5-hydroxytryptamine 2C (5-HT2C) receptor agonists with exquisite functional selectivity over 5-HT2A and 5-HT2B receptors.
J Med Chem 57: 5258-69 (2014)
Pfizer
Naturally occurring polyphenolic inhibitors of amyloid beta aggregation.
Bioorg Med Chem Lett 24: 3108-12 (2014)
Csiro Manufacturing Flagship (Biomedical)
Design, synthesis and biological evaluation of benzyl 2-(1H-imidazole-1-yl) pyrimidine analogues as selective and potent Raf inhibitors.
Bioorg Med Chem Lett 24: 3600-4 (2014)
Hanyang University
Lead optimization of 1,4-azaindoles as antimycobacterial agents.
J Med Chem 57: 5728-37 (2014)
Astrazeneca
New, potent, and selective peptidic oxytocin receptor agonists.
J Med Chem 57: 5306-17 (2014)
Ferring Research Institute
Design, synthesis, and structure-activity relationship studies of novel thioether pleuromutilin derivatives as potent antibacterial agents.
J Med Chem 57: 4772-95 (2014)
Chinese Academy Of Sciences
Structure of REV-ERBß ligand-binding domain bound to a porphyrin antagonist.
J Biol Chem 289: 20054-66 (2014)
The Scripps Research Institute
Carbonic anhydrase inhibitors. Synthesis of a novel series of 5-substituted 2,4-dichlorobenzenesulfonamides and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
Eur J Med Chem 82: 47-55 (2014)
Medical University Of Gdansk
Synthesis and structure-activity relationship studies in serotonin 5-HT4 receptor ligands based on a benzo[de][2,6]naphthridine scaffold.
Eur J Med Chem 82: 36-46 (2014)
Universit£
Further studies on ethyl 5-hydroxy-indole-3-carboxylate scaffold: design, synthesis and evaluation of 2-phenylthiomethyl-indole derivatives as efficient inhibitors of human 5-lipoxygenase.
Eur J Med Chem 81: 492-8 (2014)
University Of Naples
4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity.
J Med Chem 57: 5419-34 (2014)
Astrazeneca
Lead optimization of a novel series of imidazo[1,2-a]pyridine amides leading to a clinical candidate (Q203) as a multi- and extensively-drug-resistant anti-tuberculosis agent.
J Med Chem 57: 5293-305 (2014)
Institut Pasteur Korea
The discovery of Polo-like kinase 4 inhibitors: design and optimization of spiro[cyclopropane-1,3'[3H]indol]-2'(1'H).ones as orally bioavailable antitumor agents.
J Med Chem 58: 130-46 (2015)
Entremed
Dithiaarsanes induce oxidative stress-mediated apoptosis in HL-60 cells by selectively targeting thioredoxin reductase.
J Med Chem 57: 5203-11 (2014)
Lanzhou University
Synthesis and evaluation of (E)-2-(acrylamido)cyclohex-1-enecarboxylic acid derivatives as HCA1, HCA2, and HCA3 receptor agonists.
Bioorg Med Chem 22: 3654-69 (2014)
Latvian Institute Of Organic Synthesis
Design and synthesis of novel and highly-active pan-histone deacetylase (pan-HDAC) inhibitors.
Bioorg Med Chem 22: 3720-31 (2014)
Nippon Pharmaceutical Chemicals
4-Benzofuranyloxynicotinamide derivatives are novel potent and orally available TGR5 agonists.
Eur J Med Chem 82: 1-15 (2014)
Chinese Academy Of Sciences
DDD-028: a potent potential non-opioid, non-cannabinoid analgesic for neuropathic and inflammatory pain.
Bioorg Med Chem Lett 24: 3088-91 (2014)
University Of Missouri
Structure of the Acinetobacter baumannii dithiol oxidase DsbA bound to elongation factor EF-Tu reveals a novel protein interaction site.
J Biol Chem 289: 19869-80 (2014)
University Of Queensland
Aromatic diacylhydrazine derivatives as a new class of polo-like kinase 1 (PLK1) inhibitors.
Eur J Med Chem 81: 420-6 (2014)
Nanjing University
Guanidinium-based derivatives: searching for new kinase inhibitors.
Eur J Med Chem 81: 427-41 (2014)
Trinity College
Dibenzo[1,4,5]thiadiazepine: a hardly-known heterocyclic system with neuroprotective properties of potential usefulness in the treatment of neurodegenerative diseases.
Eur J Med Chem 81: 350-8 (2014)
Instituto De Qu£Mica M£Dica
Design, synthesis and biological evaluation of hydroxy- or methoxy-substituted 5-benzylidene(thio) barbiturates as novel tyrosinase inhibitors.
Bioorg Med Chem 22: 3279-84 (2014)
China National Analytical Center (Guangzhou)
Identification of 1-({[1-(4-fluorophenyl)-5-(2-methoxyphenyl)-1H-pyrazol-3-yl]carbonyl}amino)cyclohexane carboxylic acid as a selective nonpeptide neurotensin receptor type 2 compound.
J Med Chem 57: 5318-32 (2014)
Research Triangle Institute
Synthesis and pharmacological evaluation of analogues of benzyl quinolone carboxylic acid (BQCA) designed to bind irreversibly to an allosteric site of the M1 muscarinic acetylcholine receptor.
J Med Chem 57: 5405-18 (2014)
Monash University (Parkville Campus)
New coumarin derivatives: design, synthesis and use as inhibitors of hMAO.
Bioorg Med Chem 22: 3732-8 (2014)
Anhui Medical University
Synthesis and biological evaluation of substituted 3-anilino-quinolin-2(1H)-ones as PDK1 inhibitors.
Bioorg Med Chem 22: 3781-90 (2014)
La Trobe University
Inhibition by active site directed covalent modification of human glyoxalase I.
Bioorg Med Chem 22: 3301-8 (2014)
University Of Maryland
Oxidation of cyanobenzocycloheptatrienes: Synthesis, photooxygenation reaction and carbonic anhydrase isoenzymes inhibition properties of some new benzotropone derivatives.
Bioorg Med Chem 22: 3537-43 (2014)
Agriibrahim£E£En University
Ultrapure ajulemic acid has improved CB2 selectivity with reduced CB1 activity.
Bioorg Med Chem 22: 3245-51 (2014)
Corbus Pharmaceuticals
Combination of cyclohexane and piperazine based¿-opioid receptor agonists: Synthesis and pharmacological evaluation of trans,trans-configured perhydroquinoxalines.
Bioorg Med Chem 22: 3316-24 (2014)
Institut F£R Pharmazeutische Und Medizinische Chemie Der Universit£T M£Nster
Pharmacophore based virtual screening, molecular docking and biological evaluation to identify novel PDE5 inhibitors with vasodilatory activity.
Bioorg Med Chem Lett 24: 3137-41 (2014)
Banasthali University
Discovery of N-substituted 7-azaindoline derivatives as potent, orally available M1 and M4 muscarinic acetylcholine receptors selective agonists.
Bioorg Med Chem Lett 24: 3189-93 (2014)
Dainippon Sumitomo Pharma
Targeting the homologous recombination pathway by small molecule modulators.
Bioorg Med Chem Lett 24: 3006-13 (2014)
Drexel University College Of Medicine
trans-Caryophyllene is a natural agonistic ligand for peroxisome proliferator-activated receptor-a.
Bioorg Med Chem Lett 24: 3168-74 (2014)
Korea University
Protein-ligand interactions: probing the energetics of a putative cation-? interaction.
Bioorg Med Chem Lett 24: 3164-7 (2014)
The University Of Texas
Identification and characterization of a new reversible MAGL inhibitor.
Bioorg Med Chem 22: 3285-91 (2014)
University Of Pisa
Amino derivatives of glycyrrhetinic acid as potential inhibitors of cholinesterases.
Bioorg Med Chem 22: 3370-8 (2014)
Martin-Luther-Universit£T Halle-Wittenberg
Design, synthesis and in vitro and in vivo antitumour activity of 3-benzylideneindolin-2-one derivatives, a novel class of small-molecule inhibitors of the MDM2-p53 interaction.
Eur J Med Chem 81: 277-88 (2014)
Chinese Academy Of Medical Science And Peking Union Medical College
Discovery of N-sulfonyl-7-azaindoline derivatives as potent, orally available and selective M(4) muscarinic acetylcholine receptor agonists.
Bioorg Med Chem Lett 24: 2909-12 (2014)
Dainippon Sumitomo Pharma
Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer's disease.
J Med Chem 57: 7160-81 (2014)
Universidad Complutense De Madrid
Tranylcypromine substituted cis-hydroxycyclobutylnaphthamides as potent and selective dopamine D3 receptor antagonists.
J Med Chem 57: 4962-8 (2014)
University Of Michigan
A fragment-based approach to identifying S-adenosyl-l-methionine -competitive inhibitors of catechol O-methyl transferase (COMT).
J Med Chem 57: 5459-63 (2014)
Takeda California
Design, synthesis, and structure-activity relationships of pyridoquinazolinecarboxamides as RNA polymerase I inhibitors.
J Med Chem 57: 4950-61 (2014)
Johns Hopkins University School Of Medicine
Opioid receptor function is regulated by post-endocytic peptide processing.
J Biol Chem 289: 19613-26 (2014)
Icahn School Of Medicine At Mount Sinai
Highly potent and selective ectonucleotide pyrophosphatase/phosphodiesterase I inhibitors based on an adenosine 5'-(a or¿)-thio-(a,ß- orß,¿)-methylenetriphosphate scaffold.
J Med Chem 57: 4677-91 (2014)
Bar-Ilan University
Synthesis and biological comparison of enantiomers of mepenzolate bromide, a muscarinic receptor antagonist with bronchodilatory and anti-inflammatory activities.
Bioorg Med Chem 22: 3488-97 (2014)
Keio University
Synthesis andß-glucuronidase inhibitory activity of 2-arylquinazolin-4(3H)-ones.
Bioorg Med Chem 22: 3449-54 (2014)
University Of Karachi
Tetra- and pentacyclic triterpene acids from the ancient anti-inflammatory remedy frankincense as inhibitors of microsomal prostaglandin E(2) synthase-1.
J Nat Prod 77: 1445-51 (2014)
University Of Tuebingen
Synthesis and pharmacological characterization of new neuronal nicotinic acetylcholine receptor ligands derived from Sazetidine-A.
Bioorg Med Chem Lett 24: 2954-6 (2014)
Georgetown University Medical Center
Tryptophan hydroxylase 1 (Tph-1)-targeted bone anabolic agents for osteoporosis.
J Med Chem 57: 4692-709 (2014)
Nanjing University
The design and synthesis of novel SGLT2 inhibitors: C-glycosides with benzyltriazolopyridinone and phenylhydantoin as the aglycone moieties.
Bioorg Med Chem 22: 3414-22 (2014)
Amri
Ingol-type diterpenes from Euphorbia antiquorum with mouse 11ß-hydroxysteroid dehydrogenase type 1 inhibition activity.
J Nat Prod 77: 1452-8 (2014)
Lanzhou University
In Vitro Membrane Permeation Studies and in Vivo Antinociception of Glycosylated Dmt
ACS Med Chem Lett 5: 352-357 (2014)
Vrije Universiteit Brussel
Novel quinuclidinyl heteroarylcarbamate derivatives as muscarinic receptor antagonists.
Bioorg Med Chem 22: 3478-87 (2014)
Astellas Pharma
Novel estrogen receptor (ER) modulators containing various hydrophobic bent-core structures.
Bioorg Med Chem 22: 3508-14 (2014)
Tohoku Pharmaceutical University
Novel benzimidazole derivatives as phosphodiesterase 10A (PDE10A) inhibitors with improved metabolic stability.
Bioorg Med Chem 22: 3515-26 (2014)
Yamanouchi Pharmaceutical
Synthesis of novel 2-mercaptobenzoxazole based 1,2,3-triazoles as inhibitors of proinflammatory cytokines and suppressors of COX-2 gene expression.
Eur J Med Chem 81: 204-17 (2014)
Jamia Hamdard (Hamdard University)
Structural modifications of 4-aryl-4-oxo-2-aminylbutanamides and their acetyl- and butyrylcholinesterase inhibitory activity. Investigation of AChE-ligand interactions by docking calculations and molecular dynamics simulations.
Eur J Med Chem 81: 158-75 (2014)
Ratka Resanovica1
Tamiphosphor monoesters as effective anti-influenza agents.
Eur J Med Chem 81: 106-18 (2014)
National Taiwan University
Discovery of 3-aryl-3-ethoxypropanoic acids as orally active GPR40 agonists.
Bioorg Med Chem Lett 24: 2949-53 (2014)
Daiichi Sankyo
Structure-assisted discovery of the first non-retinoid ligands for Retinol-Binding Protein 4.
Bioorg Med Chem Lett 24: 2885-91 (2014)
Amgen
Optimization of ketone-based P2Y(12) receptor antagonists as antithrombotic agents: pharmacodynamics and receptor kinetics considerations.
Bioorg Med Chem Lett 24: 2963-8 (2014)
Astrazeneca
Discovery of TD-4306, a long-actingß2-agonist for the treatment of asthma and COPD.
Bioorg Med Chem Lett 24: 2871-6 (2014)
Theravance
Preparation, anticholinesterase activity and molecular docking of new lupane derivatives.
Bioorg Med Chem 22: 3341-50 (2014)
Universidad Nacional Del Sur
Discovery of a 4-aryloxy-1H-pyrrolo[3,2-c]pyridine and a 1-aryloxyisoquinoline series of TRPA1 antagonists.
Bioorg Med Chem Lett 24: 3199-203 (2014)
Astrazeneca
Design and synthesis of quinolinopropellane derivatives with selectived opioid receptor agonism.
Bioorg Med Chem Lett 24: 2851-4 (2014)
University Of Tsukuba
Design and synthesis of phenylisoxazole derivatives as novel human acrosin inhibitors.
Bioorg Med Chem Lett 24: 2802-6 (2014)
Second Military Medical University
ß-Secretase (BACE1)-inhibiting C-methylrotenoids from Abronia nana suspension cultures.
Bioorg Med Chem Lett 24: 2945-8 (2014)
Kyungpook National University
Small molecule inhibitors targeting activator protein 1 (AP-1).
J Med Chem 57: 6930-48 (2014)
University Of Texas Medical Branch
Functionally selective dopamine D2, D3 receptor partial agonists.
J Med Chem 57: 4861-75 (2014)
Friedrich-Alexander University
From chemical tools to clinical medicines: nonimmunosuppressive cyclophilin inhibitors derived from the cyclosporin and sanglifehrin scaffolds.
J Med Chem 57: 7145-59 (2014)
Novartis Institutes For Biomedical Research
Functionalization of ß-Caryophyllene Generates Novel Polypharmacology in the Endocannabinoid System.
ACS Chem Biol 9: 1499-507 (2014)
University Of Bern
ORA1, a zebrafish olfactory receptor ancestral to all mammalian V1R genes, recognizes 4-hydroxyphenylacetic acid, a putative reproductive pheromone.
J Biol Chem 289: 19778-88 (2014)
German Institute Of Human Nutrition Potsdam-Rehbruecke
Bazedoxifene-scaffold-based mimetics of solomonsterols A and B as novel pregnane X receptor antagonists.
J Med Chem 57: 4819-33 (2014)
University Of Ljubljana
Synthesis of rigidified eIF4E/eIF4G inhibitor-1 (4EGI-1) mimetic and their in vitro characterization as inhibitors of protein-protein interaction.
J Med Chem 57: 5094-111 (2014)
Harvard Medical School
Structure-activity relationships of privileged structures lead to the discovery of novel biased ligands at the dopamine D2 receptor.
J Med Chem 57: 4924-39 (2014)
Monash University
Solving time-dependent CYP3A4 inhibition for a series of indole-phenylacetic acid dual antagonists of the PGD(2) receptors CRTH2 and DP.
Bioorg Med Chem Lett 24: 2877-80 (2014)
Amgen
Identification of Inhibitors of PvdQ, an Enzyme Involved in the Synthesis of the Siderophore Pyoverdine.
ACS Chem Biol 9: 1536-44 (2014)
The Broad Institute , Cambridge, Massachusetts 02142, United States
Structure-activity relationship studies of N-methylated and N-hydroxylated spider polyamine toxins as inhibitors of ionotropic glutamate receptors.
J Med Chem 57: 4940-9 (2014)
University Of Copenhagen
Discovery of 1-aryloxyethyl piperazine derivatives as Kv1.5 potassium channel inhibitors (part I).
Eur J Med Chem 81: 89-94 (2014)
China Pharmaceutical University
Synthesis and structure-activity relationship studies of conformationally flexible tetrahydroisoquinolinyl triazole carboxamide and triazole substituted benzamide analogues ass2 receptor ligands.
J Med Chem 57: 4239-51 (2014)
Washington University
Farnesyltransferase inhibitors: CAAX mimetics based on different biaryl scaffolds.
Bioorg Med Chem Lett 24: 2924-7 (2014)
Universit£
The dipeptide H-Trp-Glu-OH (WE) shows agonistic activity to peroxisome proliferator-activated protein-a and reduces hepatic lipid accumulation in lipid-loaded H4IIE cells.
Bioorg Med Chem Lett 24: 2957-62 (2014)
Korea University
Identification of a neuroprotective and selective butyrylcholinesterase inhibitor derived from the natural alkaloid evodiamine.
Eur J Med Chem 81: 15-21 (2014)
University Of W£Rzburg
Structure-activity relationships and molecular modelling of new 5-arylidene-4-thiazolidinone derivatives as aldose reductase inhibitors and potential anti-inflammatory agents.
Eur J Med Chem 81: 1-14 (2014)
University Of Messina
Discovery of (10R)-7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a macrocyclic inhibitor of anaplastic lymphoma kinase (ALK) and c-ros oncogene 1 (ROS1) with preclinical brain expo
J Med Chem 57: 4720-44 (2014)
Pfizer
Structural insights into the molecular mechanism of vitamin D receptor activation by lithocholic acid involving a new mode of ligand recognition.
J Med Chem 57: 4710-9 (2014)
Institute Of Genetics And Molecular And Cellular Biology (Igbmc)
Synthesis, biological evaluation and molecular docking studies of trans-indole-3-acrylamide derivatives, a new class of tubulin polymerization inhibitors.
Bioorg Med Chem 22: 3096-104 (2014)
Gazi University
Synthesis of 2'-O,4'-C-alkylene-bridged ribonucleosides and their evaluation as inhibitors of HCV NS5B polymerase.
Bioorg Med Chem Lett 24: 2699-702 (2014)
Idenix Pharmaceuticals
Discovery of camphor-derived pyrazolones as 11ß-hydroxysteroid dehydrogenase type 1 inhibitors.
Bioorg Med Chem Lett 24: 2707-11 (2014)
Hoffmann-La Roche
Synthesis of isoquinolinone-based tricycles as novel poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors.
Bioorg Med Chem Lett 24: 2669-73 (2014)
Chinese Academy Of Sciences
8-Substituted 2-alkynyl-N(9)-propargyladenines as A2A adenosine receptor antagonists.
Bioorg Med Chem 22: 3072-82 (2014)
Yamasa
Development of a new class of proteasome inhibitors with an epoxyketone warhead: Rational hybridization of non-peptidic belactosin derivatives and peptide epoxyketones.
Bioorg Med Chem 22: 3091-5 (2014)
Hokkaido University
Discovery of novel 2-((pyridin-3-yloxy)methyl)piperazines asa7 nicotinic acetylcholine receptor modulators for the treatment of inflammatory disorders.
J Med Chem 57: 3966-83 (2014)
Critical Therapeutics
Donepezil + propargylamine + 8-hydroxyquinoline hybrids as new multifunctional metal-chelators, ChE and MAO inhibitors for the potential treatment of Alzheimer's disease.
Eur J Med Chem 80: 543-61 (2014)
Okayama University
Dual carbonic anhydrase/matrix metalloproteinase inhibitors incorporating bisphosphonic acid moieties targeting bone tumors.
Bioorg Med Chem Lett 24: 2617-20 (2014)
Universit£
Multivalent design of long-actingß(2)-adrenoceptor agonists incorporating biarylamines.
Bioorg Med Chem Lett 24: 2625-30 (2014)
Theravance
Discovery of 5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine inhibitors of Erk2.
Bioorg Med Chem Lett 24: 2635-9 (2014)
Array Biopharma
Discovery of 1-arylpyrrolidone derivatives as potent p53-MDM2 inhibitors based on molecule fusing strategy.
Bioorg Med Chem Lett 24: 2648-50 (2014)
Second Military Medical University
Adenosine analogue inhibitors of S-adenosylhomocysteine hydrolase.
Bioorg Med Chem Lett 24: 2737-40 (2014)
Merck Research Laboratories
Discovery of thienopyrimidine-based FLT3 inhibitors from the structural modification of known IKKß inhibitors.
Bioorg Med Chem Lett 24: 2655-60 (2014)
Yonsei University
Biased and unbiased strategies to identify biologically active small molecules.
Bioorg Med Chem 22: 4474-89 (2014)
Institut De Chimie Des Substances Naturelles
Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosis.
J Med Chem 57: 4889-905 (2014)
Astrazeneca
Orally active 7-substituted (4-benzylphthalazin-1-yl)-2-methylpiperazin-1-yl]nicotinonitriles as active-site inhibitors of sphingosine 1-phosphate lyase for the treatment of multiple sclerosis.
J Med Chem 57: 5074-84 (2014)
Novartis Institutes For Biomedical Research
Establishment of a structure-activity relationship of 1H-imidazo[4,5-c]quinoline-based kinase inhibitor NVP-BEZ235 as a lead for African sleeping sickness.
J Med Chem 57: 4834-48 (2014)
Northeastern University
Influence of the length and positioning of the antiestrogenic side chain of endoxifen and 4-hydroxytamoxifen on gene activation and growth of estrogen receptor positive cancer cells.
J Med Chem 57: 4569-83 (2014)
Georgetown University
Novel arylsulfonamide derivatives with 5-HT6/5-HT7 receptor antagonism targeting behavioral and psychological symptoms of dementia.
J Med Chem 57: 4543-57 (2014)
Adamed
Concise synthesis of C-1-cyano-iminosugars via a new Staudinger/aza Wittig/Strecker multicomponent reaction strategy.
Bioorg Med Chem Lett 24: 2777-80 (2014)
Technical University Graz
Arylazopyrazole AAP1742 inhibits CDKs and induces apoptosis in multiple myeloma cells via Mcl-1 downregulation.
Chem Biol Drug Des 84: 402-8 (2014)
Institute Of Experimental Botany Ascr And Palacky University
Fluorine modulates species selectivity in the triazolopyrimidine class of Plasmodium falciparum dihydroorotate dehydrogenase inhibitors.
J Med Chem 57: 5381-94 (2014)
University Of Texas At Dallas
Discovery of biarylaminoquinazolines as novel tubulin polymerization inhibitors.
J Med Chem 57: 4598-605 (2014)
Universit£
Methyl substitution of a rexinoid agonist improves potency and reveals site of lipid toxicity.
J Med Chem 57: 5370-80 (2014)
University Of Alabama At Birmingham
Design, synthesis, and biological evaluation of O-2-modified indenoisoquinolines as dual topoisomerase I-tyrosyl-DNA phosphodiesterase I inhibitors.
J Med Chem 57: 4324-36 (2014)
Purdue University
Identification of a new selective dopamine D4 receptor ligand.
Bioorg Med Chem 22: 3105-14 (2014)
Florida A&M University
Development of novel Vitamin D Receptor-Coactivator Inhibitors.
ACS Med Chem Lett 5: 199-204 (2014)
University Of Wisconsin-Milwaukee
Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.
Hepatology 60: 1015-22 (2014)
Pfizer
Human UTY(KDM6C) is a male-specific N¿-methyl lysyl demethylase.
J Biol Chem 289: 18302-13 (2014)
University Of Oxford
Acridone alkaloids from Glycosmis chlorosperma as DYRK1A inhibitors.
J Nat Prod 77: 1117-22 (2014)
Institut De Chimie Des Substances Naturelles
Synthesis and evaluation of novel marine bromopyrrole alkaloid-based derivatives as potential antidepressant agents.
Chem Biol Drug Des 84: 593-602 (2014)
University Of Kwazulu-Natal
Structural and biochemical analyses of the catalysis and potency impact of inhibitor phosphoribosylation by human nicotinamide phosphoribosyltransferase.
Chembiochem 15: 1121-30 (2014)
Genentech
Exploration of the dihydropyrimidine scaffold for the development of new potential anti-inflammatory agents blocking prostaglandin E2 synthase-1 enzyme (mPGES-1).
Eur J Med Chem 80: 407-15 (2014)
University Of Salerno
Novel aromatic-polyamine conjugates as cholinesterase inhibitors with notable selectivity toward butyrylcholinesterase.
Bioorg Med Chem 22: 3213-9 (2014)
Henan University
Structure-guided discovery of 1,3,5 tri-substituted benzenes as potent and selective matriptase inhibitors exhibiting in vivo antitumor efficacy.
Bioorg Med Chem 22: 3187-203 (2014)
Aurigene Discovery Technologies
Synthesis, biological, and biophysical studies of DAG-indololactones designed as selective activators of RasGRP.
Bioorg Med Chem 22: 3123-40 (2014)
National Institute Of Industrial Technology
Optimization of diaryl amine derivatives as kinesin spindle protein inhibitors.
Bioorg Med Chem 22: 3171-9 (2014)
Kyoto University
Design and discovery of flavonoid-based HIV-1 integrase inhibitors targeting both the active site and the interaction with LEDGF/p75.
Bioorg Med Chem 22: 3146-58 (2014)
South China Normal University
Synthesis and SAR of substituted pyrazolo[1,5-a]quinazolines as dual mGlu(2)/mGlu(3) NAMs.
Bioorg Med Chem Lett 24: 2693-8 (2014)
Vanderbilt University Medical Center
a-Methylated simplified resiniferatoxin (sRTX) thiourea analogues as potent and stereospecific TRPV1 antagonists.
Bioorg Med Chem Lett 24: 2685-8 (2014)
Seoul National University
Synthesis of 5-methyl phenanthridium derivatives: a new class of human DOPA decarboxylase inhibitors.
Bioorg Med Chem Lett 24: 2712-6 (2014)
Hunan Agricultural University
Benzo[d]isothiazole 1,1-dioxide derivatives as dual functional inhibitors of 5-lipoxygenase and microsomal prostaglandin E(2) synthase-1.
Bioorg Med Chem Lett 24: 2764-7 (2014)
Peking University
a-Tetralone derivatives as inhibitors of monoamine oxidase.
Bioorg Med Chem Lett 24: 2758-63 (2014)
North-West University
Serendipitous oxidation product of BIBN4096BS: a potent CGRP receptor antagonist.
Bioorg Med Chem Lett 24: 2744-8 (2014)
Bristol-Myers Squibb
Identification of 2,3-disubstituted pyridines as potent, non-emetic PDE4 inhibitors.
Bioorg Med Chem Lett 24: 2689-92 (2014)
Dainippon Sumitomo Pharma
Structure-activity relationships studies of quinoxalinone derivatives as aldose reductase inhibitors.
Eur J Med Chem 80: 383-92 (2014)
Beijing Institute Of Technology
Synthesis and structure-activity relationship of trisubstituted thiazoles as Cdc7 kinase inhibitors.
Eur J Med Chem 80: 364-82 (2014)
Amgen
New 2H-chromene-3-carboxamide derivatives: design, synthesis and use as inhibitors of hMAO.
Eur J Med Chem 80: 278-84 (2014)
Anhui Medical University
Investigation of a novel series of 2-hydroxyisoquinoline-1,3(2H,4H)-diones as human immunodeficiency virus type 1 integrase inhibitors.
J Med Chem 57: 4640-60 (2014)
University Of Lille
Sulfonamide inhibition studies of twoß-carbonic anhydrases from the bacterial pathogen Legionella pneumophila.
Bioorg Med Chem 22: 2939-46 (2014)
Kochi Medical School
Anti-inflammatory drimane sesquiterpene lactones from an Aspergillus species.
Bioorg Med Chem 22: 2912-8 (2014)
Institute Of Biotechnology And Drug Research (Ibwf)
Synthesis, biological evaluation, and molecular docking studies of novel 2-styryl-5-nitroimidazole derivatives containing 1,4-benzodioxan moiety as FAK inhibitors with anticancer activity.
Bioorg Med Chem 22: 2947-54 (2014)
Nanjing University
Discovery of novel type II c-Met inhibitors based on BMS-777607.
Eur J Med Chem 80: 254-66 (2014)
Fudan University
Griseorhodins D-F, neuroactive intermediates and end products of post-PKS tailoring modification in Griseorhodin biosynthesis.
J Nat Prod 77: 1224-30 (2014)
University Of Utah
Discovery of N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-fluoroaniline (EW-7197): a highly potent, selective, and orally bioavailable inhibitor of TGF-ß type I receptor kinase as cancer immunotherapeutic/antifibrotic agent.
J Med Chem 57: 4213-38 (2014)
Ewha Womans University
Synthesis and biological evaluation of a unique heparin mimetic hexasaccharide for structure-activity relationship studies.
J Med Chem 57: 4511-20 (2014)
Momenta Pharmaceuticals
Discovery of novel and selective SIRT6 inhibitors.
J Med Chem 57: 4796-804 (2014)
University Of Bologna
Discovery of novel 2,4-diarylaminopyrimidine analogues (DAAPalogues) showing potent inhibitory activities against both wild-type and mutant ALK kinases.
J Med Chem 58: 197-211 (2015)
Chinese Academy Of Sciences
Efficacious inhaled PDE4 inhibitors with low emetic potential and long duration of action for the treatment of COPD.
J Med Chem 57: 4661-76 (2014)
Astrazeneca
Molecular Basis of 1-Deoxygalactonojirimycin Arylthiourea Binding to Human a-Galactosidase A: Pharmacological Chaperoning Efficacy on Fabry Disease Mutants.
ACS Chem Biol 9: 1460-9 (2014)
Tottori University , Yonago 683-8503, Japan
In vitro resistance selections for Plasmodium falciparum dihydroorotate dehydrogenase inhibitors give mutants with multiple point mutations in the drug-binding site and altered growth.
J Biol Chem 289: 17980-95 (2014)
Harvard School Of Public Health
Dual inhibition of thea-glucosidase and butyrylcholinesterase studied by molecular field topology analysis.
Eur J Med Chem 80: 228-42 (2014)
University Of Florida
Synthesis and biological evaluation of some new pyrazoline substituted benzenesulfonylurea/thiourea derivatives as anti-hyperglycaemic agents and aldose reductase inhibitors.
Eur J Med Chem 80: 209-17 (2014)
Jamia Hamdard (Hamdard University)
Design and synthesis of novel 2-phenyl-5-(1,3-diphenyl-1H-pyrazol-4-yl)-1,3,4-oxadiazoles as selective COX-2 inhibitors with potent anti-inflammatory activity.
Eur J Med Chem 80: 167-74 (2014)
Shoolini University
Design, synthesis, and biological evaluation of novel FAK scaffold inhibitors targeting the FAK-VEGFR3 protein-protein interaction.
Eur J Med Chem 80: 154-66 (2014)
Roswell Park Cancer Institute
Synthesis, characterization, and PK/PD studies of a series of spirocyclic pyranochromene BACE1 inhibitors.
Bioorg Med Chem Lett 24: 2477-80 (2014)
Genentech
Shuttle-cargo fusion molecules of transport peptides and the hD2/3 receptor antagonist fallypride: a feasible approach to preserve ligand-receptor binding?
J Med Chem 57: 4368-81 (2014)
Mcgill University
Discovery of GS-9973, a selective and orally efficacious inhibitor of spleen tyrosine kinase.
J Med Chem 57: 3856-73 (2014)
Gilead Sciences
Identification of trisubstituted-pyrazol carboxamide analogs as novel and potent antagonists of farnesoid X receptor.
Bioorg Med Chem 22: 2919-38 (2014)
Beckman Research Institute
Highly-selective 4-(1,2,3-triazole)-based P450c17a 17,20-lyase inhibitors.
Bioorg Med Chem Lett 24: 2444-7 (2014)
Viamet Pharmaceuticals
P3 SAR exploration of biphenyl carbamate based Legumain inhibitors.
Bioorg Med Chem Lett 24: 2521-4 (2014)
Queen'S University Belfast
Pim kinase inhibitory and antiproliferative activity of a novel series of meridianin C derivatives.
Bioorg Med Chem Lett 24: 2424-8 (2014)
Keimyung University
Combination of triple bond and adamantane ring on the vitamin D side chain produced partial agonists for vitamin D receptor.
J Med Chem 57: 4073-87 (2014)
Rikkyo University
Discovery of 4-aryl-N-arylcarbonyl-2-aminothiazoles as Hec1/Nek2 inhibitors. Part I: optimization of in vitro potencies and pharmacokinetic properties.
J Med Chem 57: 4098-110 (2014)
Development Center For Biotechnology
Design and synthesis of human ABCB1 (P-glycoprotein) inhibitors by peptide coupling of diverse chemical scaffolds on carboxyl and amino termini of (S)-valine-derived thiazole amino acid.
J Med Chem 57: 4058-72 (2014)
St. John'S University
New indolylarylsulfones as highly potent and broad spectrum HIV-1 non-nucleoside reverse transcriptase inhibitors.
Eur J Med Chem 80: 101-11 (2014)
Sapienza University Of Rome
Bis-aryloxadiazoles as effective activators of the aryl hydrocarbon receptor.
Bioorg Med Chem Lett 24: 2473-6 (2014)
University Of Utah
Biological evaluation of tanshindiols as EZH2 histone methyltransferase inhibitors.
Bioorg Med Chem Lett 24: 2486-92 (2014)
Korea Research Institute Of Chemical Technology
Design, synthesis and biological evaluation of Pontin ATPase inhibitors through a molecular docking approach.
Bioorg Med Chem Lett 24: 2512-6 (2014)
University Of Bordeaux
Discovery of the first potent and selective Mycobacterium tuberculosis Zmp1 inhibitor.
Bioorg Med Chem Lett 24: 2508-11 (2014)
University Of Siena
Design and synthesis of highly potent HIV-1 protease inhibitors with novel isosorbide-derived P2 ligands.
Bioorg Med Chem Lett 24: 2465-8 (2014)
Shandong University
2-Amino-1,3,4-thiadiazoles in the 7-hydroxy-N-neopentyl spiropiperidine indolinyl series as potent P2Y1 receptor antagonists.
Bioorg Med Chem Lett 24: 2481-5 (2014)
Bristol-Myers Squibb
Discovery and optimization of indazoles as potent and selective interleukin-2 inducible T cell kinase (ITK) inhibitors.
Bioorg Med Chem Lett 24: 2448-52 (2014)
Genentech
Discovery of BRD4 bromodomain inhibitors by fragment-based high-throughput docking.
Bioorg Med Chem Lett 24: 2493-6 (2014)
University Of Zurich
Design, synthesis and biological evaluation of novel tripeptidyl epoxyketone derivatives constructed fromß-amino acid as proteasome inhibitors.
Bioorg Med Chem 22: 2955-65 (2014)
Zhejiang University
Azaindolylsulfonamides, with a more selective inhibitory effect on histone deacetylase 6 activity, exhibit antitumor activity in colorectal cancer HCT116 cells.
J Med Chem 57: 4009-22 (2014)
Taipei Medical University
Synthesis, biological evaluation, molecular docking and theoretical evaluation of ADMET properties of nepodin and chrysophanol derivatives as potential cyclooxygenase (COX-1, COX-2) inhibitors.
Eur J Med Chem 80: 47-56 (2014)
National Institute Of Pharmaceutical Education And Research
Towards the development of 5-HT7 ligands combining serotonin-like and arylpiperazine moieties.
Eur J Med Chem 80: 8-35 (2014)
Universit£
Synthesis and biological evaluation of novel (123)I-labeled 4-(4-iodophenyl)butanoyl-L-prolyl-(2S)-pyrrolidines for imaging prolyl oligopeptidase in vivo.
Eur J Med Chem 79: 436-45 (2014)
University Of Helsinki
4-Oxo-1,4-dihydro-quinoline-3-carboxamides as BACE-1 inhibitors: synthesis, biological evaluation and docking studies.
Eur J Med Chem 79: 413-21 (2014)
Peking University Health Science Center
Identification and optimization of novel Hsp90 inhibitors with tetrahydropyrido[4,3-d]pyrimidines core through shape-based screening.
Eur J Med Chem 79: 399-412 (2014)
China Pharmaceutical University
Selectively promiscuous opioid ligands: discovery of high affinity/low efficacy opioid ligands with substantial nociceptin opioid peptide receptor affinity.
J Med Chem 57: 4049-57 (2014)
University Of Bath
Structure-activity relationships and colorimetric properties of specific probes for the putative cancer biomarker human arylamine N-acetyltransferase 1.
Bioorg Med Chem 22: 3030-54 (2014)
University Of Oxford
Discovery of a potent, selective, and orally active phosphodiesterase 10A inhibitor for the potential treatment of schizophrenia.
J Med Chem 57: 4196-212 (2014)
Janssen Pharmaceutica
Nitric oxide synthase inhibitors that interact with both heme propionate and tetrahydrobiopterin show high isoform selectivity.
J Med Chem 57: 4382-96 (2014)
Northwestern University
Identifying structural determinants of potency for analogs of apelin-13: integration of C-terminal truncation with structure-activity.
Bioorg Med Chem 22: 2992-7 (2014)
Rti International
Design, synthesis and preliminary evaluation ofa-sulfonyl¿-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors.
Bioorg Med Chem 22: 3055-64 (2014)
Shandong University
The discovery of diazepinone-based 5-HT3 receptor partial agonists.
Bioorg Med Chem Lett 24: 2578-81 (2014)
Amri
The discovery of potent and selective non-steroidal glucocorticoid receptor modulators, suitable for inhalation.
Bioorg Med Chem Lett 24: 2571-7 (2014)
Astrazeneca
Structure-based design and synthesis of bicyclic fused-pyridines as MEK inhibitors.
Bioorg Med Chem Lett 24: 2555-9 (2014)
Shanghai Hengrui Pharmaceutical
Synthesis and structure-activity relationship of dihydrobenzofuran derivatives as novel human GPR119 agonists.
Bioorg Med Chem Lett 24: 2539-45 (2014)
Bristol-Myers Squibb
Inhibitors of the peptidoglycan biosynthesis enzymes MurA-F.
Bioorg Chem 55: 2-15 (2014)
University Of Ljubljana
Allosteric inhibitors of the Eya2 phosphatase are selective and inhibit Eya2-mediated cell migration.
J Biol Chem 289: 16349-61 (2014)
University Of Colorado School Of Medicine
Identification of type II and III DDR2 inhibitors.
J Med Chem 57: 4252-62 (2014)
Technical University Of Dortmund
New 5-unsubstituted dihydropyridines with improved CaV1.3 selectivity as potential neuroprotective agents against ischemic injury.
J Med Chem 57: 4313-23 (2014)
Universidad Complutense
Structural basis for isoform selectivity in a class of benzothiazole inhibitors of phosphoinositide 3-kinase¿.
J Med Chem 58: 517-21 (2015)
Vertex Pharmaceuticals
Functional rescue of Kallmann syndrome-associated prokineticin receptor 2 (PKR2) mutants deficient in trafficking.
J Biol Chem 289: 15518-26 (2014)
Central South University
Design and synthesis of paracaseolide A analogues as selective protein tyrosine phosphatase 1B inhibitors.
Org Biomol Chem 12: 3441-5 (2014)
Lanzhou University
Synthesis, pharmacological screening and in silico studies of new class of Diclofenac analogues as a promising anti-inflammatory agents.
Bioorg Med Chem 22: 2855-66 (2014)
K.L.E.U'S College Of Pharmacy
Cell permeable vanX inhibitors as vancomycin re-sensitizing agents.
Bioorg Med Chem Lett 24: 2535-8 (2014)
University Of Minnesota
Hot spot-based design of small-molecule inhibitors for protein-protein interactions.
Bioorg Med Chem Lett 24: 2546-54 (2014)
University Of Utah
Discovery of structurally novel, potent and orally efficacious GPR119 agonists.
Bioorg Med Chem Lett 24: 2383-7 (2014)
Genomics Institute Of The Novartis Research Foundation
Identification of a new series of potent diphenol HSP90 inhibitors by fragment merging and structure-based optimization.
Bioorg Med Chem Lett 24: 2525-9 (2014)
Chinese Academy Of Sciences
Optimization of pancreatic lipase inhibition by Cudrania tricuspidata fruits using response surface methodology.
Bioorg Med Chem Lett 24: 2329-33 (2014)
Chungbuk National University
Design, Synthesis and Biological Evaluation of Peptidyl Epoxyketone Proteasome Inhibitors Composed of ??????-amino Acids.
Chem Biol Drug Des 84: 497-504 (2014)
Zhejiang University
3-Substituted-N-(4-hydroxynaphthalen-1-yl)arylsulfonamides as a novel class of selective Mcl-1 inhibitors: structure-based design, synthesis, SAR, and biological evaluation.
J Med Chem 57: 4111-33 (2014)
University Of Michigan Medical School
Synthesis of novel tricyclic chromenone-based inhibitors of IRE-1 RNase activity.
J Med Chem 57: 4289-301 (2014)
H. Lee Moffitt Cancer Center And Research Institute
Carbonic anhydrase inhibitors. Inhibition of human cytosolic isoforms I and II with (reduced) Schiff's bases incorporating sulfonamide, carboxylate and carboxymethyl moieties.
Bioorg Med Chem 22: 2867-74 (2014)
Enscm/Umii/Umr-Cnrs 5635
Identification of the stereochemical requirements in the 4-aryl-2-cycloalkylidenhydrazinylthiazole scaffold for the design of selective human monoamine oxidase B inhibitors.
Bioorg Med Chem 22: 2887-95 (2014)
Sapienza University Of Rome
Identification of the first potent, selective and bioavailable PPARa antagonist.
Bioorg Med Chem Lett 24: 2267-72 (2014)
Inception Sciences
Benzylpiperidine variations on histamine H3 receptor ligands for improved drug-likeness.
Bioorg Med Chem Lett 24: 2236-9 (2014)
Johann Wolfgang Goethe University
Towards the discovery of drug-like epigallocatechin gallate analogs as Hsp90 inhibitors.
Bioorg Med Chem Lett 24: 2263-6 (2014)
Montclair State University
Design, synthesis, docking and anti-inflammatory evaluation of novel series of benzofuran based prodrugs.
Bioorg Med Chem Lett 24: 2251-5 (2014)
Banaras Hindu University
Oxysterol-binding protein (OSBP)-related protein 4 (ORP4) is essential for cell proliferation and survival.
J Biol Chem 289: 15705-17 (2014)
Dalhousie University
Structural basis for the recognition of peptide RJPXD33 by acyltransferases in lipid A biosynthesis.
J Biol Chem 289: 15527-35 (2014)
University Of Michigan
Influence of the adamantyl moiety on the activity of biphenylacrylohydroxamic acid-based HDAC inhibitors.
Eur J Med Chem 79: 251-9 (2014)
Universit£
Second generation steroidal 4-aminoquinolines are potent, dual-target inhibitors of the botulinum neurotoxin serotype A metalloprotease and P. falciparum malaria.
J Med Chem 57: 4134-53 (2014)
University Of Belgrade
A mixed population of antagonist and agonist binding conformers in a single crystal explains partial agonism against vitamin D receptor: active vitamin D analogues with 22R-alkyl group.
J Med Chem 57: 4351-67 (2014)
Showa Pharmaceutical University
Synthesis and evaluation of phosphorus containing, specific CDK9/CycT1 inhibitors.
J Med Chem 57: 3939-65 (2014)
Vichem Chemie
Rational design of broad spectrum antibacterial activity based on a clinically relevant enoyl-acyl carrier protein (ACP) reductase inhibitor.
J Biol Chem 289: 15987-6005 (2014)
University Of Wuerzburg
Identification of (R)-6-(1-(4-cyano-3-methylphenyl)-5-cyclopentyl-4,5-dihydro-1H-pyrazol-3-yl)-2-methoxynicotinic acid, a highly potent and selective nonsteroidal mineralocorticoid receptor antagonist.
J Med Chem 57: 4273-88 (2014)
Pfizer
New melatonin-N,N-dibenzyl(N-methyl)amine hybrids: potent neurogenic agents with antioxidant, cholinergic, and neuroprotective properties as innovative drugs for Alzheimer's disease.
J Med Chem 57: 3773-85 (2014)
Instituto De Qu£Mica M£Dica
Structural basis of pharmacological chaperoning for human ß-galactosidase.
J Biol Chem 289: 14560-8 (2014)
The University Of Tokyo
Elucidation of different inhibition mechanism of small chemicals on PtdInsP-binding domains using in silico docking experiments.
Bioorg Med Chem Lett 24: 2256-62 (2014)
Sookmyung Women'S University
Synthesis and biological evaluation of a novel sigma-1 receptor antagonist based on 3,4-dihydro-2(1H)-quinolinone scaffold as a potential analgesic.
Eur J Med Chem 79: 216-30 (2014)
Huazhong University Of Science And Technology
Synthesis and evaluation of cyclohexane carboxylic acid head group containing isoxazole and thiazole analogs as DGAT1 inhibitors.
Eur J Med Chem 79: 203-15 (2014)
Vit University
Imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, substrate-dependent modulators of insulin-degrading enzyme in amyloid-ß hydrolysis.
Eur J Med Chem 79: 184-93 (2014)
University Of Lille
Design and synthesis of systemically active metabotropic glutamate subtype-2 and -3 (mGlu2/3) receptor positive allosteric modulators (PAMs): pharmacological characterization and assessment in a rat model of cocaine dependence.
J Med Chem 57: 4154-72 (2014)
Sanford-Burnham Medical Research Institute
The cannabinoid acids, analogs and endogenous counterparts.
Bioorg Med Chem 22: 2830-43 (2014)
The University Of Massachusetts Medical School
Synthesis and biological evaluation of compounds which contain pyrazole, thiazole and naphthalene ring as antitumor agents.
Bioorg Med Chem Lett 24: 2324-8 (2014)
Nanjing University
Synthesis and in vitro evaluation of anti-inflammatory activity of ester and amine derivatives of indoline in RAW 264.7 and peritoneal macrophages.
Bioorg Med Chem Lett 24: 2283-7 (2014)
Bar-Ilan University
Small chemicals with inhibitory effects on PtdIns(3,4,5)P3 binding of Btk PH domain.
Bioorg Med Chem Lett 24: 2334-9 (2014)
Konkuk University
Design, syntheses, and characterization of piperazine based chemokine receptor CCR5 antagonists as anti prostate cancer agents.
Bioorg Med Chem Lett 24: 2319-23 (2014)
Virginia Commonwealth University
Trisubstituted Sulfonamides: a New Chemotype for Development of Potent and Selective CB
ACS Med Chem Lett 4: 387-392 (2013)
University Of Pittsburgh
Pyrazole-5-carboxamides, novel inhibitors of receptor for advanced glycation end products (RAGE).
Eur J Med Chem 79: 128-42 (2014)
Woosuk University
Design, synthesis and biological evaluation of benzylisoquinoline derivatives as multifunctional agents against Alzheimer's disease.
Bioorg Med Chem Lett 24: 2368-73 (2014)
China Pharmaceutical University
Scaffold hopping approach to a new series of smoothened antagonists.
Bioorg Med Chem Lett 24: 2300-4 (2014)
Soochow University
Syk inhibitors with high potency in presence of blood.
Bioorg Med Chem Lett 24: 2278-82 (2014)
Novartis Institutes For Biomedical Research
Geranyl and neryl triazole bisphosphonates as inhibitors of geranylgeranyl diphosphate synthase.
Bioorg Med Chem 22: 2791-8 (2014)
University Of Iowa
Preliminary investigations into triazole derived androgen receptor antagonists.
Bioorg Med Chem 22: 2692-706 (2014)
Deakin University
Design, synthesis and pharmacological evaluation of novel polycyclic heteroarene ethers as PDE10A inhibitors: Part I.
Bioorg Med Chem Lett 24: 2073-8 (2014)
Glenmark Pharmaceuticals
Radiosyntheses and in vivo evaluation of carbon-11 PET tracers for PDE10A in the brain of rodent and nonhuman primate.
Bioorg Med Chem 22: 2648-54 (2014)
Washington University
Synthesis and in vitro evaluation of bis-quaternary 2-(hydroxyimino)-N-(pyridin-3-yl)acetamide derivatives as reactivators against sarin and VX inhibited human acetylcholinesterase (hAChE).
Bioorg Med Chem 22: 2684-91 (2014)
Defence Research & Development Establishment (Drde)
Synthesis and evaluation of several oleanolic acid glycoconjugates as protein tyrosine phosphatase 1B inhibitors.
Eur J Med Chem 79: 34-46 (2014)
North-West University
Synthesis, molecular docking, and biological evaluation of some novel hydrazones and pyrazole derivatives as anti-inflammatory agents.
Chem Biol Drug Des 84: 473-88 (2014)
Cairo University
Inhibition of the ribonuclease H activity of HIV-1 reverse transcriptase by GSK5750 correlates with slow enzyme-inhibitor dissociation.
J Biol Chem 289: 16270-7 (2014)
Mcgill University
Design of novel multiple-acting ligands towards SERT and 5-HT2C receptors.
Bioorg Med Chem Lett 24: 2118-22 (2014)
Gedeon Richter
Pyrazolo[4,3-e][1,2,4]triazine sulfonamides as carbonic anhydrase inhibitors with antitumor activity.
Bioorg Med Chem 22: 2643-7 (2014)
Siedlce University Of Natural Sciences And Humanities
Discovery of novel inhibitors targeting the macrophage migration inhibitory factor via structure-based virtual screening and bioassays.
J Med Chem 57: 3737-45 (2014)
Zhejiang University
4-Alkyloxyimino derivatives of uridine-5'-triphosphate: distal modification of potent agonists as a strategy for molecular probes of P2Y2, P2Y4, and P2Y6 receptors.
J Med Chem 57: 3874-83 (2014)
National Institute Of Diabetes And Digestive And Kidney Diseases
Thienoquinolines as novel disruptors of the PKCe/RACK2 protein-protein interaction.
J Med Chem 57: 3235-46 (2014)
Innsbruck Medical University
Discovery of 2-[3,5-dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptorß agonist in clinical trials for the treatment of dyslipidemia.
J Med Chem 57: 3912-23 (2014)
Madrigal Pharmaceuticals
Discovery of two aminoglycoside antibiotics as inhibitors targeting the menin-mixed lineage leukaemia interface.
Bioorg Med Chem Lett 24: 2090-3 (2014)
Fuzhou University
Triaryl-substituted Schiff bases are high-affinity subtype-selective ligands for the estrogen receptor.
J Med Chem 57: 3532-45 (2014)
Key Laboratory Of Combinatorial Biosynthesis And Drug Discovery (Wuhan University)
A Selective Phenelzine Analogue Inhibitor of Histone Demethylase LSD1.
ACS Chem Biol 9: 1284-93 (2014)
Johns Hopkins University
Nucleotide-binding oligomerization domain (NOD) inhibitors: a rational approach toward inhibition of NOD signaling pathway.
J Med Chem 57: 6897-918 (2014)
University Of Ljubljana
Plasmodium falciparum UvrD activities are downregulated by DNA-interacting compounds and its dsRNA inhibits malaria parasite growth.
BMC Biochem 15: 9 (2014)
International Centre For Genetic Engineering And Biotechnology
Truncated Orexin Peptides: Structure-Activity Relationship Studies.
ACS Med Chem Lett 4: 1224-1227 (2013)
Research Triangle Institute
Design, synthesis and biological evaluation of novel tetrahydroacridine pyridine- aldoxime and -amidoxime hybrids as efficient uncharged reactivators of nerve agent-inhibited human acetylcholinesterase.
Eur J Med Chem 78: 455-67 (2014)
University Of Strasburg
Discovery of 2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide derivatives as new ROR¿ inhibitors using virtual screening, synthesis and biological evaluation.
Eur J Med Chem 78: 431-41 (2014)
Chinese Academy Of Sciences
Design, synthesis, acetylcholinesterase inhibition and larvicidal activity of girgensohnine analogs on Aedes aegypti, vector of dengue fever.
Eur J Med Chem 78: 392-400 (2014)
Universidad Industrial De Santander
4-([1,2,4]Triazolo[1,5-a]pyridin-6-yl)-5(3)-(6-methylpyridin-2-yl)imidazole and -pyrazole derivatives as potent and selective inhibitors of transforming growth factor-ß type I receptor kinase.
Bioorg Med Chem 22: 2724-32 (2014)
Ewha Womans University
The evolution of amidine-based brain penetrant BACE1 inhibitors.
Bioorg Med Chem Lett 24: 2033-45 (2014)
Janssen Pharmaceutica
Discovery of dual orexin receptor antagonists with rat sleep efficacy enabled by expansion of the acetonitrile-assisted/diphosgene-mediated 2,4-dichloropyrimidine synthesis.
Bioorg Med Chem Lett 24: 2079-85 (2014)
Merck Research Laboratories
Tetra-substituted imidazoles as a new class of inhibitors of the p53-MDM2 interaction.
Bioorg Med Chem Lett 24: 2110-4 (2014)
Novartis Institutes For Biomedical Research
Lactam and oxazolidinone derived potent 5-hydroxytryptamine 6 receptor antagonists.
Bioorg Med Chem Lett 24: 2094-7 (2014)
Cephalon
Inhibitory effects of novel synthetic methimazole derivatives on mushroom tyrosinase and melanogenesis.
Bioorg Med Chem 22: 2809-15 (2014)
Hungkuang University
From virtual to clinical: The discovery of PGN-1531, a novel antagonist of the prostanoid EP4 receptor.
Bioorg Med Chem Lett 24: 2212-21 (2014)
Argenta Discovery
RE12 derivatives displaying Vaccinia H1-related phosphatase (VHR) inhibition in the presence of detergent and their anti-proliferative activity against HeLa cells.
Bioorg Med Chem 22: 2771-82 (2014)
Japan Science And Technology Agency
Search for novel histone deacetylase inhibitors. Part II: design and synthesis of novel isoferulic acid derivatives.
Bioorg Med Chem 22: 2707-13 (2014)
Xi'An Jiaotong University
Structure-activity relationship-guided development of retinoic acid receptor-related orphan receptor gamma (ROR¿)-selective inverse agonists with a phenanthridin-6(5H)-one skeleton from a liver X receptor ligand.
Bioorg Med Chem 22: 2799-808 (2014)
The University Of Tokyo
Thermodynamic and structural characterization of halogen bonding in protein-ligand interactions: a case study of PDE5 and its inhibitors.
J Med Chem 57: 3588-93 (2014)
Chinese Academy Of Sciences (Cas)
Biased ligand modulation of seven transmembrane receptors (7TMRs): functional implications for drug discovery.
J Med Chem 57: 6887-96 (2014)
Merck Research Laboratories
Novel derivatives of 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) with improved fluorescent ands receptors binding properties.
J Med Chem 57: 3314-23 (2014)
Universit£
Discovery of a neuroprotective chemical, (S)-N-(3-(3,6-dibromo-9H-carbazol-9-yl)-2-fluoropropyl)-6-methoxypyridin-2-amine [(-)-P7C3-S243], with improved druglike properties.
J Med Chem 57: 3746-54 (2014)
University Of Texas Southwestern Medical Center
Development of pyrazolone and isoxazol-5-one cambinol analogues as sirtuin inhibitors.
J Med Chem 57: 3283-94 (2014)
Fred Hutchinson Cancer Research Center
Indirubin core structure of glycogen synthase kinase-3 inhibitors as novel chemotype for intervention with 5-lipoxygenase.
J Med Chem 57: 3715-23 (2014)
Friedrich-Schiller-University
The Parkinson disease-linked LRRK2 protein mutation I2020T stabilizes an active state conformation leading to increased kinase activity.
J Biol Chem 289: 13042-53 (2014)
Harvard Neurodiscovery Center
Siderophore receptor-mediated uptake of lactivicin analogues in gram-negative bacteria.
J Med Chem 57: 3845-55 (2014)
Pfizer
New potent antibacterial oxazolidinone (MRX-I) with an improved class safety profile.
J Med Chem 57: 4487-97 (2014)
Micurx Pharmaceuticals
Discovery of the first N-hydroxycinnamamide-based histone deacetylase 1/3 dual inhibitors with potent oral antitumor activity.
J Med Chem 57: 3324-41 (2014)
Shandong University
Structural basis for ligand regulation of the fatty acid-binding protein 5, peroxisome proliferator-activated receptor ß/d (FABP5-PPARß/d) signaling pathway.
J Biol Chem 289: 14941-54 (2014)
Emory University
SAR-studies on the importance of aromatic ring topologies in search for selective 5-HT(7) receptor ligands among phenylpiperazine hydantoin derivatives.
Eur J Med Chem 78: 324-39 (2014)
Jagiellonian University Medical College
a-Ketoheterocycle inhibitors of fatty acid amide hydrolase: exploration of conformational constraints in the acyl side chain.
Bioorg Med Chem 22: 2763-70 (2014)
The Scripps Research Institute
Antagonists of the kappa opioid receptor.
Bioorg Med Chem Lett 24: 2021-32 (2014)
The Scripps Research Institute
Exploring the water-binding pocket of the type II dehydroquinase enzyme in the structure-based design of inhibitors.
J Med Chem 57: 3494-510 (2014)
Universidad De Santiago De Compostela
Cyclic secondary sulfonamides: unusually good inhibitors of cancer-related carbonic anhydrase enzymes.
J Med Chem 57: 3522-31 (2014)
Griffith University
Optimization of an imidazopyridazine series of inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1).
J Med Chem 57: 3570-87 (2014)
Mrc Technology
Discovery of mixed type thymidine phosphorylase inhibitors endowed with antiangiogenic properties: synthesis, pharmacological evaluation and molecular docking study of 2-thioxo-pyrazolo[1,5-a][1,3,5]triazin-4-ones. Part II.
Eur J Med Chem 78: 294-303 (2014)
National University Of Singapore
Identification of tertiary sulfonamides as RORc inverse agonists.
Bioorg Med Chem Lett 24: 2182-7 (2014)
Genentech
Discovery of substituted benzamides as follicle stimulating hormone receptor allosteric modulators.
Bioorg Med Chem Lett 24: 2168-72 (2014)
Emd-Serono Research Institute
Purine derivatives as potent Bruton's tyrosine kinase (BTK) inhibitors for autoimmune diseases.
Bioorg Med Chem Lett 24: 2206-11 (2014)
Bristol-Myers Squibb Research And Development
Symmetric adamantyl-diureas as soluble epoxide hydrolase inhibitors.
Bioorg Med Chem Lett 24: 2193-7 (2014)
Volzhsky Polytechnic Institute (Branch) Volgograd State Technical University
The discovery and SAR of cyclopenta[b]furans as inhibitors of CCR2.
Bioorg Med Chem Lett 24: 2137-40 (2014)
Janssen Research And Development
Development of 3,5-dinitrobenzoate-based 5-lipoxygenase inhibitors.
Bioorg Med Chem 22: 2396-402 (2014)
Peking University
Anthranilic acid derivatives as novel ligands for farnesoid X receptor (FXR).
Bioorg Med Chem 22: 2447-60 (2014)
Goethe-University Frankfurt
Synthesis and biological evaluation of novel bis-aromatic amides as novel PTP1B inhibitors.
Bioorg Med Chem Lett 24: 1889-94 (2014)
Jiangnan University
In vivo optimization of 2,3-diaminopyrazine Rho Kinase inhibitors for the treatment of glaucoma.
Bioorg Med Chem Lett 24: 1875-9 (2014)
Alcon Laboratories
Diacylglycerol lactones targeting the structural features that distinguish the atypical C1 domains of protein kinase C¿ and¿ from typical C1 domains.
J Med Chem 57: 3835-44 (2014)
National Cancer Institute-Bethesda
Basic quinolinonyl diketo acid derivatives as inhibitors of HIV integrase and their activity against RNase H function of reverse transcriptase.
J Med Chem 57: 3223-34 (2014)
Sapienza University Of Rome
Potent and selective inhibitors of human reticulocyte 12/15-lipoxygenase as anti-stroke therapies.
J Med Chem 57: 4035-48 (2014)
Harvard Medical School
Synthesis and kinase inhibitory activity of new sulfonamide derivatives of pyrazolo[4,3-e][1,2,4]triazines.
Eur J Med Chem 78: 217-24 (2014)
Siedlce University Of Natural Sciences And Humanities
Synthesis, crystal structure and biological evaluation of some novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines.
Eur J Med Chem 78: 167-77 (2014)
Quaid-I-Azam University
Fluorinated benzophenone derivatives: balanced multipotent agents for Alzheimer's disease.
Eur J Med Chem 78: 157-66 (2014)
University Of Bologna
New aminobenzenesulfonamide-thiourea conjugates: synthesis and carbonic anhydrase inhibition and docking studies.
Eur J Med Chem 78: 140-50 (2014)
Comsats Institute Of Information Technology
Novel structural hybrids of pyrazolobenzothiazines with benzimidazoles as cholinesterase inhibitors.
Eur J Med Chem 78: 106-17 (2014)
Government College Women University
Design, synthesis and bioevaluation of N-trisubstituted pyrimidine derivatives as potent aurora A kinase inhibitors.
Eur J Med Chem 78: 65-71 (2014)
Sun Yat-Sen University
Effect of prime-site sequence of retro-inverso-modified HTLV-1 protease inhibitor.
Bioorg Med Chem 22: 2482-8 (2014)
Kyoto Prefectural University Of Medicine
Structural modifications of CH(OH)-DAPYs as new HIV-1 non-nucleoside reverse transcriptase inhibitors.
Bioorg Med Chem 22: 2535-41 (2014)
Fudan University
Anti-inflammatory components of Euphorbia humifusa Willd.
Bioorg Med Chem Lett 24: 1895-900 (2014)
Chungnam National University
Discovery of a novel series of orally active nociceptin/orphanin FQ (NOP) receptor antagonists based on a dihydrospiro(piperidine-4,7'-thieno[2,3-c]pyran) scaffold.
J Med Chem 57: 3418-29 (2014)
Eli Lilly
Identification and characterization of small molecule modulators of the Epstein-Barr virus-induced gene 2 (EBI2) receptor.
J Med Chem 57: 3358-68 (2014)
Novartis Institutes For Biomedical Research
Development of Selective Inhibitors for Human Aldehyde Dehydrogenase 3A1 (ALDH3A1) for the Enhancement of Cyclophosphamide Cytotoxicity.
Chembiochem 15: 701-712 (2014)
Indiana University
Highly potent and selective 3-N-methylquinazoline-4(3H)-one based inhibitors of B-Raf(V600E) kinase.
Bioorg Med Chem Lett 24: 1923-7 (2014)
Array Biopharma
Identification of novel SIRT2-selective inhibitors using a click chemistry approach.
Bioorg Med Chem Lett 24: 1871-4 (2014)
Nagoya City University
Design, synthesis and biological evaluation of novel aminomethyl-piperidones based DPP-IV inhibitors.
Bioorg Med Chem Lett 24: 1918-22 (2014)
M.S. University Of Baroda
Synthesis, cytotoxicity and molecular modelling studies of new phenylcinnamide derivatives as potent inhibitors of cholinesterases.
Eur J Med Chem 78: 43-53 (2014)
Quaid-I-Azam University
Solid-supported synthesis, molecular modeling, and biological activity of long-chain arylpiperazine derivatives with cyclic amino acid amide fragments as 5-HT(7) and 5-HT(1A) receptor ligands.
Eur J Med Chem 78: 10-22 (2014)
Jagiellonian University Medical College
Synthesis of substituted pyrimidines as corticotropin releasing factor (CRF) receptor ligands.
Eur J Med Chem 78: 1-9 (2014)
South Dakota State University
Structure-activity relationship study of 4EGI-1, small molecule eIF4E/eIF4G protein-protein interaction inhibitors.
Eur J Med Chem 77: 361-77 (2014)
Harvard Medical School
Design, synthesis and evaluation of novel diaryl urea derivatives as potential antitumor agents.
Eur J Med Chem 77: 351-60 (2014)
Peking Union Medical College & Chinese Academy Of Medical Sciences
Identification of dipeptidyl peptidase IV inhibitors: virtual screening, synthesis and biological evaluation.
Chem Biol Drug Des 84: 364-77 (2014)
China Pharmaceutical University
Discovery of selective 4-Amino-pyridopyrimidine inhibitors of MAP4K4 using fragment-based lead identification and optimization.
J Med Chem 57: 3484-93 (2014)
Genentech
Identification of novel HSP90a/ß isoform selective inhibitors using structure-based drug design. demonstration of potential utility in treating CNS disorders such as Huntington's disease.
J Med Chem 57: 3382-400 (2014)
Vertex Pharmaceuticals
Discovery of 6-phenylpyrimido[4,5-b][1,4]oxazines as potent and selective acyl CoA:diacylglycerol acyltransferase 1 (DGAT1) inhibitors with in vivo efficacy in rodents.
J Med Chem 57: 3464-83 (2014)
Amgen
Agonists for the adenosine A1 receptor with tunable residence time. A Case for nonribose 4-amino-6-aryl-5-cyano-2-thiopyrimidines.
J Med Chem 57: 3213-22 (2014)
Leiden University
Biochemical, cellular, and biophysical characterization of a potent inhibitor of mutant isocitrate dehydrogenase IDH1.
J Biol Chem 289: 13717-25 (2014)
National Institutes Of Health
Thiophene carboxamide inhibitors of JAK2 as potential treatments for myleoproliferative neoplasms.
Bioorg Med Chem Lett 24: 1968-73 (2014)
Merck
Discovery of trifluoromethyl(pyrimidin-2-yl)azetidine-2-carboxamides as potent, orally bioavailable TGR5 (GPBAR1) agonists: structure-activity relationships, lead optimization, and chronic in vivo efficacy.
J Med Chem 57: 3263-82 (2014)
Genomics Institute Of The Novartis Research Foundation
Allosteric inhibition of human factor XIa: discovery of monosulfated benzofurans as a class of promising inhibitors.
J Med Chem 57: 3559-69 (2014)
Virginia Commonwealth University
Discovery, optimization, and characterization of novel D2 dopamine receptor selective antagonists.
J Med Chem 57: 3450-63 (2014)
National Center For Advancing Translational Sciences
Synthesis of thio-heterocyclic analogues from Baylis-Hillman bromides as potent cyclooxygenase-2 inhibitors.
Bioorg Med Chem Lett 24: 1952-7 (2014)
Csir-Indian Institute Of Chemical Technology
Omarigliptin (MK-3102): a novel long-acting DPP-4 inhibitor for once-weekly treatment of type 2 diabetes.
J Med Chem 57: 3205-12 (2014)
Merck
Improved total synthesis and biological evaluation of potent apratoxin S4 based anticancer agents with differential stability and further enhanced activity.
J Med Chem 57: 3011-29 (2014)
University Of Florida
An Accessible Chiral Linker to Enhance Potency and Selectivity of Neuronal Nitric Oxide Synthase Inhibitors.
ACS Med Chem Lett 5: 56-60 (2014)
Northwestern University
Antimitotic and vascular disrupting agents: 2-hydroxy-3,4,5-trimethoxybenzophenones.
Eur J Med Chem 77: 306-14 (2014)
Taipei Medical University
Designing bifunctional NOP receptor-mu opioid receptor ligands from NOP-receptor selective scaffolds. Part II.
Bioorg Med Chem 22: 2508-16 (2014)
Astraea Therapeutics
Docking and SAR studies of calystegines: binding orientation and influence on pharmacological chaperone effects for Gaucher's disease.
Bioorg Med Chem 22: 2435-41 (2014)
University Of Toyama
Quinolone-benzylpiperidine derivatives as novel acetylcholinesterase inhibitor and antioxidant hybrids for Alzheimer disease.
Bioorg Med Chem 22: 2496-507 (2014)
Universit£
Polyfluorinated bis-styrylbenzenes as amyloid-ß plaque binding ligands.
Bioorg Med Chem 22: 2469-81 (2014)
Leiden University
1,2-benzisothiazol-3-one derivatives as a novel class of small-molecule caspase-3 inhibitors.
Bioorg Med Chem 22: 2416-26 (2014)
Tianjin University Of Science And Technology
Structural insights into binding of inhibitors to soluble epoxide hydrolase gained by fragment screening and X-ray crystallography.
Bioorg Med Chem 22: 2427-34 (2014)
Astellas Pharma
Synthesis, biological evaluation, and docking analysis of a novel family of 1-methyl-1H-pyrrole-2,5-diones as highly potent and selective cyclooxygenase-2 (COX-2) inhibitors.
Bioorg Med Chem Lett 24: 1958-62 (2014)
Kyung Hee University
Core modification of substituted piperidines as novel inhibitors of HDM2-p53 protein-protein interaction.
Bioorg Med Chem Lett 24: 1983-6 (2014)
Merck Research Laboratories
Discovery of a potent and dissociated non-steroidal glucocorticoid receptor agonist containing an alkyl carbinol pharmacophore.
Bioorg Med Chem Lett 24: 1934-40 (2014)
Boehringer Ingelheim Pharmaceuticals
Pharmacophoric modifications lead to superpotentavß3 integrin ligands with suppresseda5ß1 activity.
J Med Chem 57: 3410-7 (2014)
Technische Universit£T M£Nchen
New pyrazolobenzothiazine derivatives as hepatitis C virus NS5B polymerase palm site I inhibitors.
J Med Chem 57: 3247-62 (2014)
Universit£
Non-imidazole histamine H3 receptor ligands incorporating antiepileptic moieties.
Eur J Med Chem 77: 269-79 (2014)
United Arab Emirates University
Using 'biased-privileged' scaffolds to identify lysine methyltransferase inhibitors.
Bioorg Med Chem 22: 2253-60 (2014)
Rockefeller University
Structure-activity relationship of celecoxib and rofecoxib for the membrane permeabilizing activity.
Bioorg Med Chem 22: 2529-34 (2014)
Keio University
Arylamino bisphosphonates: potent and selective inhibitors of the tumor-associated carbonic anhydrase XII.
Bioorg Med Chem Lett 24: 1941-3 (2014)
Universit£
Discovery of 4-anilinoa-carbolines as novel Brk inhibitors.
Bioorg Med Chem Lett 24: 1948-51 (2014)
Martin-Luther-University Halle-Wittenberg
Discovery of a potent and selectivea3ß4 nicotinic acetylcholine receptor antagonist from ana-conotoxin synthetic combinatorial library.
J Med Chem 57: 3511-21 (2014)
Torrey Pines Institute For Molecular Studies
Oseltamivir analogues bearing N-substituted guanidines as potent neuraminidase inhibitors.
J Med Chem 57: 3154-60 (2014)
Utrecht University
Chiral Effect of a Phe Residue in Position 3 of the Dmt
ACS Med Chem Lett 4: 656-659 (2013)
University Of Arizona
Deciphering the binding of caveolin-1 to client protein endothelial nitric-oxide synthase (eNOS): scaffolding subdomain identification, interaction modeling, and biological significance.
J Biol Chem 289: 13273-83 (2014)
St. Paul'S Hospital'S Centre Of Heart And Lung Innovation
Fatty acid-binding protein 5 (FABP5) regulates cognitive function both by decreasing anandamide levels and by activating the nuclear receptor peroxisome proliferator-activated receptor ß/d (PPARß/d) in the brain.
J Biol Chem 289: 12748-58 (2014)
Case Western Reserve University School Of Medicine
Acyl hydrazides and triazoles as novel inhibitors of mammalian cathepsin B and cathepsin H.
Eur J Med Chem 77: 231-42 (2014)
Kurukshetra University
1,3-disubstituted-4-aminopyrazolo [3, 4-d] pyrimidines, a new class of potent inhibitors for phospholipase D.
Chem Biol Drug Des 84: 270-81 (2014)
University Of Massachusetts Boston
Development of a bioavailableµ opioid receptor (MOPr) agonist,d opioid receptor (DOPr) antagonist peptide that evokes antinociception without development of acute tolerance.
J Med Chem 57: 3148-53 (2014)
University Of Michigan
Discovery of AMG 925, a FLT3 and CDK4 dual kinase inhibitor with preferential affinity for the activated state of FLT3.
J Med Chem 57: 3430-49 (2014)
Amgen
Design and synthesis of high affinity inhibitors of Plasmodium falciparum and Plasmodium vivax N-myristoyltransferases directed by ligand efficiency dependent lipophilicity (LELP).
J Med Chem 57: 2773-88 (2014)
Imperial College
Pyrazoles as non-classical bioisosteres in prolylcarboxypeptidase (PrCP) inhibitors.
Bioorg Med Chem Lett 24: 1657-60 (2014)
Merck Research Laboratories
Synthesis and biologic evaluation of substituted 5-methyl-2-phenyl-1H-pyrazol-3(2H)-one derivatives as selective COX-2 inhibitors: molecular docking study.
Chem Biol Drug Des 84: 409-19 (2014)
Y.B. Chavan College Of Pharmacy
Discovery and Structure Optimization of a Series of Isatin Derivatives as Mycobacterium tuberculosis Chorismate Mutase Inhibitors.
Chem Biol Drug Des 83: 498-506 (2014)
Birla Institute Of Technology
Trimethylation of histone H3 lysine 36 by human methyltransferase PRDM9 protein.
J Biol Chem 289: 12177-88 (2014)
University Of Toronto
A novel small-molecule tumor necrosis factor a inhibitor attenuates inflammation in a hepatitis mouse model.
J Biol Chem 289: 12457-66 (2014)
Institute Of Hematology And Blood Diseases Hospital, Chinese Academy Of Medical Sciences And Peking Union Medical College
Synthesis and evaluation of c-Src kinase inhibitory activity of pyridin-2(1H)-one derivatives.
Bioorg Chem 53: 75-82 (2014)
University Of Delhi
Rational design, synthesis and evaluation of chromone-indole and chromone-pyrazole based conjugates: identification of a lead for anti-inflammatory drug.
Eur J Med Chem 77: 185-92 (2014)
Guru Nanak Dev University
1-(4-Methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-1H-1,2,4-triazole-3-carboxamides: synthesis, molecular modeling, evaluation of their anti-inflammatory activity and ulcerogenicity.
Eur J Med Chem 77: 155-65 (2014)
Minia University
Novel insights on the structural determinants of clozapine and olanzapine multi-target binding profiles.
Eur J Med Chem 77: 91-5 (2014)
Universitat Pompeu Fabra
Synthesis and biological evaluation of new pyrazolone-pyridazine conjugates as anti-inflammatory and analgesic agents.
Bioorg Med Chem 22: 2080-9 (2014)
Cairo University
Fused heterocyclic compounds bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 1: design, synthesis and biological evaluation of novel 5,7-disubstituted pyrazolo[1,5-a]pyrimidine derivatives.
Bioorg Med Chem 22: 2052-9 (2014)
Shandong University
N-Acyl-phosphoramidates as potential novel form of gemcitabine prodrugs.
Bioorg Med Chem 22: 2133-40 (2014)
Polish Academy Of Sciences
Structure-based design and synthesis of tricyclic IAP (Inhibitors of Apoptosis Proteins) inhibitors.
Bioorg Med Chem Lett 24: 1820-4 (2014)
Astrazeneca
Optimization of plasmepsin inhibitor by focusing on similar structural feature with chloroquine to avoid drug-resistant mechanism of Plasmodium falciparum.
Bioorg Med Chem Lett 24: 1698-701 (2014)
Kyoto Pharmaceutical University
Decreasing acidity in a series of aldose reductase inhibitors: 2-Fluoro-4-(1H-pyrrol-1-yl)phenol as a scaffold for improved membrane permeation.
Bioorg Med Chem 22: 2194-207 (2014)
Aristotle University Of Thessaloniki
Design and synthesis of silicon-containing steroid sulfatase inhibitors possessing pro-estrogen antagonistic character.
Bioorg Med Chem 22: 2244-52 (2014)
The University Of Tokyo
Some non-conventional biomolecular targets for diamidines. A short survey.
Bioorg Med Chem 22: 1983-92 (2014)
Xavier University Of Louisiana
Synthesis and evaluation of carbon-linked analogs of dual orexin receptor antagonist filorexant.
Bioorg Med Chem Lett 24: 1784-9 (2014)
Merck Research Laboratories
Inhibitory effect of Rhus verniciflua Stokes extract on human aromatase activity; butin is its major bioactive component.
Bioorg Med Chem Lett 24: 1730-3 (2014)
Hanyang University
Design, synthesis, and characterization of novel, nonquaternary reactivators of GF-inhibited human acetylcholinesterase.
Bioorg Med Chem Lett 24: 1711-4 (2014)
Southwest Research Institute
Schiff's base derivatives bearing nitroimidazole and quinoline nuclei: new class of anticancer agents and potential EGFR tyrosine kinase inhibitors.
Bioorg Med Chem Lett 24: 1734-6 (2014)
Nanjing University
Mineralocorticoid receptor antagonists: identification of heterocyclic amide replacements in the oxazolidinedione series.
Bioorg Med Chem Lett 24: 1681-4 (2014)
Merck Research Laboratories
Computer-aided identification of novel 3,5-substituted rhodanine derivatives with activity against Staphylococcus aureus DNA gyrase.
Bioorg Med Chem 22: 2176-87 (2014)
University Of The Sciences
Synthetic approaches to the 2012 new drugs.
Bioorg Med Chem 22: 2005-32 (2014)
Pharmaphase
Structure-activity relationship studies toward the discovery of selective apelin receptor agonists.
J Med Chem 57: 2908-19 (2014)
University Of Strasburg
Chromodomain antagonists that target the polycomb-group methyllysine reader protein chromobox homolog 7 (CBX7).
J Med Chem 57: 2874-83 (2014)
University Of Victoria
A new potential approach to block HIV-1 replication via protein-protein interaction and strand-transfer inhibition.
Bioorg Med Chem 22: 2269-79 (2014)
Universit£
Discovery of novel quinoline carboxylic acid series as DGAT1 inhibitors.
Bioorg Med Chem Lett 24: 1790-4 (2014)
Merck Research Laboratories
Synthesis and biological evaluation of a series of benzoxazole/benzothiazole-containing 2,3-dihydrobenzo[b][1,4]dioxine derivatives as potential antidepressants.
Bioorg Med Chem Lett 24: 1766-70 (2014)
Huazhong University Of Science And Technology
Extended structure-activity relationship and pharmacokinetic investigation of (4-quinolinoyl)glycyl-2-cyanopyrrolidine inhibitors of fibroblast activation protein (FAP).
J Med Chem 57: 3053-74 (2014)
University Of Antwerp
Synthesis, pharmacological evaluation, ands1 receptor interaction analysis of hydroxyethyl substituted piperazines.
J Med Chem 57: 2884-94 (2014)
University Of M£Nster
Synthesis and in vitro evaluation of small-molecule [18F] labeled gonadotropin-releasing hormone (GnRH) receptor antagonists as potential PET imaging agents for GnRH receptor expression.
Bioorg Med Chem Lett 24: 1846-50 (2014)
Norwegian Medical Cyclotron Centre
Benzophenone C-glucosides and gallotannins from mango tree stem bark with broad-spectrum anti-viral activity.
Bioorg Med Chem 22: 2236-43 (2014)
Chinese Academy Of Sciences
Synthesis, biological evaluation and 3D-QSAR studies of new chalcone derivatives as inhibitors of human P-glycoprotein.
Bioorg Med Chem 22: 2311-9 (2014)
Medical University Vienna
The identification, analysis and structure-based development of novel inhibitors of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase.
Bioorg Med Chem 22: 2157-65 (2014)
St. Jude Children'S Research Hospital
Endomorphin analogues with mixedµ-opioid (MOP) receptor agonism/d-opioid (DOP) receptor antagonism and lackingß-arrestin2 recruitment activity.
Bioorg Med Chem 22: 2208-19 (2014)
Nanjing Medical University
Alkylsulfone-containing trisubstituted cyclohexanes as potent and bioavailable chemokine receptor 2 (CCR2) antagonists.
Bioorg Med Chem Lett 24: 1843-5 (2014)
Bristol-Myers Squibb
Pyrrolopyrimidine-inhibitors with hydantoin moiety as spacer can explore P4/S4 interaction on plasmin.
Bioorg Med Chem 22: 2339-52 (2014)
Hiroshima International University
Discovery of novel secretory phospholipase A2 inhibitors using virtual screen.
Chem Biol Drug Des 84: 216-22 (2014)
Peking University
Symmetric bis-chalcones as a new type of breast cancer resistance protein inhibitors with a mechanism different from that of chromones.
J Med Chem 57: 2930-41 (2014)
Bmssi Umr 5086 Cnrs/Universit£
Small molecule disruptors of the glucokinase-glucokinase regulatory protein interaction: 3. Structure-activity relationships within the aryl carbinol region of the N-arylsulfonamido-N'-arylpiperazine series.
J Med Chem 57: 3094-116 (2014)
Amgen
Discovery of ML314, a Brain Penetrant Non-Peptidic?-Arrestin Biased Agonist of the Neurotensin NTR1 Receptor.
ACS Med Chem Lett 4: 846-851 (2013)
Sanford-Burnham Medical Research Institute
Thrombin inhibitory activity of some polyphenolic compounds.
Med Chem Res 23: 2324-2337 (2014)
University Of Lodz
New synthesis of 3-(ß-D-glucopyranosyl)-5-substituted-1,2,4-triazoles, nanomolar inhibitors of glycogen phosphorylase.
Eur J Med Chem 76: 567-79 (2014)
University Of Debrecen
SAR study on arylmethyloxyphenyl scaffold: looking for a P-gp nanomolar affinity.
Eur J Med Chem 76: 558-66 (2014)
Universit£
Design, synthesis and molecular modeling of pyrazole-quinoline-pyridine hybrids as a new class of antimicrobial and anticancer agents.
Eur J Med Chem 76: 549-57 (2014)
Nanjing University
Celecoxib analogs bearing benzofuran moiety as cyclooxygenase-2 inhibitors: design, synthesis and evaluation as potential anti-inflammatory agents.
Eur J Med Chem 76: 482-93 (2014)
Cairo University
Synthesis and evaluation of 2-anilinopyrimidines bearing 3-aminopropamides as potential epidermal growth factor receptor inhibitors.
Eur J Med Chem 77: 75-83 (2014)
China Pharmaceutical University
Development of novel pyrazolone derivatives as inhibitors of aldose reductase: an eco-friendly one-pot synthesis, experimental screening and in silico analysis.
Bioorg Chem 53: 67-74 (2014)
Swami Ramanand Teerth Marathwada University
Alkaloids from the roots of Stichoneuron caudatum and their acetylcholinesterase inhibitory activities.
J Nat Prod 77: 894-901 (2014)
University Of Wollongong
Fragment-based identification of an inducible binding site on cell surface receptor CD44 for the design of protein-carbohydrate interaction inhibitors.
J Med Chem 57: 2714-25 (2014)
University Of Minnesota
Evaluation of bisindole as potentß-glucuronidase inhibitors: synthesis and in silico based studies.
Bioorg Med Chem Lett 24: 1825-9 (2014)
University Of Karachi
Discovery of nitropyridine derivatives as potent HIV-1 non-nucleoside reverse transcriptase inhibitors via a structure-based core refining approach.
Eur J Med Chem 76: 531-8 (2014)
Shandong University
Identification of human presequence protease (hPreP) agonists for the treatment of Alzheimer's disease.
Eur J Med Chem 76: 506-16 (2014)
University Of Kansas
Benzimidazole: an emerging scaffold for analgesic and anti-inflammatory agents.
Eur J Med Chem 76: 494-505 (2014)
Asbasjsm College Of Pharmacy
Development and characterization of 3-(benzylsulfonamido)benzamides as potent and selective SIRT2 inhibitors.
Eur J Med Chem 76: 414-26 (2014)
Northwestern University
[Dmt(1)]DALDA analogues with enhancedµ opioid agonist potency and with a mixedµ/¿ opioid activity profile.
Bioorg Med Chem 22: 2333-8 (2014)
Nanjing Medical University
Potential anti-angiogenesis effects of p-terphenyl compounds from Polyozellus multiplex.
J Nat Prod 77: 963-8 (2014)
Meiji Pharmaceutical University
Novel inhibitors of the MDM2-p53 interaction featuring hydrogen bond acceptors as carboxylic acid isosteres.
J Med Chem 57: 2963-88 (2014)
Amgen
Imidazol-1-ylethylindazole voltage-gated sodium channel ligands are neuroprotective during optic neuritis in a mouse model of multiple sclerosis.
J Med Chem 57: 2942-52 (2014)
University College London
The SAMPL4 host-guest blind prediction challenge: an overview.
J Comput Aided Mol Des 28: 305-17 (2014)
University Of California San Diego
Prenylated coumarins: natural phosphodiesterase-4 inhibitors from Toddalia asiatica.
J Nat Prod 77: 955-62 (2014)
Sun Yat-Sen University
Optimization of potency and pharmacokinetic properties of tetrahydroisoquinoline transient receptor potential melastatin 8 (TRPM8) antagonists.
J Med Chem 57: 2989-3004 (2014)
Amgen
Design, synthesis and biological evaluation of D-ring opened galantamine analogs as multifunctional anti-Alzheimer agents.
Eur J Med Chem 76: 376-86 (2014)
Southeast University
Synthesis and discovery of highly functionalized mono- and bis-spiro-pyrrolidines as potent cholinesterase enzyme inhibitors.
Bioorg Med Chem Lett 24: 1815-9 (2014)
Universiti Sains Malaysia
Application of encoded library technology (ELT) to a protein-protein interaction target: discovery of a potent class of integrin lymphocyte function-associated antigen 1 (LFA-1) antagonists.
Bioorg Med Chem 22: 2353-65 (2014)
Glaxosmithkline
Highly conjugated norditerpenoid and pyrroloquinoline alkaloids with potent PTP1B inhibitory activity from Nigella glandulifera.
J Nat Prod 77: 807-12 (2014)
Chinese Academy Of Sciences
Targeting Staphylococcus aureus quorum sensing with nonpeptidic small molecule inhibitors.
J Med Chem 57: 2813-9 (2014)
University Of Nottingham
Protein kinase CK-1 inhibitors as new potential drugs for amyotrophic lateral sclerosis.
J Med Chem 57: 2755-72 (2014)
Csic
Cathepsin C inhibitors: property optimization and identification of a clinical candidate.
J Med Chem 57: 2357-67 (2014)
Astrazeneca
Synthesis and carbonic anhydrase I, II, IX and XII inhibition studies of 4-N,N-disubstituted sulfanilamides incorporating 4,4,4-trifluoro-3-oxo-but-1-enyl, phenacylthiourea and imidazol-2(3H)-one/thione moieties.
Bioorg Med Chem Lett 24: 1776-9 (2014)
University Of Cagliari
Design, synthesis and evaluation of genistein-O-alkylbenzylamines as potential multifunctional agents for the treatment of Alzheimer's disease.
Eur J Med Chem 76: 314-31 (2014)
Sichuan University
Total synthesis of burkholdacs A and B and 5,6,20-tri-epi-burkholdac A: HDAC inhibition and antiproliferative activity.
Eur J Med Chem 76: 301-13 (2014)
Tohoku Pharmaceutical University
4-Functionalized 1,3-diarylpyrazoles bearing benzenesulfonamide moiety as selective potent inhibitors of the tumor associated carbonic anhydrase isoforms IX and XII.
Eur J Med Chem 76: 284-90 (2014)
Kurukshetra University
Discovery of 3-(4-methanesulfonylphenoxy)-N-[1-(2-methoxy-ethoxymethyl)-1H-pyrazol-3-yl]-5-(3-methylpyridin-2-yl)-benzamide as a novel glucokinase activator (GKA) for the treatment of type 2 diabetes mellitus.
Bioorg Med Chem 22: 2280-93 (2014)
Yuhan Research Institute
Design and synthesis of conformationally restricted inhibitors of active thrombin activatable fibrinolysis inhibitor (TAFIa).
Bioorg Med Chem 22: 2261-8 (2014)
Astrazeneca
Biologically active eremophilane-type sesquiterpenes from Camarops sp., an endophytic fungus isolated from Alibertia macrophylla.
J Nat Prod 77: 668-72 (2014)
Universidade Estadual Paulista
Synthesis and evaluation of new Hsp90 inhibitors based on a 1,4,5-trisubstituted 1,2,3-triazole scaffold.
J Med Chem 57: 2258-74 (2014)
Universit£
Identification and optimization of new dual inhibitors of B-Raf and epidermal growth factor receptor kinases for overcoming resistance against vemurafenib.
J Med Chem 57: 2692-703 (2014)
Chinese Academy Of Sciences
Discovery of novel urea derivatives as dual-target hypoglycemic agents that activate glucokinase and PPAR¿.
Eur J Med Chem 76: 182-92 (2014)
Chinese Academy Of Medical Sciences & Peking Union Medical College
Recent advances in the structural library of functionalized quinazoline and quinazolinone scaffolds: synthetic approaches and multifarious applications.
Eur J Med Chem 76: 193-244 (2014)
Quaid-I-Azam University
The applications of binuclear metallohydrolases in medicine: recent advances in the design and development of novel drug leads for purple acid phosphatases, metallo-ß-lactamases and arginases.
Eur J Med Chem 76: 132-44 (2014)
The University Of Queensland
Homoisoflavonoids as potential imaging agents for ?-amyloid plaques in Alzheimer's disease.
Eur J Med Chem 76: 125-31 (2014)
Hefei University Of Technology
The discovery of reverse tricyclic pyridone JAK2 inhibitors. Part 2: lead optimization.
Bioorg Med Chem Lett 24: 1466-71 (2014)
Merck
Fragment-based discovery of potent inhibitors of the anti-apoptotic MCL-1 protein.
Bioorg Med Chem Lett 24: 1484-8 (2014)
Research & Development, Abbvie
5-Hydroxy-2-(2-phenylethyl)chromone (5-HPEC): a novel non-nitrogenous ligand for 5-HT2B receptor.
Bioorg Med Chem Lett 24: 1489-92 (2014)
Virginia Commonwealth University
Synthesis and evaluation of a novel class Hsp90 inhibitors containing 1-phenylpiperazine scaffold.
Bioorg Med Chem Lett 24: 1557-61 (2014)
China Pharmaceutical University
cis-1-Oxo-heterocyclyl-4-amido cyclohexane derivatives as NPY5 receptor antagonists.
Bioorg Med Chem Lett 24: 1458-61 (2014)
Lundbeck Research Usa
Interaction kinetics of liposome-incorporated unsaturated fatty acids with fatty acid-binding protein 3 by surface plasmon resonance.
Bioorg Med Chem 22: 1804-8 (2014)
Osaka University
Discovery of 2-pyridone derivatives as potent HIV-1 NNRTIs using molecular hybridization based on crystallographic overlays.
Bioorg Med Chem 22: 1863-72 (2014)
Shandong University
Structure-activity relationship refinement and further assessment of 4-phenylquinazoline-2-carboxamide translocator protein ligands as antiproliferative agents in human glioblastoma tumors.
J Med Chem 57: 2413-28 (2014)
Universit£
Differences in conformational dynamics between Plasmodium falciparum and human Hsp90 orthologues enable the structure-based discovery of pathogen-selective inhibitors.
J Med Chem 57: 2524-35 (2014)
University Of Geneva
Part I. Synthesis, biological evaluation and docking studies of new 2-furylbenzimidazoles as antiangiogenic agents.
Eur J Med Chem 87: 868-80 (2014)
National Research Centre, Dokki
Spiromastixones A-O, antibacterial chlorodepsidones from a deep-sea-derived Spiromastix sp. fungus.
J Nat Prod 77: 1021-30 (2014)
Peking University
Targeting carnitine biosynthesis: discovery of new inhibitors against¿-butyrobetaine hydroxylase.
J Med Chem 57: 2213-36 (2014)
Latvian Biomedical Research And Study Centre
Discovery of dual ZAP70 and Syk kinases inhibitors by docking into a rare C-helix-out conformation of Syk.
Bioorg Med Chem Lett 24: 1523-7 (2014)
University Of Zurich
Strategies to inhibit tumor associated integrin receptors: rationale for dual and multi-antagonists.
J Med Chem 57: 6301-15 (2014)
University Of Bradford
Propargyl-linked antifolates are dual inhibitors of Candida albicans and Candida glabrata.
J Med Chem 57: 2643-56 (2014)
University Of Connecticut
Design of novel potent antihyperlipidemic agents with antioxidant/anti-inflammatory properties: exploiting phenothiazine's strong antioxidant activity.
J Med Chem 57: 2568-81 (2014)
University Of Athens
Multitarget drug discovery for tuberculosis and other infectious diseases.
J Med Chem 57: 3126-39 (2014)
University Of Illinois At Urbana-Champaign
Synthesis and multitarget biological profiling of a novel family of rhein derivatives as disease-modifying anti-Alzheimer agents.
J Med Chem 57: 2549-67 (2014)
Universitat De Barcelona
X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human coronavirus papain-like proteases.
J Med Chem 57: 2393-412 (2014)
Purdue University
Novel spiroketal pyrrolidine GSK2336805 potently inhibits key hepatitis C virus genotype 1b mutants: from lead to clinical compound.
J Med Chem 57: 2058-73 (2014)
Glaxosmithkline
wALADin benzimidazoles differentially modulate the function of porphobilinogen synthase orthologs.
J Med Chem 57: 2498-510 (2014)
University Hospital Of Bonn
One-step semisynthesis of oleacein and the determination as a 5-lipoxygenase inhibitor.
J Nat Prod 77: 441-5 (2014)
University Of Athens
Development of novel tetrahydrothieno[2,3-c]pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: molecular hybridization from known antimycobacterial leads.
Bioorg Med Chem 22: 1938-47 (2014)
Birla Institute Of Technology
Design, synthesis and biological evaluation of novel 6-alkenylamides substituted of 4-anilinothieno[2,3-d]pyrimidines as irreversible epidermal growth factor receptor inhibitors.
Bioorg Med Chem 22: 2366-78 (2014)
Chinese Academy Of Sciences
Polyphenols bearing cinnamaldehyde scaffold showing cell growth inhibitory effects on the cisplatin-resistant A2780/Cis ovarian cancer cells.
Bioorg Med Chem 22: 1809-20 (2014)
Konkuk University
4,5,6,7-Tetrahydro-isoxazolo-[4,5-c]-pyridines as a new class of cytotoxic Hsp90 inhibitors.
Eur J Med Chem 76: 53-60 (2014)
Universit£
Diamidine compounds for selective inhibition of protein arginine methyltransferase 1.
J Med Chem 57: 2611-22 (2014)
The University Of Georgia
Design, synthesis, and structure-activity relationship studies of novel fused heterocycles-linked triazoles with good activity and water solubility.
J Med Chem 57: 3687-706 (2014)
Chinese Academy Of Sciences
Preparation and activities of macromolecule conjugates of the CCR5 antagonist Maraviroc.
ACS Med Chem Lett 5: 133-137 (2014)
The Scripps Research Institute
Identification of a new series of amides as non-covalent proteasome inhibitors.
Eur J Med Chem 76: 1-9 (2014)
Universit£
Design, synthesis and evaluation of N-substituted saccharin derivatives as selective inhibitors of tumor-associated carbonic anhydrase XII.
Bioorg Med Chem 22: 1821-31 (2014)
Sapienza University Of Rome
Alkynyl-coumarinyl ethers as MAO-B inhibitors.
Bioorg Med Chem 22: 1916-28 (2014)
University Of Bonn
Benzenesulfonamide bearing 1,2,4-triazole scaffolds as potent inhibitors of tumor associated carbonic anhydrase isoforms hCA IX and hCA XII.
Bioorg Med Chem 22: 1873-82 (2014)
Kurukshetra University
Preparation and optimization of new 4-(2-(indolin-1-yl)-2-oxoethyl)-2-morpholinothiazole-5-carboxylic acid and amide derivatives as potent and selective PI3Kß inhibitors.
Bioorg Med Chem Lett 24: 1506-10 (2014)
Sanofi
Discovery of 1,3,4-oxidiazole scaffold compounds as inhibitors of superoxide dismutase expression.
Bioorg Med Chem Lett 24: 1532-7 (2014)
Northwestern University
Preparation and evaluation of novel pyrazolo[1,5-a]pyrimidine acetamides, closely related to DPA-714, as potent ligands for imaging the TSPO 18kDa with PET.
Bioorg Med Chem Lett 24: 1550-6 (2014)
Cea
Development of novel silicon-containing inverse agonists of retinoic acid receptor-related orphan receptors.
Bioorg Med Chem 22: 1948-59 (2014)
The University Of Tokyo
Development of tag-free photoprobes for studies aimed at identifying the target of novel Group A Streptococcus antivirulence agents.
Bioorg Med Chem Lett 24: 1538-44 (2014)
University Of Michigan
A perspective on natural products research and ethnopharmacology in Mexico: the eagle and the serpent on the prickly pear cactus.
J Nat Prod 77: 678-89 (2014)
University Of London
Discovery of a tetracyclic quinoxaline derivative as a potent and orally active multifunctional drug candidate for the treatment of neuropsychiatric and neurological disorders.
J Med Chem 57: 2670-82 (2014)
Intra-Cellular Therapies
Synthesis and evaluation of 2-(1H-indol-3-yl)-4-phenylquinolines as inhibitors of cholesterol esterase.
Bioorg Med Chem Lett 24: 1545-9 (2014)
Universidad De Buenos Aires
Quality by design (QbD) of amide isosteres: 5,5-Disubstituted isoxazolines as potent CRTh2 antagonists with favorable pharmacokinetic and drug-like properties.
Bioorg Med Chem Lett 24: 1615-20 (2014)
Merck Research Laboratories
Synthesis of novel l-rhamnose derived acyclic C-nucleosides with substituted 1,2,3-triazole core as potent sodium-glucose co-transporter (SGLT) inhibitors.
Bioorg Med Chem Lett 24: 1528-31 (2014)
Csir-Indian Institute Of Chemical Technology
Novel 8-(p-substituted-phenyl/benzyl)xanthines with selectivity for the A2A adenosine receptor possess bronchospasmolytic activity.
Eur J Med Chem 75: 327-35 (2014)
Panjab University
Monovalent mannose-based DC-SIGN antagonists: targeting the hydrophobic groove of the receptor.
Eur J Med Chem 75: 308-26 (2014)
University Of Ljubljana
Design, synthesis and molecular modeling of aloe-emodin derivatives as potent xanthine oxidase inhibitors.
Eur J Med Chem 75: 289-96 (2014)
Hainan University
Discovery and early clinical evaluation of BMS-605339, a potent and orally efficacious tripeptidic acylsulfonamide NS3 protease inhibitor for the treatment of hepatitis C virus infection.
J Med Chem 57: 1708-29 (2014)
Bristol-Myers Squibb Research And Development
Selective and potent morpholinone inhibitors of the MDM2-p53 protein-protein interaction.
J Med Chem 57: 2472-88 (2014)
Amgen
Heat shock protein 70 inhibitors. 1. 2,5'-thiodipyrimidine and 5-(phenylthio)pyrimidine acrylamides as irreversible binders to an allosteric site on heat shock protein 70.
J Med Chem 57: 1188-207 (2014)
Memorial Sloan-Kettering Cancer Center
Isolation and synthesis of pulmonarins A and B, acetylcholinesterase inhibitors from the colonial ascidian Synoicum pulmonaria.
J Nat Prod 77: 364-9 (2014)
University Of Troms£
Bis(ammonio)alkane-type agonists of muscarinic acetylcholine receptors: synthesis, in vitro functional characterization, and in vivo evaluation of their analgesic activity.
Eur J Med Chem 75: 222-32 (2014)
Universit£
New C(4)- and C(1)-derivatives of furo[3,4-c]pyridine-3-ones and related compounds: evidence for site-specific inhibition of the constitutive proteasome and its immunoisoform.
Bioorg Med Chem Lett 24: 1571-80 (2014)
Yerevan State University
2-Amino-7-substituted benzoxazole analogs as potent RSK2 inhibitors.
Bioorg Med Chem Lett 24: 1592-6 (2014)
Novartis Institutes For Biomedical Research
Synthesis, biological evaluation, and structure-activity relationships of potent noncovalent and nonpeptidic cruzain inhibitors as anti-Trypanosoma cruzi agents.
J Med Chem 57: 2380-92 (2014)
Universidade De S£O Paulo
2-[N-Alkyl(R-phenyl)-aminomethyl]-3-phenyl-7-trifluoromethylquinoxalines as anticancer agents inhibitors of folate enzymes.
Eur J Med Chem 75: 169-83 (2014)
Universit£
New 1-arylindoles based serotonin 5-HT7 antagonists. Synthesis and binding evaluation studies.
Eur J Med Chem 75: 159-68 (2014)
Universit£
Design, synthesis and biological evaluation of hetero-aromatic moieties substituted pyrrole-2-carbonitrile derivatives as dipeptidyl peptidase IV inhibitors.
Eur J Med Chem 75: 111-22 (2014)
Shenyang Pharmaceutical University
Selective COX-1 inhibition as a target of theranostic novel diarylisoxazoles.
Eur J Med Chem 74: 606-18 (2014)
University Of Bari "A. Moro
Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease.
Eur J Med Chem 75: 82-95 (2014)
Laboratorio De Quimica Medica (Iqog, Csic)
Synthesis, biological evaluation and molecular modelling studies of 4-anilinoquinazoline derivatives as protein kinase inhibitors.
Bioorg Med Chem 22: 1909-15 (2014)
Rajiv Gandhi Proudyogiki Vishwavidyalaya
Structure-based optimization of cyclopropyl urea derivatives as potent soluble epoxide hydrolase inhibitors for potential decrease of renal injury without hypotensive action.
Bioorg Med Chem 22: 1548-57 (2014)
Dainippon Sumitomo Pharma
Design, synthesis and biological evaluation of 7-nitro-1H-indole-2-carboxylic acid derivatives as allosteric inhibitors of fructose-1,6-bisphosphatase.
Bioorg Med Chem 22: 1850-62 (2014)
Chinese Academy Of Medical Sciences & Peking Union Medical College
Inhibition of cellular proliferation and induction of apoptosis in human lung adenocarcinoma A549 cells by T-type calcium channel antagonist.
Bioorg Med Chem Lett 24: 1565-70 (2014)
Kyung Hee University
Synthesis of 2,6-disubstituted benzylamine derivatives as reversible selective inhibitors of copper amine oxidases.
Bioorg Med Chem 22: 1558-67 (2014)
Universit£
1-(2-Hydroxy-2-methyl-3-phenoxypropanoyl)indoline-4-carbonitrile derivatives as potent and tissue selective androgen receptor modulators.
J Med Chem 57: 2462-71 (2014)
Pfizer
Design, synthesis, crystallographic studies, and preliminary biological appraisal of new substituted triazolo[4,3-b]pyridazin-8-amine derivatives as tankyrase inhibitors.
J Med Chem 57: 2807-12 (2014)
Universit£
The discovery of N-((2H-tetrazol-5-yl)methyl)-4-((R)-1-((5r,8R)-8-(tert-butyl)-3-(3,5-dichlorophenyl)-2-oxo-1,4-diazaspiro[4.5]dec-3-en-1-yl)-4,4-dimethylpentyl)benzamide (SCH 900822): a potent and selective glucagon receptor antagonist.
J Med Chem 57: 2601-10 (2014)
Merck Research Laboratories
Design, synthesis and preliminary bioactivity studies of 1,2-dihydrobenzo[d]isothiazol-3-one-1,1-dioxide hydroxamic acid derivatives as novel histone deacetylase inhibitors.
Bioorg Med Chem 22: 1529-38 (2014)
Shandong University
Structurally novel highly potent proteasome inhibitors created by the structure-based hybridization of nonpeptidic belactosin derivatives and peptide boronates.
J Med Chem 57: 2726-35 (2014)
Hokkaido University
Coregulator control of androgen receptor action by a novel nuclear receptor-binding motif.
J Biol Chem 289: 8839-51 (2014)
Karlsruhe Institute Of Technology
Hepatitis C virus NS5A replication complex inhibitors: the discovery of daclatasvir.
J Med Chem 57: 2013-32 (2014)
Bristol-Myers Squibb Research And Development
Isolation of arginase inhibitors from the bioactivity-guided fractionation of Byrsonima coccolobifolia leaves and stems.
J Nat Prod 77: 392-6 (2014)
Universidade Federal De S£O Carlos
Chemical composition of the bark of Tetrapterys mucronata and identification of acetylcholinesterase inhibitory constituents.
J Nat Prod 77: 650-6 (2014)
Universidade Estadual Paulista (Unesp)
Nitric oxide (NO) releasing poly ADP-ribose polymerase 1 (PARP-1) inhibitors targeted to glutathione S-transferase P1-overexpressing cancer cells.
J Med Chem 57: 2292-302 (2014)
National Cancer Institute-Frederick
2-Amino-3-(phenylsulfanyl)norbornane-2-carboxylate: an appealing scaffold for the design of Rac1-Tiam1 protein-protein interaction inhibitors.
J Med Chem 57: 2953-62 (2014)
Universit£
Using ovality to predict nonmutagenic, orally efficacious pyridazine amides as cell specific spleen tyrosine kinase inhibitors.
J Med Chem 57: 2683-91 (2014)
Hoffmann-La Roche
Design, synthesis, and pharmacological evaluation of fluorinated tetrahydrouridine derivatives as inhibitors of cytidine deaminase.
J Med Chem 57: 2582-8 (2014)
Eisai
1,2-Dihydro-2-oxopyridine-3-carboxamides: the C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptor.
Eur J Med Chem 74: 524-32 (2014)
Universit£
Discovery of simplified N²-substituted pyrazolo[3,4-d]pyrimidine derivatives as novel adenosine receptor antagonists: efficient synthetic approaches, biological evaluations and molecular docking studies.
Bioorg Med Chem 22: 1751-65 (2014)
National University Of Singapore
6-Triazolyl-substituted sulfocoumarins are potent, selective inhibitors of the tumor-associated carbonic anhydrases IX and XII.
Bioorg Med Chem Lett 24: 1256-60 (2014)
Latvian Institute Of Organic Synthesis
Identification of tetrapeptides from a mixture based positional scanning library that can restore nM full agonist function of the L106P, I69T, I102S, A219V, C271Y, and C271R human melanocortin-4 polymorphic receptors (hMC4Rs).
J Med Chem 57: 4615-28 (2014)
University Of Florida
Therapeutic melting pot of never in mitosis gene a related kinase 2 (Nek2): a perspective on Nek2 as an oncology target and recent advancements in Nek2 small molecule inhibition.
J Med Chem 57: 5835-44 (2014)
The University Of Arizona
Synthesis and biological evaluation of new carbohydrate-substituted indenoisoquinoline topoisomerase I inhibitors and improved syntheses of the experimental anticancer agents indotecan (LMP400) and indimitecan (LMP776).
J Med Chem 57: 1495-512 (2014)
Purdue University
Discovery and SAR study of hydroxyacetophenone derivatives as potent, non-steroidal farnesoid X receptor (FXR) antagonists.
Bioorg Med Chem 22: 1596-607 (2014)
East China University Of Science And Technology
Synthesis of 6-tetrazolyl-substituted sulfocoumarins acting as highly potent and selective inhibitors of the tumor-associated carbonic anhydrase isoforms IX and XII.
Bioorg Med Chem 22: 1522-8 (2014)
Latvian Institute Of Organic Synthesis
Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, IX and XII with benzene sulfonamides incorporating 4- and 3-nitrophthalimide moieties.
Bioorg Med Chem 22: 1586-95 (2014)
Birla Institute Of Technology
1-Aryl-2-((6-aryl)pyrimidin-4-yl)amino)ethanols as competitive inhibitors of fatty acid amide hydrolase.
Bioorg Med Chem Lett 24: 1280-4 (2014)
Janssen Pharmaceutical Companies Of Johnson & Johnson
Lactam sulfonamides as potent inhibitors of the Kv1.5 potassium ion channel.
Bioorg Med Chem Lett 24: 1269-73 (2014)
Astrazeneca
Identification of 1-{2-[4-chloro-1'-(2,2-dimethylpropyl)-7-hydroxy-1,2-dihydrospiro[indole-3,4'-piperidine]-1-yl]phenyl}-3-{5-chloro-[1,3]thiazolo[5,4-b]pyridin-2-yl}urea, a potent, efficacious and orally bioavailable P2Y(1) antagonist as an antiplatelet agent.
Bioorg Med Chem Lett 24: 1294-8 (2014)
Bristol-Myers Squibb
Discovery of (1R,6S)-5-[4-(1-cyclobutyl-piperidin-4-yloxy)-phenyl]-3,4-diaza-bicyclo[4.1.0]hept-4-en-2-one (R,S-4a): histamine H(3) receptor inverse agonist demonstrating potent cognitive enhancing and wake promoting activity.
Bioorg Med Chem Lett 24: 1303-6 (2014)
Teva Pharmaceutical Global R & D
Design, synthesis, and structure-activity relationship of a novel series of GluN2C-selective potentiators.
J Med Chem 57: 2334-56 (2014)
Emory University
Discovery of potent Keap1-Nrf2 protein-protein interaction inhibitor based on molecular binding determinants analysis.
J Med Chem 57: 2736-45 (2014)
China Pharmaceutical University
Discovery of isoquinolinone indole acetic acids as antagonists of chemoattractant receptor homologous molecule expressed on Th2 cells (CRTH2) for the treatment of allergic inflammatory diseases.
J Med Chem 57: 1299-322 (2014)
Pfizer
Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.
Eur J Med Chem 75: 21-30 (2014)
Khon Kaen University
Integrating docking scores, interaction profiles and molecular descriptors to improve the accuracy of molecular docking: toward the discovery of novel Akt1 inhibitors.
Eur J Med Chem 75: 11-20 (2014)
Zhejiang University
Discovery of a novel series of indoline carbamate and indolinylpyrimidine derivatives as potent GPR119 agonists.
Bioorg Med Chem 22: 1649-66 (2014)
Takeda Pharmaceutical
Lead modification: amino acid appended indoles as highly effective 5-LOX inhibitors.
Bioorg Med Chem 22: 1642-8 (2014)
Guru Nanak Dev University
Design, synthesis, radiolabeling and in vivo evaluation of potential positron emission tomography (PET) radioligands for brain imaging of the 5-HT? receptor.
Bioorg Med Chem 22: 1736-50 (2014)
Universit£
Syntheses and structure-activity relationships for some triazolyl p38? MAPK inhibitors.
Bioorg Med Chem Lett 24: 1352-7 (2014)
Syncom
Discovery of 2-(1H-indazol-1-yl)-thiazole derivatives as selective EP(1) receptor antagonists for treatment of overactive bladder by core structure replacement.
Bioorg Med Chem Lett 24: 1327-33 (2014)
Asahi Kasei Pharma
HTS followed by NMR based counterscreening. Discovery and optimization of pyrimidones as reversible and competitive inhibitors of xanthine oxidase.
Bioorg Med Chem Lett 24: 1315-21 (2014)
Astrazeneca
Switching cannabinoid response from CB(2) agonists to FAAH inhibitors.
Bioorg Med Chem Lett 24: 1322-6 (2014)
University Of Lille
Discovery of a cyclopentylamine as an orally active dual NK1 receptor antagonist-serotonin reuptake transporter inhibitor.
Bioorg Med Chem Lett 24: 1611-4 (2014)
Bristol-Myers Squibb
Synthesis, biological evaluation, hydration site thermodynamics, and chemical reactivity analysis ofa-keto substituted peptidomimetics for the inhibition of Plasmodium falciparum.
Bioorg Med Chem Lett 24: 1274-9 (2014)
University Of Mississippi
3-Amino-N-adamantyl-3-methylbutanamide derivatives as 11ß-hydroxysteroid dehydrogenase 1 inhibitor.
Bioorg Med Chem Lett 24: 1421-5 (2014)
Yonsei University
Substituted benzene sulfonamides incorporating 1,3,5-triazinyl moieties potently inhibit human carbonic anhydrases II, IX and XII.
Bioorg Med Chem Lett 24: 1310-4 (2014)
Shri G.S. Institute Of Technology And Science
Reaction intermediate analogues as bisubstrate inhibitors of pantothenate synthetase.
Bioorg Med Chem 22: 1726-35 (2014)
Soochow University
Identification of highly efficacious glucocorticoid receptor agonists with a potential for reduced clinical bone side effects.
J Med Chem 57: 1583-98 (2014)
Boehringer Ingelheim Pharmaceuticals
Synthesis, [¹8F] radiolabeling, and evaluation of poly (ADP-ribose) polymerase-1 (PARP-1) inhibitors for in vivo imaging of PARP-1 using positron emission tomography.
Bioorg Med Chem 22: 1700-7 (2014)
Washington University Saint Louis
Toxicological and pharmacological evaluation, antioxidant, ADMET and molecular modeling of selected racemic chromenotacrines {11-amino-12-aryl-8,9,10,12-tetrahydro-7H-chromeno[2,3-b]quinolin-3-ols} for the potential prevention and treatment of Alzheimer's disease.
Eur J Med Chem 74: 491-501 (2014)
Universidad Complutense De Madrid
Modulators of the nuclear receptor retinoic acid receptor-related orphan receptor-¿ (ROR¿ or RORc).
J Med Chem 57: 5871-92 (2014)
Genentech
Bioactive limonoids from the leaves of Azaridachta indica (Neem).
J Nat Prod 77: 596-602 (2014)
Universidad De Los Andes
Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1.
J Biol Chem 289: 9304-19 (2014)
Bayer Healthcare
Structure activity relationship studies of 3-arylsulfonyl-pyrido[1,2-a]pyrimidin-4-imines as potent 5-HT? antagonists.
Bioorg Med Chem 22: 1782-90 (2014)
Bristol-Myers Squibb Research And Development
Lipoxygenase inhibitors derived from marine macroalgae.
Bioorg Med Chem Lett 24: 1383-5 (2014)
Hokkaido University
A facile one-pot synthesis of 2-arylamino-5-aryloxylalkyl-1,3,4-oxadiazoles and their urease inhibition studies.
Chem Biol Drug Des 84: 92-8 (2014)
Mirpur University Of Science And Technology (Must)
Study of marine natural products including resorcyclic acid lactones from Humicola fuscoatra that reactivate latent HIV-1 expression in an in vitro model of central memory CD4+ T cells.
J Nat Prod 77: 618-24 (2014)
University Of California
Discovery and SAR of 6-alkyl-2,4-diaminopyrimidines as histamine H4 receptor antagonists.
J Med Chem 57: 2429-39 (2014)
Janssen Research And Development
Elucidation of structural elements for selectivity across monoamine transporters: novel 2-[(diphenylmethyl)sulfinyl]acetamide (modafinil) analogues.
J Med Chem 57: 1000-13 (2014)
National Institute On Drug Abuse-Intramural Research Program
Potent and selective inhibitors of CDPK1 from
ACS Med Chem Lett 5: 40-44 (2014)
University Of Washington
Chemical constituents of Plectranthus amboinicus and the synthetic analogs possessing anti-inflammatory activity.
Bioorg Med Chem 22: 1766-72 (2014)
National Defense Medical Center, Taiwan
Synthesis and biological evaluation of novel benzamide derivatives as potent smoothened antagonists.
Bioorg Med Chem Lett 24: 1426-31 (2014)
Sichuan University
Discovery of a potent stapled helix peptide that binds to the 70N domain of replication protein A.
J Med Chem 57: 2455-61 (2014)
Vanderbilt University School Of Medicine
Imaging evaluation of 5HT2C agonists, [(11)C]WAY-163909 and [(11)C]vabicaserin, formed by Pictet-Spengler cyclization.
J Med Chem 57: 1488-94 (2014)
Harvard Medical School
Optimization, pharmacophore modeling and 3D-QSAR studies of sipholanes as breast cancer migration and proliferation inhibitors.
Eur J Med Chem 73: 310-24 (2014)
University Of Louisiana At Monroe
Synthesis and evaluation of new coumarin derivatives as potential atypical antipsychotics.
Eur J Med Chem 74: 427-39 (2014)
Huazhong University Of Science And Technology
Synthesis and in vitro urease inhibitory activity of N,N'-disubstituted thioureas.
Eur J Med Chem 74: 314-23 (2014)
University Karachi
Substituted piperidines as HDM2 inhibitors.
Bioorg Med Chem Lett 24: 1026-30 (2014)
Merck Research Laboratories
IV. Discovery of CXCR3 antagonists substituted with heterocycles as amide surrogates: improved PK, hERG and metabolic profiles.
Bioorg Med Chem Lett 24: 1085-8 (2014)
Merck Research Laboratories
Synthesis and receptor binding studies of some new arylcarboxamide derivatives as sigma-1 ligands.
Bioorg Med Chem Lett 24: 1021-5 (2014)
University Of Trieste
Discovery of novel 6,7-disubstituted-4-phenoxyquinoline derivatives bearing 5-(aminomethylene)pyrimidine-2,4,6-trione moiety as c-Met kinase inhibitors.
Bioorg Med Chem 22: 1236-49 (2014)
Shenyang Pharmaceutical University
Synthesis of aminoalkyl-substituted coumarin derivatives as acetylcholinesterase inhibitors.
Bioorg Med Chem 22: 1262-7 (2014)
Kyung Hee University
A perylene derivative regulates HIF-1a and Stat3 signaling pathways.
Bioorg Med Chem 22: 1496-505 (2014)
Baylor College Of Medicine
Activation and inhibition of thermosensitive TRP channels by voacangine, an alkaloid present in Voacanga africana, an African tree.
J Nat Prod 77: 285-97 (2014)
University Of Shizuoka
Rational Design of Novel Pyridinol-Fused Ring Acetaminophen Analogues.
ACS Med Chem Lett 4: 710-714 (2013)
Vanderbilt University
Semi-synthesis of acylated triterpenes from olive-oil industry wastes for the development of anticancer and anti-HIV agents.
Eur J Med Chem 74: 278-301 (2014)
Universidad De Granada
Cytotoxic and protein kinase inhibiting nakijiquinones and nakijiquinols from the sponge Dactylospongia metachromia.
J Nat Prod 77: 218-26 (2014)
Heinrich Heine Universit£T
Study of the structural and dynamic effects in the FimH adhesin upona-d-heptyl mannose binding.
J Med Chem 57: 1416-27 (2014)
Vrije Universiteit Brussel
Simplified 2-aminoquinoline-based scaffold for potent and selective neuronal nitric oxide synthase inhibition.
J Med Chem 57: 1513-30 (2014)
Northwestern University
High-affinity small-molecule inhibitors of the menin-mixed lineage leukemia (MLL) interaction closely mimic a natural protein-protein interaction.
J Med Chem 57: 1543-56 (2014)
University Of Michigan
Structural modifications of neuroprotective anti-Parkinsonian (-)-N6-(2-(4-(biphenyl-4-yl)piperazin-1-yl)-ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine (D-264): an effort toward the improvement of in vivo efficacy of the parent molecule.
J Med Chem 57: 1557-72 (2014)
Wayne State University
Discovery of (E)-3-((styrylsulfonyl)methyl)pyridine and (E)-2-((styrylsulfonyl)methyl)pyridine derivatives as anticancer agents: synthesis, structure-activity relationships, and biological activities.
J Med Chem 57: 2275-91 (2014)
University Of South Australia
Euodenine A: a small-molecule agonist of human TLR4.
J Med Chem 57: 1252-75 (2014)
Griffith University
Bicyclic 1-hydroxy-2-oxo-1,2-dihydropyridine-3-carboxamide-containing HIV-1 integrase inhibitors having high antiviral potency against cells harboring raltegravir-resistant integrase mutants.
J Med Chem 57: 1573-82 (2014)
National Cancer Institute-Frederick
Novel inhibitors of human DOPA decarboxylase extracted from Euonymus glabra Roxb.
ACS Chem Biol 9: 897-903 (2014)
Shanghai Center For Systems Biomedicine
Indoloditerpenes from a marine-derived fungal strain of Dichotomomyces cejpii with antagonistic activity at GPR18 and cannabinoid receptors.
J Nat Prod 77: 673-7 (2014)
University Of Bonn
Octulosonic acid derivatives from Roman chamomile (Chamaemelum nobile) with activities against inflammation and metabolic disorder.
J Nat Prod 77: 509-15 (2014)
University Of Mississippi
Synthesis, structure-activity relationships and brain uptake of a novel series of benzopyran inhibitors of insulin-regulated aminopeptidase.
J Med Chem 57: 1368-77 (2014)
Monash Institute Of Pharmaceutical Sciences
Importance of sphingosine kinase (SphK) as a target in developing cancer therapeutics and recent developments in the synthesis of novel SphK inhibitors.
J Med Chem 57: 5509-24 (2014)
Penn State Hershey Cancer Institute
Discovery of potent and selective inhibitors of
ACS Med Chem Lett 4: 1148-1151 (2013)
Duquesne University
Nonclassical antifolates, part 5. Benzodiazepine analogs as a new class of DHFR inhibitors: synthesis, antitumor testing and molecular modeling study.
Eur J Med Chem 74: 234-45 (2014)
Future University
Synthesis and biological evaluation of benzo[4,5]imidazo[1,2-c]pyrimidine and benzo[4,5]imidazo[1,2-a]pyrazine derivatives as anaplastic lymphoma kinase inhibitors.
Bioorg Med Chem 22: 1303-12 (2014)
Universit£
Bridged tetrahydroisoquinolines as selective NADPH oxidase 2 (Nox2) inhibitors.
Medchemcomm 4: 1085-1092 (2013)
University Of Pittsburgh
The structure-activity relationships of L3MBTL3 inhibitors: flexibility of the dimer interface.
Medchemcomm 4: 1501-1507 (2013)
University Of North Carolina
Synthesis, structure-activity relationship of iodinated-4-aryloxymethyl-coumarins as potential anti-cancer and anti-mycobacterial agents.
Eur J Med Chem 74: 225-33 (2014)
P.C. Jabin Science College
New class of azaheptapyridine FPT inhibitors as potential cancer therapy agents.
Bioorg Med Chem Lett 24: 1228-31 (2014)
Merck Research Laboratories
Discovery of 6-aryl-azabenzimidaoles that inhibit the TBK1/IKK-e kinases.
Bioorg Med Chem Lett 24: 1138-43 (2014)
Astrazeneca
Discovery of novel indazole derivatives as dual angiotensin II antagonists and partial PPAR¿ agonists.
Bioorg Med Chem Lett 24: 1098-103 (2014)
Glaxosmithkline
Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 2: development of a [3.3.0]-based series and other piperidine bioisosteres.
Bioorg Med Chem Lett 24: 1062-6 (2014)
Vanderbilt University Medical Center
Identification of dihydrostilbenes in Pholidota chinensis as a new scaffold for GABAA receptor modulators.
Bioorg Med Chem 22: 1276-84 (2014)
University Of Basel
Synthesis of a C-phosphonate mimic of maltose-1-phosphate and inhibition studies on Mycobacterium tuberculosis GlgE.
Bioorg Med Chem 22: 1404-11 (2014)
The University Of Toledo
Ionic liquid mediated synthesis of mono- and bis-spirooxindole-hexahydropyrrolidines as cholinesterase inhibitors and their molecular docking studies.
Bioorg Med Chem 22: 1318-28 (2014)
Universiti Sains Malaysia
Synthesis and biological evaluation of a new series of ebselen derivatives as glutathione peroxidase (GPx) mimics and cholinesterase inhibitors against Alzheimer's disease.
Bioorg Med Chem 22: 1355-61 (2014)
Sun Yat-Sen University
Design and synthesis of prostate cancer antigen-1 (PCA-1/ALKBH3) inhibitors as anti-prostate cancer drugs.
Bioorg Med Chem Lett 24: 1071-4 (2014)
Hyogo University Of Health Science
Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 1: development of a potent and CNS penetrant [3.1.0]-based lead.
Bioorg Med Chem Lett 24: 1067-70 (2014)
Vanderbilt University Medical Center
Anilino-monoindolylmaleimides as potent and selective JAK3 inhibitors.
Bioorg Med Chem Lett 24: 1116-21 (2014)
Fox Chase Chemical Diversity Center
Anion inhibition studies of two new ?-carbonic anhydrases from the bacterial pathogen Legionella pneumophila.
Bioorg Med Chem Lett 24: 1127-32 (2014)
Kochi Medical School
Rat intestinal sucrase inhibition of constituents from the roots of Rosa rugosa Thunb.
Bioorg Med Chem Lett 24: 1192-6 (2014)
Chungnam National University
Heterocyclic core analogs of a direct thrombin inhibitor.
Bioorg Med Chem Lett 24: 1111-5 (2014)
Merck Research Laboratories
Benzimidazole CB2 agonists: design, synthesis and SAR.
Bioorg Med Chem Lett 24: 1218-21 (2014)
Merck Research Laboratories
Novel lung adenocarcinoma and nuclear factor-kappa B (NF-¿B) inhibitors: synthesis and evaluation of lantadene congeners.
Eur J Med Chem 74: 135-44 (2014)
Jaypee University Of Information Technology
Inhibition of I¿B kinase-ß and I¿B kinase-a by heterocyclic adamantyl arotinoids.
Bioorg Med Chem 22: 1285-302 (2014)
Universidade De Vigo
Degrasyn-like symmetrical compounds: possible therapeutic agents for multiple myeloma (MM-I).
Bioorg Med Chem 22: 1450-8 (2014)
The University Of Texas M.D. Anderson Cancer Center
Synthesis and biological evaluation of all eight stereoisomers of DPP-IV inhibitor saxagliptin.
Bioorg Med Chem 22: 1383-93 (2014)
China Pharmaceutical University
Design and synthesis of N?-aryl-benzimidazoles 2-substituted as novel HIV-1 non-nucleoside reverse transcriptase inhibitors.
Bioorg Med Chem 22: 1459-67 (2014)
Universit£
Synthesis and biological evaluation of novel pazopanib derivatives as antitumor agents.
Bioorg Med Chem Lett 24: 1108-10 (2014)
Tianjin University
Isochromans and ?-pyrones from Penicillium corylophilum.
J Nat Prod 77: 206-12 (2014)
Carleton University
Synthesis and anti-renal fibrosis activity of conformationally locked truncated 2-hexynyl-N(6)-substituted-(N)-methanocarba-nucleosides as A3 adenosine receptor antagonists and partial agonists.
J Med Chem 57: 1344-54 (2014)
Seoul National University
Discovery of AMG 232, a potent, selective, and orally bioavailable MDM2-p53 inhibitor in clinical development.
J Med Chem 57: 1454-72 (2014)
Amgen
Drug design targeting protein-protein interactions (PPIs) using multiple ligand simultaneous docking (MLSD) and drug repositioning: discovery of raloxifene and bazedoxifene as novel inhibitors of IL-6/GP130 interface.
J Med Chem 57: 632-41 (2014)
The Ohio State University
De-novo designed library of benzoylureas as inhibitors of BCL-XL: synthesis, structural and biochemical characterization.
J Med Chem 57: 1323-43 (2014)
The Walter And Eliza Hall Institute Of Medical Research
Design, synthesis, and biological evaluation of deuterated C-aryl glycoside as a potent and long-acting renal sodium-dependent glucose cotransporter 2 inhibitor for the treatment of type 2 diabetes.
J Med Chem 57: 1236-51 (2014)
Fudan University
Design, synthesis, and characterization ofa-ketoheterocycles that additionally target the cytosolic port Cys269 of fatty acid amide hydrolase.
J Med Chem 57: 1079-89 (2014)
The Scripps Research Institute
Discovery of?2 Adrenergic Receptor Ligands Using Biosensor Fragment Screening of Tagged Wild-Type Receptor.
ACS Med Chem Lett 4: 1005-1010 (2013)
University Of Dundee
Encoded library technology as a source of hits for the discovery and lead optimization of a potent and selective class of bactericidal direct inhibitors of Mycobacterium tuberculosis InhA.
J Med Chem 57: 1276-88 (2014)
Glaxosmithkline
Discovery of substituted lactams as novel dual orexin receptor antagonists. Synthesis, preliminary structure-activity relationship studies and efforts towards improved metabolic stability and pharmacokinetic properties. Part 1.
Bioorg Med Chem Lett 24: 1201-8 (2014)
Actelion Pharmaceuticals
Potent and selective double-headed thiophene-2-carboximidamide inhibitors of neuronal nitric oxide synthase for the treatment of melanoma.
J Med Chem 57: 686-700 (2014)
Northwestern University
Structure-based optimization of tyrosine kinase inhibitor CLM3. Design, synthesis, functional evaluation, and molecular modeling studies.
J Med Chem 57: 1225-35 (2014)
Universit£
Glucocorticoid receptor modulators informed by crystallography lead to a new rationale for receptor selectivity, function, and implications for structure-based design.
J Med Chem 57: 849-60 (2014)
Eli Lilly
2,4-Diaminothienopyrimidines as orally active antimalarial agents.
J Med Chem 57: 1014-22 (2014)
University Of Cape Town
Benzofuran derivatives as a novel class of inhibitors of mTOR signaling.
Eur J Med Chem 74: 41-9 (2014)
Cnrs/Universit£
Design, synthesis, biological evaluation, and comparative docking study of 1,2,4-triazolones as CB1 receptor selective antagonists.
Eur J Med Chem 74: 73-84 (2014)
Zhejiang University
Development of selective inhibitors for aldehyde dehydrogenases based on substituted indole-2,3-diones.
J Med Chem 57: 714-22 (2014)
Indiana University School Of Medicine
The different inhibition mechanisms of OXA-1 and OXA-24 ß-lactamases are determined by the stability of active site carboxylated lysine.
J Biol Chem 289: 6152-64 (2014)
Case Western Reserve University
Insights into the mechanism of streptonigrin-induced protein arginine deiminase inactivation.
Bioorg Med Chem 22: 1362-9 (2014)
The Scripps Research Institute-Florida
Discovery of N-(3-((7H-purin-6-yl)thio)-4-hydroxynaphthalen-1-yl)-sulfonamide derivatives as novel protein kinase and angiogenesis inhibitors for the treatment of cancer: Synthesis and biological evaluation. Part III.
Bioorg Med Chem 22: 1487-95 (2014)
Shandong University
Design, synthesis, and biological evaluation of a series of piperazine ureas as fatty acid amide hydrolase inhibitors.
Bioorg Med Chem 22: 1468-78 (2014)
Takeda Pharmaceutical
Substituted 4-phenyl-2-aminoimidazoles and 4-phenyl-4,5-dihydro-2-aminoimidazoles as voltage-gated sodium channel modulators.
Eur J Med Chem 74: 23-30 (2014)
University Of Ljubljana
N-(3-Arylaminopyridin-4-yl)alkanesulfonamides as pyridine analogs of nimesulide: cyclooxygenases inhibition, anti-inflammatory studies and insight on metabolism.
Eur J Med Chem 74: 12-22 (2014)
University Of Li£Ge
Discovery and optimization of 5-(2-((1-(phenylsulfonyl)-1,2,3,4-tetrahydroquinolin-7-yl)oxy)pyridin-4-yl)-1,2,4-oxadiazoles as novel gpr119 agonists.
Bioorg Med Chem Lett 24: 1133-7 (2014)
Amgen
Virtual screening reveals allosteric inhibitors of the Toxoplasma gondii thymidylate synthase-dihydrofolate reductase.
Bioorg Med Chem Lett 24: 1232-5 (2014)
Yale University
Discovery of C-(1-aryl-cyclohexyl)-methylamines as selective, orally available inhibitors of dipeptidyl peptidase IV.
Bioorg Med Chem Lett 24: 731-6 (2014)
Novartis Institutes For Biomedical Research
Design, synthesis, and evaluation of conformationally restricted acetanilides as potent and selectiveß3 adrenergic receptor agonists for the treatment of overactive bladder.
J Med Chem 57: 1437-53 (2014)
Merck And
Is NMR Fragment Screening Fine-Tuned to Assess Druggability of Protein-Protein Interactions?
ACS Med Chem Lett 5: 23-28 (2014)
University Of Cambridge
Structure-activity relationships of substituted oxyoxalamides as inhibitors of the human soluble epoxide hydrolase.
Bioorg Med Chem 22: 1163-75 (2014)
Ehime University
Heteroarylureas with spirocyclic diamine cores as inhibitors of fatty acid amide hydrolase.
Bioorg Med Chem Lett 24: 737-41 (2014)
Janssen Research And Development
Discovery of MK-7655, aß-lactamase inhibitor for combination with Primaxin®.
Bioorg Med Chem Lett 24: 780-5 (2014)
Merck Research Labs
Identification of novel 7-amino-5-methyl-1,6-naphthyridin-2(1H)-one derivatives as potent PI3K/mTOR dual inhibitors.
Bioorg Med Chem Lett 24: 790-3 (2014)
Pkucare Pharmaceutical R & D Center
Fragment-based design of 3-aminopyridine-derived amides as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT).
Bioorg Med Chem Lett 24: 954-62 (2014)
Genentech
Design of potent and selective inhibitors to overcome clinical anaplastic lymphoma kinase mutations resistant to crizotinib.
J Med Chem 57: 1170-87 (2014)
Pfizer
Back pocket flexibility provides group II p21-activated kinase (PAK) selectivity for type I 1/2 kinase inhibitors.
J Med Chem 57: 1033-45 (2014)
Genentech
Sulfur incorporation generally improves Ricin inhibition in pterin-appended glycine-phenylalanine dipeptide mimics.
Bioorg Med Chem Lett 23: 6799-804 (2014)
TBA
Tissue transglutaminase: an emerging target for therapy and imaging.
Bioorg Med Chem Lett 23: 6528-43 (2014)
TBA
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 2'-fluoro-3'-(substituted pyridinyl)-7-deschloroepibatidine analogues.
J Med Chem 57: 836-48 (2014)
Research Triangle Institute
Structure-based design of new dihydrofolate reductase antibacterial agents: 7-(benzimidazol-1-yl)-2,4-diaminoquinazolines.
J Med Chem 57: 651-68 (2014)
Trius Therapeutics
Design, synthesis, and pharmacological evaluation of a novel series of pyridopyrazine-1,6-dione¿-secretase modulators.
J Med Chem 57: 1046-62 (2014)
Pfizer
Recent progress in the identification of BRAF inhibitors as anti-cancer agents.
Eur J Med Chem 72: 170-205 (2014)
Cairo University
Diphenylpyridylethanamine (DPPE)-based aminoheterocycles as cholesteryl ester transfer protein inhibitors.
Bioorg Med Chem Lett 24: 860-4 (2014)
Bristol-Myers Squibb
Optimization of brain penetrant 11ß-hydroxysteroid dehydrogenase type I inhibitors and in vivo testing in diet-induced obese mice.
J Med Chem 57: 970-86 (2014)
Astrazeneca
Development of novel potent orally bioavailable oseltamivir derivatives active against resistant influenza A.
J Med Chem 57: 759-69 (2014)
Christian-Albrechts University Of Kiel
Aldosterone synthase inhibitors as promising treatments for mineralocorticoid dependent cardiovascular and renal diseases.
J Med Chem 57: 5011-22 (2014)
Saarland University And Helmholtz Institute For Pharmaceutical Research Saarland (Hips)
Inhibition of reverse transcriptase and Taq DNA polymerase by compounds possessing the coumarin framework.
Bioorg Med Chem Lett 24: 760-4 (2014)
Intequi-Conicet
A biochemical screen for GroEL/GroES inhibitors.
Bioorg Med Chem Lett 24: 786-9 (2014)
Indiana University
Design, synthesis, and SAR of a series of activated protein C (APC) inhibitors with selectivity against thrombin for the treatment of haemophilia.
Bioorg Med Chem Lett 24: 821-7 (2014)
Astrazeneca
Direct interaction of garcinol and related polyisoprenylated benzophenones of Garcinia cambogia fruits with the transcription factor STAT-1 as a likely mechanism of their inhibitory effect on cytokine signaling pathways.
J Nat Prod 77: 543-9 (2014)
Universit£
Discovery of 8-cyclopentyl-2-[4-(4-methyl-piperazin-1-yl)-phenylamino]-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidine-6-carbonitrile (7x) as a potent inhibitor of cyclin-dependent kinase 4 (CDK4) and AMPK-related kinase 5 (ARK5).
J Med Chem 57: 578-99 (2014)
Icahn School Of Medicine At Mount Sinai
Discovery and development of Janus kinase (JAK) inhibitors for inflammatory diseases.
J Med Chem 57: 5023-38 (2014)
Pfizer
Rapid identification of Keap1-Nrf2 small-molecule inhibitors through structure-based virtual screening and hit-based substructure search.
J Med Chem 57: 1121-6 (2014)
University Of Minnesota
Synthesis and assay of retro-a4ß1 integrin-targeting motifs.
Eur J Med Chem 73: 225-32 (2014)
University Of Bologna
Synthesis, biological evaluation and molecular docking studies of benzyloxyacetohydroxamic acids as LpxC inhibitors.
Bioorg Med Chem 22: 1016-28 (2014)
Institut F£R Pharmazeutische Und Medizinische Chemie Der Westf£Lischen Wilhelms-Universit£T M£Nster
Inhibition of tyrosinase activity by polyphenol compounds from Flemingia philippinensis roots.
Bioorg Med Chem 22: 1115-20 (2014)
Gyeongsang National University
Discovery of novel chiral diazepines as bombesin receptor subtype-3 (BRS-3) agonists with low brain penetration.
Bioorg Med Chem Lett 24: 750-5 (2014)
Daiichi Sankyo
Successful reduction of off-target hERG toxicity by structural modification of a T-type calcium channel blocker.
Bioorg Med Chem Lett 24: 880-3 (2014)
The Catholic University Of Korea
Structure-activity relationships of diamine inhibitors of cytochrome P450 (CYP) 3A as novel pharmacoenhancers. Part II: P2/P3 region and discovery of cobicistat (GS-9350).
Bioorg Med Chem Lett 24: 995-9 (2014)
Gilead Sciences
Identification of a selective inhibitor of murine intestinal alkaline phosphatase (ML260) by concurrent ultra-high throughput screening against human and mouse isozymes.
Bioorg Med Chem Lett 24: 1000-4 (2014)
Sanford-Burnham Medical Research Institute
Identification of the 5,5-dioxo-7,8-dihydro-6H-thiopyrano[3,2-d]pyrimidine derivatives as highly selective PDE4B inhibitors.
Bioorg Med Chem Lett 24: 893-9 (2014)
Kyushu University
Structure-activity relationships of N-substituted 4-(trifluoromethoxy)benzamidines with affinity for GluN2B-containing NMDA receptors.
Bioorg Med Chem Lett 24: 828-30 (2014)
The University Of Sydney
Discovery of pyrazolo[3,4-d]pyrimidine derivatives as GPR119 agonists.
Bioorg Med Chem Lett 24: 949-53 (2014)
Hoffmann-La Roche
Carbamazepine derivatives with P2X4 receptor-blocking activity.
Bioorg Med Chem 22: 1077-88 (2014)
University Of Bonn
Morpholylureas are a new class of potent and selective inhibitors of the type 5 17-ß-hydroxysteroid dehydrogenase (AKR1C3).
Bioorg Med Chem 22: 967-77 (2014)
University Of Auckland
Formosusin A, a novel specific inhibitor of mammalian DNA polymeraseß from the fungus Paecilomyces formosus.
Bioorg Med Chem 22: 1070-6 (2014)
Kobe Gakuin University
Synthesis and biological evaluation of novel oxadiazole derivatives: a new class of thymidine phosphorylase inhibitors as potential anti-tumor agents.
Bioorg Med Chem 22: 1008-15 (2014)
Institute Of Information Technology
Synthesis, modelling and biological characterization of 3-substituted-1H-indoles as ligands of GluN2B-containing N-methyl-d-aspartate receptors.
Bioorg Med Chem 22: 1040-8 (2014)
Universit£
Structure-activity relationships of diamine inhibitors of cytochrome P450 (CYP) 3A as novel pharmacoenhancers, part I: core region.
Bioorg Med Chem Lett 24: 989-94 (2014)
Gilead Sciences
Synthesis and biological evaluation of novel tricyclic oxazine and oxazepine fused quinazolines. Part 1: erlotinib analogs.
Bioorg Med Chem Lett 24: 884-7 (2014)
Jiangsu Aosaikang Pharmaceutical
Discovery of spirofused piperazine and diazepane amides as selective histamine-3 antagonists with in vivo efficacy in a mouse model of cognition.
J Med Chem 57: 733-58 (2014)
Astrazeneca
Effects of novel diarylpentanoid analogues of curcumin on secretory phospholipase A2 , cyclooxygenases, lipo-oxygenase, and microsomal prostaglandin E synthase-1.
Chem Biol Drug Des 83: 670-81 (2014)
Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300, Kuala Lumpur, Malaysia
Identification of potent CNS-penetrant thiazolidinones as novel CGRP receptor antagonists.
Bioorg Med Chem Lett 24: 845-9 (2014)
Vertex Pharmaceuticals
4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable stearoyl-CoA desaturase-1 (SCD1) inhibitors: part 2. Pyridazine-based analogs.
Bioorg Med Chem Lett 24: 1437-41 (2014)
Janssen Research And Development
Thiazolopyridone ureas as DNA gyrase B inhibitors: optimization of antitubercular activity and efficacy.
Bioorg Med Chem Lett 24: 870-9 (2014)
Astrazeneca
Fragment-based identification of amides derived from trans-2-(pyridin-3-yl)cyclopropanecarboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT).
J Med Chem 57: 770-92 (2014)
Genentech
Mutagenesis studies of the 14 Å internal cavity of histone deacetylase 1: insights toward the acetate-escape hypothesis and selective inhibitor design.
J Med Chem 57: 642-50 (2014)
Wayne State University
Tetrahydroquinoline derivatives as potent and selective factor XIa inhibitors.
J Med Chem 57: 955-69 (2014)
Bristol-Myers Squibb
Small molecule disruptors of the glucokinase-glucokinase regulatory protein interaction: 2. Leveraging structure-based drug design to identify analogues with improved pharmacokinetic profiles.
J Med Chem 57: 325-38 (2014)
Amgen
Small molecule disruptors of the glucokinase-glucokinase regulatory protein interaction: 1. Discovery of a novel tool compound for in vivo proof-of-concept.
J Med Chem 57: 309-24 (2014)
Amgen
Long residence times revealed by Aurora A kinase-targeting fluorescent probes derived from inhibitors MLN8237 and VX-689.
Chembiochem 15: 443-50 (2014)
University Of Tartu
Novel class of benzoic acid ester derivatives as potent PDE4 inhibitors for inhaled administration in the treatment of respiratory diseases.
J Med Chem 57: 793-816 (2014)
Chiesi Farmaceutici
Synthesis of novel indenoquinoxaline derivatives as potenta-glucosidase inhibitors.
Bioorg Med Chem 22: 1195-200 (2014)
University Of The Punjab
7-Azaindole-1-carboxamides as a new class of PARP-1 inhibitors.
Bioorg Med Chem 22: 1089-103 (2014)
Universit£
Linear propargylic alcohol functionality attached to the indazole-7-carboxamide as a JAK1-specific linear probe group.
Bioorg Med Chem 22: 1156-62 (2014)
Konkuk University
Targeting the Warburg Effect in cancer; relationships for 2-arylpyridazinones as inhibitors of the key glycolytic enzyme 6-phosphofructo-2-kinase/2,6-bisphosphatase 3 (PFKFB3).
Bioorg Med Chem 22: 1029-39 (2014)
University Of Auckland
The benzimidazole based drugs show good activity against T. gondii but poor activity against its proposed enoyl reductase enzyme target.
Bioorg Med Chem Lett 24: 911-6 (2014)
University Of Leeds
Discovery of 7-tetrahydropyran-2-yl chromans:ß-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors that reduce amyloidß-protein (Aß) in the central nervous system.
J Med Chem 57: 878-902 (2014)
Array Biopharma
Discovery and preclinical characterization of the cyclopropylindolobenzazepine BMS-791325, a potent allosteric inhibitor of the hepatitis C virus NS5B polymerase.
J Med Chem 57: 1855-79 (2014)
Bristol-Myers Squibb Research And Development
Novel sphingosine-containing analogues selectively inhibit sphingosine kinase (SK) isozymes, induce SK1 proteasomal degradation and reduce DNA synthesis in human pulmonary arterial smooth muscle cells.
Medchemcomm 4: (2013)
The City University Of New York
A novel series of 6-substituted 3-(pyrrolidin-1-ylmethyl)chromen-2-ones as selective monoamine oxidase (MAO) A inhibitors.
Eur J Med Chem 73: 177-86 (2014)
Neurosearch Sweden
Danshen diversity defeating dementia.
Bioorg Med Chem Lett 24: 708-16 (2014)
Rmit University
Virtual screening and biochemical evaluation to identify new inhibitors of mammalian target of rapamycin (mTOR).
Bioorg Med Chem Lett 24: 835-8 (2014)
Sejong University
Synthesis and structure-activity relationship studies of 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase.
J Med Chem 57: 495-506 (2014)
National Institutes Of Health
Discovery and preclinical characterization of 1-methyl-3-(4-methylpyridin-3-yl)-6-(pyridin-2-ylmethoxy)-1H-pyrazolo-[3,4-b]pyrazine (PF470): a highly potent, selective, and efficacious metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator.
J Med Chem 57: 861-77 (2014)
Pfizer
Structure-based design, synthesis and biological evaluation of diphenylmethylamine derivatives as novel Akt1 inhibitors.
Eur J Med Chem 73: 167-76 (2014)
Zhejiang University
1,2,3,4-Tetrahydrobenzo[h][1,6]naphthyridines as a new family of potent peripheral-to-midgorge-site inhibitors of acetylcholinesterase: synthesis, pharmacological evaluation and mechanistic studies.
Eur J Med Chem 73: 141-52 (2014)
Universitat De Barcelona
Discovery of novel N-(5-(arylcarbonyl)thiazol-2-yl)amides and N-(5-(arylcarbonyl)thiophen-2-yl)amides as potent ROR¿t inhibitors.
Bioorg Med Chem 22: 692-702 (2014)
Glaxosmithkline
Insights on pregnane-X-receptor modulation. Natural and semisynthetic steroids from Theonella marine sponges.
Eur J Med Chem 73: 126-34 (2014)
Universit£
Microwave assisted synthesis of naphthopyrans catalysed by silica supported fluoroboric acid as a new class of non purine xanthine oxidase inhibitors.
Bioorg Med Chem Lett 24: 495-500 (2014)
Guru Nanak Dev University
New natural products as new leads for antibacterial drug discovery.
Bioorg Med Chem Lett 24: 413-8 (2014)
Astrazeneca
Novel PARP-1 inhibitors based on a 2-propanoyl-3H-quinazolin-4-one scaffold.
Bioorg Med Chem Lett 24: 462-6 (2014)
R&D Sigma-Tau Industrie Farmaceutiche Riunite
Synthesis and evaluation of isoleucine derived angiotensin II AT(2) receptor ligands.
Bioorg Med Chem Lett 24: 476-9 (2014)
Uppsala University
Synthesis and evaluation of novel benzimidazole derivatives as sirtuin inhibitors with antitumor activities.
Bioorg Med Chem 22: 703-10 (2014)
Universiti Sains Malaysia
Design, synthesis, and biological evaluation of potent dual agonists of nuclear and membrane bile acid receptors.
J Med Chem 57: 937-54 (2014)
Istituto Italiano Di Tecnologia
Identification of clinically viable quinolinol inhibitors of botulinum neurotoxin A light chain.
J Med Chem 57: 669-76 (2014)
The Scripps Research Institute
Discovery of a new binding site on human choline kinasea1: design, synthesis, crystallographic studies, and biological evaluation of asymmetrical bispyridinium derivatives.
J Med Chem 57: 507-15 (2014)
Universidad De Granada
Discovery and optimization of pyrimidone indoline amide PI3Kß inhibitors for the treatment of phosphatase and tensin homologue (PTEN)-deficient cancers.
J Med Chem 57: 903-20 (2014)
Sanofi
Selective non-nucleoside inhibitors of human DNA methyltransferases active in cancer including in cancer stem cells.
J Med Chem 57: 701-13 (2014)
Sapienza University Of Rome
Selective ALDH3A1 inhibition by benzimidazole analogues increase mafosfamide sensitivity in cancer cells.
J Med Chem 57: 449-61 (2014)
Indiana University School Of Medicine
Design, synthesis and evaluation of second generation MurF inhibitors based on a cyanothiophene scaffold.
Eur J Med Chem 73: 83-96 (2014)
University Of Ljubljana
Structure-activity relationship analysis of imidazoquinolines with Toll-like receptors 7 and 8 selectivity and enhanced cytokine induction.
J Med Chem 57: 339-47 (2014)
University Of Minnesota
A novel sirtuin 2 (SIRT2) inhibitor with p53-dependent pro-apoptotic activity in non-small cell lung cancer.
J Biol Chem 289: 5208-16 (2014)
Universität Duisburg-Essen
Specific features of HIV-1 integrase inhibition by bisphosphonate derivatives.
Eur J Med Chem 73: 73-82 (2014)
Lomonosov Moscow State University
Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer's disease.
Eur J Med Chem 73: 56-72 (2014)
Instituto De Qu£Mica M£Dica (Csic)
[DOTA]Somatostatin-14 analogs and their (111)In-radioligands: effects of decreasing ring-size on sst1-5 profile, stability and tumor targeting.
Eur J Med Chem 73: 30-7 (2014)
Inrastes
Discovery of Inhibitors of
ACS Med Chem Lett 4: 699-703 (2013)
Northern Illinois University
Identification of small molecule sphingomyelin synthase inhibitors.
Eur J Med Chem 73: 1-7 (2014)
Fudan University
Design and synthesis of potential dual NK(1)/NK(3) receptor antagonists.
Bioorg Med Chem Lett 24: 510-4 (2014)
Universit£
Systematic evaluation of amide bioisosteres leading to the discovery of novel and potent thiazolylimidazolidinone inhibitors of SCD1 for the treatment of metabolic diseases.
Bioorg Med Chem Lett 24: 520-5 (2014)
Xenon Pharmaceuticals
Bifunctional thiosialosides inhibit influenza virus.
Bioorg Med Chem Lett 24: 636-43 (2014)
Georgia State University
Structurally diverse low molecular weight activators of the mammalian pre-mRNA 3' cleavage reaction.
Bioorg Med Chem 22: 834-41 (2014)
The City University Of New York
Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors.
Bioorg Med Chem 22: 772-86 (2014)
Universit£
Discovery of 1-oxa-4,9-diazaspiro[5.5]undecane-based trisubstituted urea derivatives as highly potent soluble epoxide hydrolase inhibitors and orally active drug candidates for treating of chronic kidney diseases.
Bioorg Med Chem Lett 24: 565-70 (2014)
Toray Industries
Discovery of thiazolylpyridinone SCD1 inhibitors with preferential liver distribution and reduced mechanism-based adverse effects.
Bioorg Med Chem Lett 24: 526-31 (2014)
Xenon Pharmaceuticals
Cholinesterase inhibitory activity versus aromatic core multiplicity: a facile green synthesis and molecular docking study of novel piperidone embedded thiazolopyrimidines.
Bioorg Med Chem 22: 906-16 (2014)
Universiti Sains Malaysia
Design and synthesis of 2-amino-6-(1H,3H-benzo[de]isochromen-6-yl)-1,3,5-triazines as novel Hsp90 inhibitors.
Bioorg Med Chem 22: 892-905 (2014)
Chugai Pharmaceutical
A development of chimeric VEGFR2 TK inhibitor based on two ligand conformers from PDB: 1Y6A complex--medicinal chemistry consequences of a TKs analysis.
Eur J Med Chem 72: 146-59 (2014)
Comenius University
Inhibition of LOX by flavonoids: a structure-activity relationship study.
Eur J Med Chem 72: 137-45 (2014)
Universidade Do Porto
Structural studies, homology modeling and molecular docking of novel non-competitive antagonists of GluK1/GluK2 receptors.
Bioorg Med Chem 22: 787-95 (2014)
Medical University Of Lublin
Novel S1P(1) receptor agonists--part 3: from thiophenes to pyridines.
J Med Chem 57: 110-30 (2014)
Actelion Pharmaceuticals
Ligands of the neuropeptide Y Y2 receptor.
Bioorg Med Chem Lett 24: 430-41 (2014)
The Scripps Research Institute
Synthesis and evaluation of 4-substituted piperidines and piperazines as balanced affinity ? opioid receptor (MOR) agonist/? opioid receptor (DOR) antagonist ligands.
Bioorg Med Chem Lett 24: 548-51 (2014)
University Of Michigan
The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.
Bioorg Med Chem Lett 24: 576-9 (2014)
University Of Missouri
Synthesis and activity of substituted heteroaromatics as positive allosteric modulators fora4ß2a5 nicotinic acetylcholine receptors.
Bioorg Med Chem Lett 24: 674-8 (2014)
The Scripps Research Institute
The marine cyanobacterial metabolite gallinamide A is a potent and selective inhibitor of human cathepsin L.
J Nat Prod 77: 92-9 (2014)
University Of California
Synthesis and antibacterial evaluation of anziaic acid and analogues as topoisomerase I inhibitors.
Medchemcomm 4: (2013)
University Of Hawai'I At Hilo
Bisubstrate Inhibitors of Biotin Protein Ligase in
ACS Med Chem Lett 4: 1213-7 (2013)
University Of Minnesota
Amino and carboxy functionalized modified nucleosides: a potential class of inhibitors for angiogenin.
Bioorg Chem 52: 56-61 (2014)
Sastra University
Synthesis, docking simulation, biological evaluations and 3D-QSAR study of 5-Aryl-6-(4-methylsulfonyl)-3-(metylthio)-1,2,4-triazine as selective cyclooxygenase-2 inhibitors.
Bioorg Med Chem 22: 865-73 (2014)
Mazandaran University Of Medical Sciences
Synthesis/biological evaluation of hydroxamic acids and their prodrugs as inhibitors for Botulinum neurotoxin A light chain.
Bioorg Med Chem 22: 1208-17 (2014)
The Scripps Research Institute
4,4'-Unsymmetrically substituted 3,3'-biphenyl alpha helical proteomimetics as potential coactivator binding inhibitors.
Bioorg Med Chem 22: 917-26 (2014)
Northeastern University
Synthesis and structure-activity relationship of 2-adamantylmethyl tetrazoles as potent and selective inhibitors of human 11ß-hydroxysteroid dehydrogenase type 1 (11ß-HSD1).
Bioorg Med Chem Lett 24: 654-60 (2014)
Bristol-Myers Squibb
The effect of chain length and unsaturation on Mtb Dxr inhibition and antitubercular killing activity of FR900098 analogs.
Bioorg Med Chem Lett 24: 649-53 (2014)
George Washington University
Synthesis and evaluation of curcumin derivatives toward an inhibitor of beta-site amyloid precursor protein cleaving enzyme 1.
Bioorg Med Chem Lett 24: 685-90 (2014)
Yamagata University
Structure-activity relationship studies and biological characterization of human NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase inhibitors.
Bioorg Med Chem Lett 24: 630-5 (2014)
National Center For Advancing Translational Sciences
Structure-activity relationship study of BACE1 inhibitors possessing a chelidonic or 2,6-pyridinedicarboxylic scaffold at the P(2) position.
Bioorg Med Chem Lett 24: 618-23 (2014)
Kobe Gakuin University
Methyl-substituted conformationally constrained rexinoid agonists for the retinoid X receptors demonstrate improved efficacy for cancer therapy and prevention.
Bioorg Med Chem 22: 178-85 (2013)
University Of Alabama At Birmingham
Second-generation derivatives of the eukaryotic translation initiation inhibitor pateamine A targeting eIF4A as potential anticancer agents.
Bioorg Med Chem 22: 116-25 (2013)
St. John'S University
Optimization of furin inhibitors to protect against the activation of influenza hemagglutinin H5 and Shiga toxin.
J Med Chem 57: 29-41 (2014)
Universit£
Discovery of a rapidly metabolized, long-actingß(2) adrenergic receptor agonist with a short onset time incorporating a sulfone group suitable for once-daily dosing.
J Med Chem 57: 159-70 (2014)
Glaxosmithkline
Discovery of 1-methyl-1H-imidazole derivatives as potent Jak2 inhibitors.
J Med Chem 57: 144-58 (2014)
Astrazeneca
Structure-guided development of specific pyruvate dehydrogenase kinase inhibitors targeting the ATP-binding pocket.
J Biol Chem 289: 4432-43 (2014)
University Of Texas Southwestern Medical Center
4-Thiazolidinones: the advances continue?.
Eur J Med Chem 72: 52-77 (2014)
Institute Of Technology
Identification of quinones as HER2 inhibitors for the treatment of trastuzumab resistant breast cancer.
Bioorg Med Chem Lett 24: 126-31 (2014)
Xavier University Of Louisiana
The identification of AF38469: an orally bioavailable inhibitor of the VPS10P family sorting receptor Sortilin.
Bioorg Med Chem Lett 24: 177-80 (2013)
H. Lundbeck
d-Thiolactones as prodrugs of thiol-based glutamate carboxypeptidase II (GCPII) inhibitors.
J Med Chem 57: 243-7 (2014)
Johns Hopkins University
Discovery of highly potent, selective, and brain-penetrant aminopyrazole leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors.
J Med Chem 57: 921-36 (2014)
Genentech
Exploring the determinants of trace amine-associated receptor 1's functional selectivity for the stereoisomers of amphetamine and methamphetamine.
J Med Chem 57: 378-90 (2014)
Oregon Health & Science University
Substituted 2-phenylimidazopyridines: a new class of drug leads for human African trypanosomiasis.
J Med Chem 57: 828-35 (2014)
University Of Washington
Inhibition of 5-oxo-6,8,11,14-eicosatetraenoic acid-induced activation of neutrophils and eosinophils by novel indole OXE receptor antagonists.
J Med Chem 57: 364-77 (2014)
Mcgill University
Design, synthesis, and structure-activity relationship studies of a potent PACE4 inhibitor.
J Med Chem 57: 98-109 (2014)
Universit£
Investigation of fluorinated and bifunctionalized 3-phenylchroman-4-one (isoflavanone) aromatase inhibitors.
Bioorg Med Chem 22: 126-34 (2013)
Northern Kentucky University
Azide-alkyne cycloaddition affording enzymatically tunable bisubstrate based inhibitors of histone acetyltransferase PCAF.
Bioorg Med Chem Lett 24: 113-6 (2013)
Utrecht University
Lactam based 7-amino suberoylamide hydroxamic acids as potent HDAC inhibitors.
Bioorg Med Chem Lett 24: 61-4 (2014)
Universit£
Design, synthesis, and biological activity of pyridopyrimidine scaffolds as novel PI3K/mTOR dual inhibitors.
J Med Chem 57: 613-31 (2014)
Universit£
Novel S1P(1) receptor agonists--part 2: from bicyclo[3.1.0]hexane-fused thiophenes to isobutyl substituted thiophenes.
J Med Chem 57: 78-97 (2014)
Actelion Pharmaceuticals
A tetradecapeptide somatostatin dicarba-analog: Synthesis, structural impact and biological activity.
Bioorg Med Chem Lett 24: 103-7 (2014)
Institute For Research In Biomedicine (Irb Barcelona)
Design of an amide N-glycoside derivative of ?-glucogallin: a stable, potent, and specific inhibitor of aldose reductase.
J Med Chem 57: 71-7 (2014)
University Of Colorado Anschutz Medical Campus
The Discovery of Novel 10,11-Dihydro-5H-dibenz[b,f]azepine SIRT2 Inhibitors.
Medchemcomm (2012)
Imperial College London
Inhibition of carbonic anhydrases from the extremophilic bacteria Sulfurihydrogenibium yellostonense (SspCA) and S. azorense (SazCA) with a new series of sulfonamides incorporating aroylhydrazone-, [1,2,4]triazolo[3,4-b][1,3,4]thiadiazinyl- or 2-(cyanophenylmethylene)-1,3,4-thiadiazol-3(2H)-yl moiet
Bioorg Med Chem 22: 141-7 (2014)
Salman Bin Abdulaziz University
Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual and high-throughput screenings.
Bioorg Med Chem 22: 167-77 (2014)
University Of Illinois At Chicago
Synthesis and biological evaluation of novel 2-amino-3-aroyl-4-neopentyl-5-substituted thiophene derivatives as allosteric enhancers of the A? adenosine receptor.
Bioorg Med Chem 22: 148-66 (2014)
Universit£
Design, synthesis and antibacterial activities of 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol derivatives containing Schiff base formation as FabH inhibitory.
Bioorg Med Chem Lett 24: 90-5 (2013)
Nanjing University
Synthesis and biological evaluation of cyclopentyl-triazolol-pyrimidine (CPTP) based P2Y12 antagonists.
Bioorg Med Chem Lett 24: 141-6 (2013)
Shanghai Hengrui Pharmaceutical
Replacement of amide with bioisosteres led to a new series of potent adenosine A2A receptor antagonists.
Bioorg Med Chem Lett 24: 152-5 (2014)
Soochow University
Chemical synthesis and tyrosinase inhibitory activity of rhododendrol glycosides.
Bioorg Med Chem Lett 24: 122-5 (2014)
Tokyo University Of Agriculture And Technology
Synthesis, biological evaluation and SAR of 3-benzoates of ingenol for treatment of actinic keratosis and non-melanoma skin cancer.
Bioorg Med Chem Lett 24: 54-60 (2014)
Leo Pharma
The discovery of potent, orally bioavailable pyrazolo and triazolopyrimidine CXCR2 receptor antagonists.
Bioorg Med Chem Lett 24: 72-6 (2014)
Novartis Institutes For Biomedical Research
Rationally designed hybrid molecules with appreciable COX-2 inhibitory and anti-nociceptive activities.
Bioorg Med Chem Lett 24: 77-82 (2014)
Guru Nanak Dev University
Discovery and optimization of N-(3-(1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c]pyridin-4-yloxy)phenyl)benzenesulfonamides as novel GPR119 agonists.
Bioorg Med Chem Lett 24: 156-60 (2013)
Amgen
Correlation between chemotype-dependent binding conformations of HSP90a/ß and isoform selectivity-Implications for the structure-based design of HSP90a/ß selective inhibitors for treating neurodegenerative diseases.
Bioorg Med Chem Lett 24: 204-8 (2013)
Vertex Pharmaceuticals
Synthesis and SAR of novel isoxazoles as potent c-jun N-terminal kinase (JNK) inhibitors.
Bioorg Med Chem Lett 24: 161-4 (2014)
The Scripps Research Institute
Structure activity relationships of fused bicyclic and urea derivatives of spirocyclic compounds as potent CCR1 antagonists.
Bioorg Med Chem Lett 24: 108-12 (2013)
Astrazeneca
(E)-Alkenes as replacements of amide bonds: development of novel and potent acyclic CGRP receptor antagonists.
Bioorg Med Chem Lett 24: 258-61 (2013)
Merck
Synthesis and biological properties of thiazole-analogues of pyochelin, a siderophore of Pseudomonas aeruginosa.
Bioorg Med Chem Lett 24: 132-5 (2013)
University Of Strasburg
Synthesis and biological evaluation of the pirfenidone derivatives as antifibrotic agents.
Bioorg Med Chem Lett 24: 220-3 (2013)
Zhejiang Academy Of Medical Sciences
Imidazole-derived agonists for the neurotensin 1 receptor.
Bioorg Med Chem Lett 24: 262-7 (2013)
Sanford-Burnham Medical Research Institute
Modulating the interaction between CDK2 and cyclin A with a quinoline-based inhibitor.
Bioorg Med Chem Lett 24: 199-203 (2013)
Merck Research Laboratories
Involvement of apoptosis and autophagy in the death of RPMI 8226 multiple myeloma cells by two enantiomeric sigma receptor ligands.
Bioorg Med Chem 22: 221-33 (2013)
University Of Greifswald
Pyrrolizines: Promising scaffolds for anticancer drugs.
Bioorg Med Chem 22: 46-53 (2013)
Beni-Suef University
Design, synthesis and biological evaluation of pyridin-3-yl pyrimidines as potent Bcr-Abl inhibitors.
Chem Biol Drug Des 83: 592-9 (2014)
Xi'An Jiaotong University
Protein kinase and HDAC inhibitors from the endophytic fungus Epicoccum nigrum.
J Nat Prod 77: 49-56 (2014)
Heinrich-Heine-Universit£T D£Sseldorf
Synthesis and evaluation of analogues of N-phthaloyl-l-tryptophan (RG108) as inhibitors of DNA methyltransferase 1.
J Med Chem 57: 421-34 (2014)
Universit£
Discovery of a non-estrogenic irreversible inhibitor of 17?-hydroxysteroid dehydrogenase type 1 from 3-substituted-16?-(m-carbamoylbenzyl)-estradiol derivatives.
J Med Chem 57: 204-22 (2014)
Laval University
The molecular chaperone Hsp70 activates protein phosphatase 5 (PP5) by binding the tetratricopeptide repeat (TPR) domain.
J Biol Chem 289: 2908-17 (2014)
University Of Michigan
Design, synthesis and biological evaluation of ezrin inhibitors targeting metastatic osteosarcoma.
Bioorg Med Chem 22: 478-87 (2013)
George Mason University
Comparative molecular field analysis of fenoterol derivatives interacting with an agonist-stabilized form of the ??-adrenergic receptor.
Bioorg Med Chem 22: 234-46 (2014)
Medical University Of Lublin
Pan-histone demethylase inhibitors simultaneously targeting Jumonji C and lysine-specific demethylases display high anticancer activities.
J Med Chem 57: 42-55 (2014)
Sapienza University Of Rome
Synthesis and characterization of a novel series of agonist compounds as potential radiopharmaceuticals for imaging dopamine D2/3 receptors in their high-affinity state.
J Med Chem 57: 391-410 (2014)
University Of Amsterdam
Exploring novel strategies for AIDS protozoal pathogens: ?-helix mimetics targeting a key allosteric protein-protein interaction in
Medchemcomm 4: (2013)
Yale University
A novel tamoxifen derivative, ridaifen-F, is a nonpeptidic small-molecule proteasome inhibitor.
Eur J Med Chem 71: 290-305 (2014)
Institute Of Bio-Science And Technology
Synthesis and evaluation of the antiparasitic activity of bis-(arylmethylidene) cycloalkanones.
Eur J Med Chem 71: 282-9 (2014)
Universidade Federal De Minas Gerais
Preparation and evaluation of deconstruction analogues of 7-deoxykalafungin as AKT kinase inhibitors.
Bioorg Med Chem Lett 24: 271-4 (2013)
Virginia Commonwealth University
Asymmetric synthesis and receptor activity of chiral simplified resiniferatoxin (sRTX) analogues as transient receptor potential vanilloid 1 (TRPV1) ligands.
Bioorg Med Chem Lett 24: 382-5 (2013)
Seoul National University
Discovery of a novel class of dimeric Smac mimetics as potent IAP antagonists resulting in a clinical candidate for the treatment of cancer (AZD5582).
J Med Chem 56: 9897-919 (2013)
Astrazeneca
Mechanistic characterization of a 2-thioxanthine myeloperoxidase inhibitor and selectivity assessment utilizing click chemistry--activity-based protein profiling.
Biochemistry 52: 9187-201 (2013)
Pfizer
Design, synthesis, and biological evaluation of novel piperidine-4-carboxamide derivatives as potent CCR5 inhibitors.
Eur J Med Chem 71: 259-66 (2014)
Zhejiang University
Discovery of a benzimidazole series of ADAMTS-5 (aggrecanase-2) inhibitors by scaffold hopping.
Eur J Med Chem 71: 250-8 (2014)
Asahi Kasei Pharma
Synthesis, modification and docking studies of 5-sulfonyl isatin derivatives as SARS-CoV 3C-like protease inhibitors.
Bioorg Med Chem 22: 292-302 (2014)
Tianjin University Of Science And Technology
Synthesis and biological evaluation of a series of aminoalkyl-tetralones and tetralols as dual dopamine/serotonin ligands.
Eur J Med Chem 71: 237-49 (2014)
Universidad De Santiago De Compostela
Flexible and biomimetic analogs of triple uptake inhibitor 4-((((3S,6S)-6-benzhydryltetrahydro-2H-pyran-3-yl)amino)methyl)phenol: Synthesis, biological characterization, and development of a pharmacophore model.
Bioorg Med Chem 22: 311-24 (2013)
Wayne State University
Biphenyl derivatives incorporating urea unit as novel VEGFR-2 inhibitors: design, synthesis and biological evaluation.
Bioorg Med Chem 22: 277-84 (2014)
Xi'An Jiaotong University
Probing the human estrogen receptor-? binding requirements for phenolic mono- and di-hydroxyl compounds: a combined synthesis, binding and docking study.
Bioorg Med Chem 22: 303-10 (2014)
Marquette University
Synthesis of 3-(3-aryl-pyrrolidin-1-yl)-5-aryl-1,2,4-triazines that have antibacterial activity and also inhibit inorganic pyrophosphatase.
Bioorg Med Chem 22: 406-18 (2013)
Purdue University
Purinergic receptor P2X?: a novel target for anti-inflammatory therapy.
Bioorg Med Chem 22: 54-88 (2014)
Punjabi University
Inhibition of serine and proline racemases by substrate-product analogues.
Bioorg Med Chem Lett 24: 390-3 (2013)
Dalhousie University
Sulfonamide inhibition studies of thed-carbonic anhydrase from the diatom Thalassiosira weissflogii.
Bioorg Med Chem Lett 24: 275-9 (2013)
Universit£
Computer-guided approach to access the anti-influenza activity of licorice constituents.
J Nat Prod 77: 563-70 (2014)
University Of Innsbruck
[1,2,4]triazolo[4,3-a]phthalazines: inhibitors of diverse bromodomains.
J Med Chem 57: 462-76 (2014)
University Of Oxford
Analogs of the Allosteric Heat Shock Protein 70 (Hsp70) Inhibitor, MKT-077, as Anti-Cancer Agents.
ACS Med Chem Lett 4: 1042-7 (2013)
University Of California San Francisco
Phenylspirodrimanes with anti-HIV activity from the sponge-derived fungus Stachybotrys chartarum MXH-X73.
J Nat Prod 76: 2298-306 (2013)
Ocean University Of China
Design, synthesis, and biological activity of novel dicoumarol glucagon-like peptide 1 conjugates.
J Med Chem 56: 9955-68 (2013)
China Pharmaceutical University
Novel pyridazinone inhibitors for vascular adhesion protein-1 (VAP-1): old target-new inhibition mode.
J Med Chem 56: 9837-48 (2013)
£Bo Akademi University
Structure-activity relationships of chromone derivatives toward the mechanism of interaction with and inhibition of breast cancer resistance protein ABCG2.
J Med Chem 56: 9849-60 (2013)
Bmssi Umr 5086 Cnrs/Universit£
Synthesis and structure-activity relationship of 3-hydroxypyridine-2-thione-based histone deacetylase inhibitors.
J Med Chem 56: 9969-81 (2013)
Georgia Institute Of Technology
Targeting low-druggability bromodomains: fragment based screening and inhibitor design against the BAZ2B bromodomain.
J Med Chem 56: 10183-7 (2013)
University Of Cambridge
8-Substituted O(6)-cyclohexylmethylguanine CDK2 inhibitors: using structure-based inhibitor design to optimize an alternative binding mode.
J Med Chem 57: 56-70 (2014)
University Of Oxford
Structure-activity relationship of adenosine 5'-diphosphoribose at the transient receptor potential melastatin 2 (TRPM2) channel: rational design of antagonists.
J Med Chem 56: 10079-102 (2013)
University Of Bath
Two analogues of fenarimol show curative activity in an experimental model of Chagas disease.
J Med Chem 56: 10158-70 (2013)
Epichem
Combining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: solution and X-ray crystallographic studies.
Bioorg Med Chem 22: 334-40 (2014)
Universit£
New insights into molecular recognition of 1,1-bisphosphonic acids by farnesyl diphosphate synthase.
Bioorg Med Chem 22: 398-405 (2013)
Universidad De Buenos Aires
Design, synthesis and evaluation of dual pharmacologyß2-adrenoceptor agonists and PDE4 inhibitors.
Bioorg Med Chem Lett 24: 249-53 (2013)
Sun Yat-Sen University
The human liver fatty acid binding protein T94A variant alters the structure, stability, and interaction with fibrates.
Biochemistry 52: 9347-57 (2013)
Texas A&M University
Development of 1,8-naphthalimides as clathrin inhibitors.
J Med Chem 57: 131-43 (2014)
The University Of Newcastle
Design, synthesis, and evaluation of hydroxamic acid derivatives as promising agents for the management of Chagas disease.
J Med Chem 57: 298-308 (2014)
Instituto Militar De Engenharia
Synthesis and anticancer activities of thieno[3,2-d]pyrimidines as novel HDAC inhibitors.
Bioorg Med Chem 22: 358-65 (2014)
Nantong University
Synthesis and SAR study of a novel series of dopamine receptor agonists.
Bioorg Med Chem 22: 381-92 (2013)
University Of Copenhagen
Novel di-tertiary-butyl phenylhydrazones as dual cyclooxygenase-2/5-lipoxygenase inhibitors: synthesis, COX/LOX inhibition, molecular modeling, and insights into their cytotoxicities.
Bioorg Med Chem Lett 24: 317-24 (2013)
Medical University Of South Carolina
Discrimination of potent inhibitors of Toxoplasma gondii enoyl-acyl carrier protein reductase by a thermal shift assay.
Biochemistry 52: 9155-66 (2013)
Johns Hopkins Bloomberg School Of Public Health
Design, synthesis, and biological evaluation of 1-phenylpyrazolo[3,4-e]pyrrolo[3,4-g]indolizine-4,6(1H,5H)-diones as new glycogen synthase kinase-3ß inhibitors.
J Med Chem 56: 10066-78 (2013)
Universit£
Medicinal chemistry of inhibitors of 11ß-hydroxysteroid dehydrogenase type 1 (11ß-HSD1).
J Med Chem 57: 4466-86 (2014)
Astrazeneca
Development of novel dual binders as potent, selective, and orally bioavailable tankyrase inhibitors.
J Med Chem 56: 10003-15 (2013)
Amgen
Piperazine oxadiazole inhibitors of acetyl-CoA carboxylase.
J Med Chem 56: 10132-41 (2013)
Amgen
Small-Molecule Allosteric Activation of Human Glucokinase in the Absence of Glucose.
ACS Med Chem Lett 4: 580-4 (2013)
Florida State University
2-(1H-Pyrazol-1-yl)acetic acids as chemoattractant receptor-homologous molecule expressed on Th2 lymphocytes (CRTh2) antagonists.
Eur J Med Chem 71: 168-84 (2014)
RhôNe-Poulenc Rorer
Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
Eur J Med Chem 71: 135-47 (2014)
Medical University Of Gdansk
Synthesis, anti-HIV activity, integrase enzyme inhibition and molecular modeling of catechol, hydroquinone and quinol labdane analogs.
Bioorg Med Chem Lett 24: 302-7 (2014)
Mumbai University
Synthesis and preliminary evaluation of a new fluorine-18 labelled triazine derivative for PET imaging of cannabinoid CB2 receptor.
Bioorg Med Chem Lett 24: 283-7 (2014)
Sanofi R&D
Synthesis and pharmacological characterization of 1-benzyl-4-aminoindole-based thyroid hormone receptorß agonists.
Bioorg Med Chem 22: 488-98 (2013)
Sanwa Kagaku Kenkyusho
From NMDA receptor antagonists to discovery of selectives2 receptor ligands.
Bioorg Med Chem 22: 393-7 (2013)
Universit£
Small molecule inhibitors of anthrax lethal factor toxin.
Bioorg Med Chem 22: 419-34 (2013)
Microbiotix
Synthesis, biological activity and structure-activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in mouse C2C12 skeletal muscle cells.
Eur J Med Chem 71: 112-27 (2014)
University Of Messina
Structure-based screening for the discovery of new carbonic anhydrase VII inhibitors.
Eur J Med Chem 71: 105-11 (2014)
Universit£
Identification through structure-based methods of a bacterial NAD(+)-dependent DNA ligase inhibitor that avoids known resistance mutations.
Bioorg Med Chem Lett 24: 360-6 (2013)
Astrazeneca
Fragment based discovery of arginine isosteres through REPLACE: towards non-ATP competitive CDK inhibitors.
Bioorg Med Chem 22: 616-22 (2013)
University Of South Carolina
Controlled-deactivation cannabinergic ligands.
J Med Chem 56: 10142-57 (2013)
Northeastern University
Imatinib analogs as potential agents for PET imaging of Bcr-Abl and c-KIT expression at a kinase level.
Bioorg Med Chem 22: 623-32 (2013)
The University Of Texas M.D. Anderson Cancer Center
Discovery of potent and efficacious cyanoguanidine-containing nicotinamide phosphoribosyltransferase (Nampt) inhibitors.
Bioorg Med Chem Lett 24: 337-43 (2013)
Forma Therapeutics
Prostanoid receptor EP2 as a therapeutic target.
J Med Chem 57: 4454-65 (2014)
Emory University
Design, synthesis and preliminary SAR studies of novel N-arylmethyl substituted piperidine-linked aniline derivatives as potent HIV-1 NNRTIs.
Bioorg Med Chem 22: 633-42 (2014)
Shandong University
Synthesis and biological evaluation of new epalrestat analogues as aldose reductase inhibitors (ARIs).
Eur J Med Chem 71: 53-66 (2014)
Csir-Indian Institute Of Chemical Technology
2-Aminonicotinic acid 1-oxides are chemically stable inhibitors of quinolinic acid synthesis in the mammalian brain: a step toward new antiexcitotoxic agents.
J Med Chem 56: 9482-95 (2014)
Universit£
Scaffold ranking and positional scanning utilized in the discovery of nAChR-selective compounds suitable for optimization studies.
J Med Chem 56: 10103-17 (2013)
Torrey Pines Institute For Molecular Studies
Homodimers of the Antiviral Abacavir as Modulators of P-glycoprotein Transport in Cell Culture: Probing Tether Length.
Medchemcomm 4: (2013)
Purdue University
Design, synthesis, molecular docking studies and in vitro screening of ethyl 4-(3-benzoylthioureido) benzoates as urease inhibitors.
Bioorg Chem 52: 1-7 (2014)
Quaid-I-Azam University, Islamabad, Pakistan.
Novel 2-chloro-4-anilino-quinazoline derivatives as EGFR and VEGFR-2 dual inhibitors.
Eur J Med Chem 71: 1-14 (2014)
Federal University Of Rio De Janeiro
Identification of clinical candidates from the benzazepine class of histamine H3 receptor antagonists.
Bioorg Med Chem Lett 23: 6890-6 (2013)
Glaxosmithkline
Potent P2Y1 urea antagonists bearing various cyclic amine scaffolds.
Bioorg Med Chem Lett 23: 6825-8 (2013)
Bristol-Myers Squibb
(S)-4-Trimethylsilyl-3-butyn-2-ol as an auxiliary for stereocontrolled synthesis of salinosporamide analogs with modifications at positions C2 and C5.
Bioorg Med Chem Lett 23: 6905-10 (2013)
The Pennsylvania State University
NAD-based inhibitors with anticancer potential.
Bioorg Med Chem Lett 24: 332-6 (2014)
University Of Minnesota
Evaluation of benzoic acid derivatives as sirtuin inhibitors.
Bioorg Med Chem Lett 24: 349-52 (2013)
San Francisco State University
Synthesis, antioxidant capacity, and structure-activity relationships of tri-O-methylnorbergenin analogues on tyrosinase inhibition.
Bioorg Med Chem Lett 23: 6580-4 (2013)
Kinki University
Structure-activity relationship (SAR) optimization of 6-(indol-2-yl)pyridine-3-sulfonamides: identification of potent, selective, and orally bioavailable small molecules targeting hepatitis C (HCV) NS4B.
J Med Chem 57: 2121-35 (2014)
Ptc Therapeutics
Bisphenol A binds to Ras proteins and competes with guanine nucleotide exchange: implications for GTPase-selective antagonists.
J Med Chem 56: 9664-72 (2014)
Ruhr University Of Bochum
Novel S1P1 receptor agonists--part 1: From pyrazoles to thiophenes.
J Med Chem 56: 9737-55 (2014)
Actelion Pharmaceuticals
The most effective influence of 17-(3-ethoxypropyl) substituent on the binding affinity and the agonistic activity in KNT-127 derivatives, ? opioid receptor agonists.
Bioorg Med Chem 21: 7628-47 (2013)
Kitasato University
Discovery and characterisation of hydrazines as inhibitors of the immune suppressive enzyme, indoleamine 2,3-dioxygenase 1 (IDO1).
Bioorg Med Chem 21: 7595-603 (2013)
University Of Auckland
Discovery of N-{5-[3-(3-hydroxypiperidin-1-yl)-1,2,4-oxadiazol-5-yl]-4-methyl-1,3-thiazol-2-yl}acetamide (TASP0415914) as an orally potent phosphoinositide 3-kinase¿ inhibitor for the treatment of inflammatory diseases.
Bioorg Med Chem 21: 7578-83 (2013)
Taisho Pharmaceutical
Synthesis, docking and pharmacological evaluation of novel homo- and hetero-bis 3-piperazinylpropylindole derivatives at SERT and 5-HT1A receptor.
Bioorg Med Chem 21: 7604-11 (2013)
Universidad De Chile
Further discovery of caffeic acid derivatives as novel influenza neuraminidase inhibitors.
Bioorg Med Chem 21: 7715-23 (2013)
Shandong University
Synthesis, radiosynthesis and first in vitro evaluation of novel PET-tracers for the dopamine transporter: [(11)C]IPCIT and [(18)F]FE@IPCIT.
Bioorg Med Chem 21: 7562-9 (2013)
Medical University Of Vienna
Protease inhibitors from Microcystis aeruginosa bloom material collected from the Dalton Reservoir, Israel.
J Nat Prod 76: 2307-15 (2013)
Tel-Aviv University
Design, synthesis, and biological evaluation of potent and selective class IIa histone deacetylase (HDAC) inhibitors as a potential therapy for Huntington's disease.
J Med Chem 56: 9934-54 (2013)
Biofocus
A L-lysine transporter of high stereoselectivity of the amino acid-polyamine-organocation (APC) superfamily: production, functional characterization, and structure modeling.
J Biol Chem 289: 1377-87 (2014)
Max Planck Institute Of Biophysics
Recent advances in the discovery of small molecules targeting exchange proteins directly activated by cAMP (EPAC).
J Med Chem 57: 3651-65 (2014)
University Of Texas Medical Branch
Structure-based design of orally bioavailable 1H-pyrrolo[3,2-c]pyridine inhibitors of mitotic kinase monopolar spindle 1 (MPS1).
J Med Chem 56: 10045-65 (2013)
The Institute Of Cancer Research
SAR-based optimization of 2-(1H-pyrazol-1-yl)-thiazole derivatives as highly potent EP1 receptor antagonists.
Bioorg Med Chem Lett 23: 6569-76 (2013)
Asahi Kasei Pharma
Discovery of an irreversible HCV NS5B polymerase inhibitor.
Bioorg Med Chem Lett 23: 6585-7 (2013)
Merck Research Laboratories
Lipoamide channel-binding sulfonamides selectively inhibit mycobacterial lipoamide dehydrogenase.
Biochemistry 52: 9375-84 (2013)
Weill Cornell Medical College
Development and pharmacological characterization of conformationally constrained urotensin II-related peptide agonists.
J Med Chem 56: 9612-22 (2014)
Universit£
Sulphonamide 1,4-dithia-7-azaspiro[4,4]nonane derivatives as gelatinase A inhibitors.
Bioorg Med Chem 21: 7752-62 (2013)
Shandong University
Design and synthesis of potent and selective P2X3 receptor antagonists derived from PPADS as potential pain modulators.
Eur J Med Chem 70: 811-30 (2013)
Gwangju Institute Of Science And Technology (Gist)
Unraveling phosphodiesterase surfaces. Identification of phosphodiesterase 7 allosteric modulation cavities.
Eur J Med Chem 70: 781-8 (2013)
Instituto De Qu£Mica M£Dica (Csic)
Discovery of an intravenous hepatoselective glucokinase activator for the treatment of inpatient hyperglycemia.
Bioorg Med Chem Lett 23: 6588-92 (2013)
Pfizer
Novel piperidinylamino-diarylpyrimidine derivatives with dual structural conformations as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
Bioorg Med Chem Lett 23: 6593-7 (2013)
Shandong University
Substituted phenyl as a steroid A-ring mimetic: providing agonist activity to a class of arylsulfonamide nonsteroidal glucocorticoid ligands.
Bioorg Med Chem Lett 23: 6645-9 (2013)
Boehringer Ingelheim Pharmaceuticals
Pyrido[2,3-d]pyrimidines: discovery and preliminary SAR of a novel series of DYRK1B and DYRK1A inhibitors.
Bioorg Med Chem Lett 23: 6610-5 (2013)
Hoffmann-La Roche
Structure-based design of substituted hexafluoroisopropanol-arylsulfonamides as modulators of RORc.
Bioorg Med Chem Lett 23: 6604-9 (2013)
Genentech
Design, synthesis and biological evaluation of ?-substituted isonipecotic acid benzothiazole analogues as potent bacterial type II topoisomerase inhibitors.
Bioorg Med Chem Lett 23: 6598-603 (2013)
Biota Holdings
Design and synthesis of novel benzimidazole derivatives as phosphodiesterase 10A inhibitors with reduced CYP1A2 inhibition.
Bioorg Med Chem 21: 7612-23 (2013)
Astellas Pharma
The synthesis and biodistribution of [(11)C]metformin as a PET probe to study hepatobiliary transport mediated by the multi-drug and toxin extrusion transporter 1 (MATE1) in vivo.
Bioorg Med Chem 21: 7584-90 (2013)
Riken Center For Life Science Technologies
High-throughput virtual screening identifies novel N'-(1-phenylethylidene)-benzohydrazides as potent, specific, and reversible LSD1 inhibitors.
J Med Chem 56: 9496-508 (2014)
University Of Utah
Design and synthesis of 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile (citalopram) analogues as novel probes for the serotonin transporter S1 and S2 binding sites.
J Med Chem 56: 9709-24 (2013)
National Institute On Drug Abuse-Intramural Research Program
3-Azatetracyclo[5.2.1.1(5,8).0(1,5)]undecane derivatives: from wild-type inhibitors of the M2 ion channel of influenza A virus to derivatives with potent activity against the V27A mutant.
J Med Chem 56: 9265-74 (2013)
Universitat De Barcelona
Discovery of a novel activator of 5-lipoxygenase from an anacardic acid derived compound collection.
Bioorg Med Chem 21: 7763-78 (2013)
University Of Groningen
Discovery of benzo[d]imidazo[5,1-b]thiazole as a new class of phosphodiesterase 10A inhibitors.
Bioorg Med Chem Lett 23: 6747-54 (2013)
Glenmark Pharmaceuticals
Fine molecular tuning at position 4 of 2H-chromen-2-one derivatives in the search of potent and selective monoamine oxidase B inhibitors.
Eur J Med Chem 70: 723-39 (2013)
Universit£
MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.
J Med Chem 57: 3161-85 (2014)
The German University In Cairo
Identification of a small peptide that inhibits PCSK9 protein binding to the low density lipoprotein receptor.
J Biol Chem 289: 942-55 (2014)
Genentech
Protein tyrosine phosphatase 1B (PTP1B) inhibitors from Morinda citrifolia (Noni) and their insulin mimetic activity.
J Nat Prod 76: 2080-7 (2013)
Chosun University
Removal of human ether-à-go-go related gene (hERG) K+ channel affinity through rigidity: a case of clofilium analogues.
J Med Chem 56: 9427-40 (2013)
Leiden University
Imidazopyridazine hepatitis C virus polymerase inhibitors. Structure-activity relationship studies and the discovery of a novel, traceless prodrug mechanism.
J Med Chem 57: 1964-75 (2014)
Glaxosmithkline Research & Development
Identification of potent and selective cathepsin S inhibitors containing different central cyclic scaffolds.
J Med Chem 56: 9789-801 (2014)
Pharma Research And Early
Optimization of O3-acyl kojic acid derivatives as potent and selective human neutrophil elastase inhibitors.
J Med Chem 56: 9802-6 (2014)
Universidade De Lisboa
Preparation, in vitro evaluation and molecular modelling of pyridinium-quinolinium/isoquinolinium non-symmetrical bisquaternary cholinesterase inhibitors.
Bioorg Med Chem Lett 23: 6663-6 (2013)
Charles University In Prague
Novel tacrine-ebselen hybrids with improved cholinesterase inhibitory, hydrogen peroxide and peroxynitrite scavenging activity.
Bioorg Med Chem Lett 23: 6737-42 (2013)
Sun Yat-Sen University
Novel glycosylated endomorphin-2 analog produces potent centrally-mediated antinociception in mice after peripheral administration.
Bioorg Med Chem Lett 23: 6673-6 (2013)
Medical University Of Lodz
In vitro cytotoxicity on human ovarian cancer cells by T-type calcium channel blockers.
Bioorg Med Chem Lett 23: 6656-62 (2013)
Kyung Hee University
Discovery of Mer specific tyrosine kinase inhibitors for the treatment and prevention of thrombosis.
J Med Chem 56: 9693-700 (2014)
Eshelman School Of Pharmacy�Department Of Pharmacology�Lineberger Compreh
Isoquinoline derivatives as potent CRTH2 antagonists: design, synthesis and SAR.
Bioorg Med Chem 21: 7674-85 (2013)
Taisho Pharmaceutical
Structure-based design, synthesis, and evaluation of imidazo[1,2-b]pyridazine and imidazo[1,2-a]pyridine derivatives as novel dual c-Met and VEGFR2 kinase inhibitors.
Bioorg Med Chem 21: 7686-98 (2013)
Takeda Pharmaceutical
Discovery of 2,5-diarylnicotinamides as selective orexin-2 receptor antagonists (2-SORAs).
Bioorg Med Chem Lett 23: 6620-4 (2013)
Merck Research Laboratories
Function-regulating pharmacophores in a sulfonamide class of glucocorticoid receptor agonists.
Bioorg Med Chem Lett 23: 6640-4 (2013)
Boehringer Ingelheim Pharmaceuticals
Synthesis and biological evaluation of nimesulide based new class of triazole derivatives as potential PDE4B inhibitors against cancer cells.
Bioorg Med Chem Lett 23: 6721-7 (2013)
Mnr Degree & Pg College
Metabolism-guided discovery of a potent and orally bioavailable urea-based calcimimetic for the treatment of secondary hyperparathyroidism.
Bioorg Med Chem Lett 23: 6625-8 (2013)
Amgen
Identification of sulfonic acids as efficient ecto-5'-nucleotidase inhibitors.
Eur J Med Chem 70: 685-91 (2013)
Comsats Institute Of Information Technology
Discovery of potent Mcl-1/Bcl-xL dual inhibitors by using a hybridization strategy based on structural analysis of target proteins.
J Med Chem 56: 9635-45 (2014)
Takeda Pharmaceutical
Identification by in silico and in vitro screenings of small organic molecules acting as reversible inhibitors of kallikreins.
Eur J Med Chem 70: 661-8 (2013)
Universit£
An efficient approach to novel 17-5'-(1',2',4')-oxadiazolyl androstenes via the cyclodehydration of cytotoxic O-steroidacylamidoximes, and an evaluation of their inhibitory action on 17a-hydroxylase/C17,20-lyase.
Eur J Med Chem 70: 649-60 (2013)
University Of Szeged
Novel coumarin-3-carboxamides bearing N-benzylpiperidine moiety as potent acetylcholinesterase inhibitors.
Eur J Med Chem 70: 623-30 (2013)
Kerman University Of Medical Sciences
Advances in the studies of roles of Rho/Rho-kinase in diseases and the development of its inhibitors.
Eur J Med Chem 70: 613-22 (2013)
Sun Yat-Sen University
Synthesis of novel 1,2,3-triazole based benzoxazolinones: their TNF-? based molecular docking with in-vivo anti-inflammatory, antinociceptive activities and ulcerogenic risk evaluation.
Eur J Med Chem 70: 579-88 (2013)
Jamia Hamdard (Hamdard University)
Discovery of XEN445: a potent and selective endothelial lipase inhibitor raises plasma HDL-cholesterol concentration in mice.
Bioorg Med Chem 21: 7724-34 (2013)
Xenon Pharmaceuticals
Chlorophenylpiperazine analogues as high affinity dopamine transporter ligands.
Bioorg Med Chem Lett 23: 6920-6922 (2013)
University Of Maryland
Design and synthesis of novel 3-(benzo[d]oxazol-2-yl)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine derivatives as selective G-protein-coupled receptor kinase-2 and -5 inhibitors.
Bioorg Med Chem Lett 23: 6711-6 (2013)
Korea Research Institute Of Chemical Technology
Radionuclide labeling and evaluation of candidate radioligands for PET imaging of histone deacetylase in the brain.
Bioorg Med Chem Lett 23: 6700-5 (2013)
Chonbuk National University
Anion inhibition studies of aß-carbonic anhydrase from Clostridium perfringens.
Bioorg Med Chem Lett 23: 6706-10 (2013)
Universit£
Novel, broad-spectrum anticonvulsants containing a sulfamide group: pharmacological properties of (S)-N-[(6-chloro-2,3-dihydrobenzo[1,4]dioxin-2-yl)methyl]sulfamide (JNJ-26489112).
J Med Chem 56: 9019-30 (2013)
Janssen Pharmaceutical Companies Of Johnson & Johnson
Design, synthesis, and biological evaluation of 1,2,4-triazole bearing 5-substituted biphenyl-2-sulfonamide derivatives as potential antihypertensive candidates.
Bioorg Med Chem 21: 7742-51 (2013)
China Pharmaceutical University
Oxime-based inhibitors of glucose transporter 1 displaying antiproliferative effects in cancer cells.
Bioorg Med Chem Lett 23: 6923-7 (2013)
Universit£
Characterization of a novela-conotoxin TxID from Conus textile that potently blocks rata3ß4 nicotinic acetylcholine receptors.
J Med Chem 56: 9655-63 (2014)
Hainan University
A prodrug approach toward cancer-related carbonic anhydrase inhibition.
J Med Chem 56: 9623-34 (2013)
Griffith University
Exploration of a series of 5-arylidene-2-thioxoimidazolidin-4-ones as inhibitors of the cytolytic protein perforin.
J Med Chem 56: 9542-55 (2014)
University Of Auckland
Pseudo-cyclization through intramolecular hydrogen bond enables discovery of pyridine substituted pyrimidines as new Mer kinase inhibitors.
J Med Chem 56: 9683-92 (2014)
University Of North Carolina At Chapel Hill
Aurora isoform selectivity: design and synthesis of imidazo[4,5-b]pyridine derivatives as highly selective inhibitors of Aurora-A kinase in cells.
J Med Chem 56: 9122-35 (2013)
The Institute Of Cancer Research
Evidence of ternary complex formation in Trypanosoma cruzi trans-sialidase catalysis.
J Biol Chem 289: 423-36 (2014)
Universidade Federal Do Rio De Janeiro
Potent reversible inhibition of myeloperoxidase by aromatic hydroxamates.
J Biol Chem 288: 36636-47 (2013)
University Of Otago Christchurch
Insights into distinct modulation of a7 and a7ß2 nicotinic acetylcholine receptors by the volatile anesthetic isoflurane.
J Biol Chem 288: 35793-800 (2013)
University Of Pittsburgh
8-(2-Furyl)adenine derivatives as A?A adenosine receptor ligands.
Eur J Med Chem 70: 525-35 (2013)
University Of Camerino
Synthesis and structure-activity relationships of new carbonyl guanidine derivatives as novel dual 5-HT2B and 5-HT7 receptor antagonists.
Bioorg Med Chem 21: 7841-52 (2013)
Astellas Pharma
Salen and tetrahydrosalen derivatives act as effective inhibitors of the tumor-associated carbonic anhydrase XII--a new scaffold for designing isoform-selective inhibitors.
Bioorg Med Chem Lett 23: 6759-63 (2013)
Sapienza University Of Rome
PDE2 inhibition: potential for the treatment of cognitive disorders.
Bioorg Med Chem Lett 23: 6522-7 (2013)
Dart Neuroscience
Chemical probes to study ADP-ribosylation: synthesis and biochemical evaluation of inhibitors of the human ADP-ribosyltransferase ARTD3/PARP3.
J Med Chem 56: 9556-68 (2014)
Ume£
Development of DANDYs, new 3,5-diaryl-7-azaindoles demonstrating potent DYRK1A kinase inhibitory activity.
J Med Chem 56: 9569-85 (2014)
Upr 2301, Cnrs
Design, synthesis, and biological evaluation of Erythrina alkaloid analogues as neuronal nicotinic acetylcholine receptor antagonists.
J Med Chem 56: 9673-82 (2014)
University Of Copenhagen
Defining the communication between agonist and coactivator binding in the retinoid X receptor a ligand binding domain.
J Biol Chem 289: 814-26 (2014)
University Of Alabama At Birmingham
Solution-phase microwave assisted parallel synthesis of N,N'-disubstituted thioureas derived from benzoic acid: biological evaluation and molecular docking studies.
Eur J Med Chem 70: 487-96 (2013)
Quaid-I-Azam University
Design, synthesis and molecular modelling studies of novel 3-acetamido-4-methyl benzoic acid derivatives as inhibitors of protein tyrosine phosphatase 1B.
Eur J Med Chem 70: 469-76 (2013)
School Of Pharmaceutical Sciences
Synthesis, structure-activity relationship and biological evaluation of 2,4,5-trisubstituted pyrimidine CDK inhibitors as potential anti-tumour agents.
Eur J Med Chem 70: 447-55 (2013)
University Of Nottingham
Synthesis, biological evaluation and molecular docking studies of flavone and isoflavone derivatives as a novel class of KSP (kinesin spindle protein) inhibitors.
Eur J Med Chem 70: 427-33 (2013)
Nanjing University
Investigation of quinazolines as inhibitors of breast cancer resistance protein (ABCG2).
Bioorg Med Chem 21: 7858-73 (2013)
University Of Bonn
Recycling antimalarial leads for cancer: Antiproliferative properties of N-cinnamoyl chloroquine analogues.
Bioorg Med Chem Lett 23: 6769-72 (2013)
Centro De Investiga££O Em Qu£Mica Da Universidade Do Porto
Design, synthesis and biological evaluation of novel 4-anilinoquinazolines with C-6 urea-linked side chains as inhibitors of the epidermal growth factor receptor.
Bioorg Med Chem 21: 7988-98 (2013)
Chinese Academy Of Sciences
Inhibitors of tissue-nonspecific alkaline phosphatase: design, synthesis, kinetics, biomineralization and cellular tests.
Bioorg Med Chem 21: 7981-7 (2013)
Universit£
Synthesis and pharmacological characterization of benzenesulfonamides as dual species inhibitors of human and murine mPGES-1.
Bioorg Med Chem 21: 7874-83 (2013)
Goethe-University Frankfurt
Towards tropomyosin-related kinase B (TrkB) receptor ligands for brain imaging with PET: radiosynthesis and evaluation of 2-(4-[(18)F]fluorophenyl)-7,8-dihydroxy-4H-chromen-4-one and 2-(4-([N-methyl-(11)C]-dimethylamino)phenyl)-7,8-dihydroxy-4H-chromen-4-one.
Bioorg Med Chem 21: 7816-29 (2013)
Universit£
Novel Mps1 kinase inhibitors: from purine to pyrrolopyrimidine and quinazoline leads.
Bioorg Med Chem Lett 23: 6829-33 (2013)
Myrexis
Reductions in log P improved protein binding and clearance predictions enabling the prospective design of cannabinoid receptor (CB1) antagonists with desired pharmacokinetic properties.
J Med Chem 56: 9586-600 (2014)
Bristol-Myers Squibb
Fragment-based approach to the design of 5-chlorouracil-linked-pyrazolo[1,5-a][1,3,5]triazines as thymidine phosphorylase inhibitors.
Eur J Med Chem 70: 400-10 (2013)
National University Of Singapore
Novel toll-like receptor 4 (TLR4) antagonists identified by structure- and ligand-based virtual screening.
Eur J Med Chem 70: 393-9 (2013)
Blood Transfusion Centre Of Slovenia
Synthesis of novel 7-substituted pyrido[2',3':4,5]furo[3,2-d]pyrimidin-4-amines and their N-aryl analogues and evaluation of their inhibitory activity against Ser/Thr kinases.
Bioorg Med Chem Lett 23: 6784-8 (2013)
Cobra
The discovery of novel N-(2-pyrimidinylamino) benzamide derivatives as potent hedgehog signaling pathway inhibitors.
Bioorg Med Chem Lett 23: 6777-83 (2013)
Jiangsu Simcere Pharmaceutical
2-(2-Phenylmorpholin-4-yl)pyrimidin-4(3H)-ones; a new class of potent, selective and orally active glycogen synthase kinase-3ß inhibitors.
Bioorg Med Chem Lett 23: 6933-7 (2013)
Mitsubishi Tanabe Pharma
Identification of CB1/CB2 ligands from Zanthoxylum bungeanum.
J Nat Prod 76: 2060-4 (2013)
National Institute On Aging
5-Chlorothiophene-2-carboxylic acid [(S)-2-[2-methyl-3-(2-oxopyrrolidin-1-yl)benzenesulfonylamino]-3-(4-methylpiperazin-1-yl)-3-oxopropyl]amide (SAR107375), a selective and potent orally active dual thrombin and factor Xa inhibitor.
J Med Chem 56: 9441-56 (2014)
Sanofi-Aventis R&D
6-Alkoxy-5-aryl-3-pyridinecarboxamides, a new series of bioavailable cannabinoid receptor type 1 (CB1) antagonists including peripherally selective compounds.
J Med Chem 56: 9874-96 (2013)
F. Hoffmann-La Roche
Expanding the Scope of Human DNA Polymerase ¿ and ß Inhibitors.
ACS Chem Biol 9: 282-90 (2014)
University Of Konstanz
Aminothiazole-featured pirinixic acid derivatives as dual 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 inhibitors with improved potency and efficiency in vivo.
J Med Chem 56: 9031-44 (2013)
Goethe-University Frankfurt
Structure-activity relationship study of permethyl ningalin B analogues as P-glycoprotein chemosensitizers.
J Med Chem 56: 9057-70 (2013)
Ocean University Of China
Structure-activity relationship of imidazopyridinium analogues as antagonists of neuropeptide s receptor.
J Med Chem 56: 9045-56 (2013)
National Institutes Of Health
Chromenylchalcones with inhibitory effects on monoamine oxidase B.
Bioorg Med Chem 21: 7890-7 (2013)
Konkuk University
Design, synthesis, and biological activities of novel hexahydropyrazino[1,2-a]indole derivatives as potent inhibitors of apoptosis (IAP) proteins antagonists with improved membrane permeability across MDR1 expressing cells.
Bioorg Med Chem 21: 7938-54 (2013)
Takeda Pharmaceutical
Design and Synthesis of Potent Bivalent Peptide Agonists Targeting the EphA2 Receptor.
ACS Med Chem Lett 4: 344-8 (2013)
State University Of New York
Beyond topoisomerase inhibition: antitumor 1,4-naphthoquinones as potential inhibitors of human monoamine oxidase.
Chem Biol Drug Des 83: 401-10 (2014)
Federal University Of Rio De Janeiro
Identification of type II inhibitors targeting BRAF using privileged pharmacophores.
Chem Biol Drug Des 83: 27-36 (2014)
Shanghai Institute Of Pharmaceutical Industry
Adenosine A2A receptor as a drug discovery target.
J Med Chem 57: 3623-50 (2014)
Merck Research Laboratories
Discovery of the first M5-selective and CNS penetrant negative allosteric modulator (NAM) of a muscarinic acetylcholine receptor: (S)-9b-(4-chlorophenyl)-1-(3,4-difluorobenzoyl)-2,3-dihydro-1H-imidazo[2,1-a]isoindol-5(9bH)-one (ML375).
J Med Chem 56: 9351-5 (2013)
Vanderbilt University
Conformationally constrained ortho-anilino diaryl ureas: discovery of 1-(2-(1'-neopentylspiro[indoline-3,4'-piperidine]-1-yl)phenyl)-3-(4-(trifluoromethoxy)phenyl)urea, a potent, selective, and bioavailable P2Y1 antagonist.
J Med Chem 56: 9275-95 (2013)
Bristol-Myers Squibb
Structure-activity relationships and molecular modeling of sphingosine kinase inhibitors.
J Med Chem 56: 9310-27 (2013)
The City University Of New York
Santacruzamate A, a potent and selective histone deacetylase inhibitor from the Panamanian marine cyanobacterium cf. Symploca sp.
J Nat Prod 76: 2026-33 (2013)
University Of Connecticut
Nicotinamide phosphoribosyltransferase inhibitors, design, preparation, and structure-activity relationship.
J Med Chem 56: 9071-88 (2013)
Topotarget
The discovery of the benzazepine class of histamine H3 receptor antagonists.
Bioorg Med Chem Lett 23: 6897-901 (2013)
Glaxosmithkline
Development of 3,4-dihydroisoquinolin-1(2H)-one derivatives for the Positron Emission Tomography (PET) imaging ofs2 receptors.
Eur J Med Chem 69: 920-30 (2013)
Universit£
Synthesis and evaluation of a (18)F-labeled diarylpyrazole glycoconjugate for the imaging of NTS1-positive tumors.
J Med Chem 56: 9361-5 (2013)
Friedrich-Alexander University
Synthesis and evaluation of multi-target-directed ligands against Alzheimer's disease based on the fusion of donepezil and ebselen.
J Med Chem 56: 9089-99 (2013)
Sun Yat-Sen University
Design and synthesis of P1-P3 macrocyclic tertiary-alcohol-comprising HIV-1 protease inhibitors.
J Med Chem 56: 8999-9007 (2013)
Uppsala University
Transition state analogues of Plasmodium falciparum and human orotate phosphoribosyltransferases.
J Biol Chem 288: 34746-54 (2013)
Albert Einstein College Of Medicine
A stereoselective approach to peptidomimetic BACE1 inhibitors.
Eur J Med Chem 70: 233-47 (2013)
University Of Siena
Scorpiand-like azamacrocycles prevent the chronic establishment of Trypanosoma cruzi in a murine model.
Eur J Med Chem 70: 189-98 (2013)
Universidad De Granada
The sulfamide moiety affords higher inhibitory activity and oral bioavailability to a series of coumarin dual selective RAF/MEK inhibitors.
Bioorg Med Chem Lett 23: 6223-7 (2013)
Chugai Pharmaceutical
Synthesis and biological evaluation of positron emission tomography radiotracers targeting serotonin 4 receptors in brain: [18F]MNI-698 and [18F]MNI-699.
Bioorg Med Chem Lett 23: 6243-7 (2013)
Molecular Neuroimaging
Cytidine derivatives as IspF inhibitors of Burkolderia pseudomallei.
Bioorg Med Chem Lett 23: 6860-3 (2013)
Northern Illinois University
Discovery and optimization of orally active cyclohexane-based prolylcarboxypeptidase (PrCP) inhibitors.
Bioorg Med Chem Lett 23: 6228-33 (2013)
Merck Research Laboratories
Design and synthesis of aryl sulfonamide-based nonsteroidal mineralocorticoid receptor antagonists.
Bioorg Med Chem Lett 23: 6239-42 (2013)
Pfizer
The 3,7-diazabicyclo[3.3.1]nonane scaffold for subtype selective nicotinic acetylcholine receptor (nAChR) ligands. Part 1: the influence of different hydrogen bond acceptor systems on alkyl and (hetero)aryl substituents.
Bioorg Med Chem 21: 7283-308 (2013)
University Of Bonn
Synthesis and
Medchemcomm 4: 1283-1289 (2013)
Washington University School Of Medicine
Synthesis and biological evaluation of pyrrolidine-2-carbonitrile and 4-fluoropyrrolidine-2-carbonitrile derivatives as dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes.
Bioorg Med Chem 21: 7418-29 (2013)
Chinese Academy Of Sciences
4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable Stearoyl-CoA desaturase-1 (SCD1) inhibitors. Part 1: urea-based analogs.
Bioorg Med Chem Lett 23: 6773-6 (2013)
Janssen Research And Development
Discovery and optimization of piperidyl-1,2,3-triazole ureas as potent, selective, and in vivo-active inhibitors of a/ß-hydrolase domain containing 6 (ABHD6).
Cell Chem Biol 56: 8270-9 (2013)
The Scripps Research Institute
Acetylcholinesterase inhibitors as Alzheimer therapy: from nerve toxins to neuroprotection.
Eur J Med Chem 70: 165-88 (2013)
Punjabi University
Novel state-dependent voltage-gated sodium channel modulators, based on marine alkaloids from Agelas sponges.
Eur J Med Chem 70: 154-64 (2013)
University Of Ljubljana
Thiazole-aminopiperidine hybrid analogues: design and synthesis of novel Mycobacterium tuberculosis GyrB inhibitors.
Eur J Med Chem 70: 143-53 (2013)
Birla Institute Of Technology
Design, synthesis and evaluation of novel 4-dimethylamine flavonoid derivatives as potential multi-functional anti-Alzheimer agents.
Bioorg Med Chem 21: 7275-82 (2013)
Henan University
Discovery of novel PTP1B inhibitors via pharmacophore-oriented scaffold hopping from Ertiprotafib.
Bioorg Med Chem Lett 23: 6217-22 (2013)
Chinese Academy Of Medical Sciences And Peking Union Medical College
Synthesis and evaluation in monkey of [(18)F]4-fluoro-N-methyl-N-(4-(6-(methylamino)pyrimidin-4-yl)thiazol-2-yl)benzamide ([(18)F]FIMX): a promising radioligand for PET imaging of brain metabotropic glutamate receptor 1 (mGluR1).
J Med Chem 56: 9146-55 (2013)
National Institute Of Mental Health
2'-Deoxyuridine 5'-monophosphate substrate displacement in thymidylate synthase through 6-hydroxy-2H-naphtho[1,8-bc]furan-2-one derivatives.
J Med Chem 56: 9356-60 (2013)
University Of Modena And Reggio Emilia
Discovery of a potent inhibitor of replication protein a protein-protein interactions using a fragment-linking approach.
J Med Chem 56: 9242-50 (2013)
Vanderbilt University School Of Medicine
The 3,7-diazabicyclo[3.3.1]nonane scaffold for subtype selective nicotinic acetylcholine receptor ligands. Part 2: carboxamide derivatives with different spacer motifs.
Bioorg Med Chem 21: 7309-29 (2013)
University Of Bonn
Schiff's base derivatives bearing nitroimidazole moiety: new class of antibacterial, anticancer agents and potential EGFR tyrosine kinase inhibitors.
Bioorg Med Chem Lett 23: 6264-8 (2013)
Nanjing University
Synthesis of 3-spiromorpholinone androsterone derivatives as inhibitors of 17ß-hydroxysteroid dehydrogenase type 3.
Bioorg Med Chem Lett 23: 6360-2 (2013)
Laval University
Anti-cancer evaluation of carboxamides of furano-sesquiterpene carboxylic acids from the soft coral Sinularia kavarattiensis.
Bioorg Med Chem Lett 23: 6234-8 (2013)
Csir-Iict
4?-Methyl-5-(3-hydroxyphenyl)morphan opioid agonist and partial agonist derived from a 4?-methyl-5-(3-hydroxyphenyl)morphan pure antagonist.
J Med Chem 56: 8826-33 (2013)
Research Triangle Institute
Structure-guided design of potent diazobenzene inhibitors for the BET bromodomains.
J Med Chem 56: 9251-64 (2013)
Icahn School Of Medicine At Mount Sinai
Design, synthesis, and biological evaluation of 14-heteroaromatic-substituted naltrexone derivatives: pharmacological profile switch from mu opioid receptor selectivity to mu/kappa opioid receptor dual selectivity.
J Med Chem 56: 9156-69 (2013)
Virginia Commonwealth University
Synthetic cannabinoid quinones: preparation, in vitro antiproliferative effects and in vivo prostate antitumor activity.
Eur J Med Chem 70: 111-9 (2013)
Instituto De Qu£Mica M£Dica
Novel polyamine analogues: from substrates towards potential inhibitors of monoamine oxidases.
Eur J Med Chem 70: 88-101 (2013)
University Of Padova
Design, synthesis and receptor affinity of novel conformationally restricteds ligands based on the [4.3.3]propellane scaffold.
Eur J Med Chem 70: 78-87 (2013)
Institut F£R Pharmazeutische Und Medizinische Chemie Der Westf£Lischen Wilhelms-Universit£T M£Nster
Synthesis and evaluation of N-alkyl-S-[3-(piperidin-1-yl)propyl]isothioureas: high affinity and human/rat species-selective histamine H(3) receptor antagonists.
Bioorg Med Chem Lett 23: 6415-20 (2013)
Osaka University Of Pharmaceutical Sciences
GluK1 antagonists from 6-(tetrazolyl)phenyl decahydroisoquinoline derivatives: in vitro profile and in vivo analgesic efficacy.
Bioorg Med Chem Lett 23: 6463-6 (2013)
Centro De Investigaci�N Lilly
Quinones bearing non-steroidal anti-inflammatory fragments as multitarget ligands for Alzheimer's disease.
Bioorg Med Chem Lett 23: 6254-8 (2013)
Alma Mater Studiorum University Of Bologna
Design and synthesis of silicon-containing tubulin polymerization inhibitors: replacement of the ethylene moiety of combretastatin A-4 with a silicon linker.
Bioorg Med Chem 21: 7381-91 (2013)
The University Of Tokyo
Development of fluorinated CB(2) receptor agonists for PET studies.
Bioorg Med Chem 21: 7481-98 (2013)
Institut F£R Pharmazeutische Und Medizinische Chemie Der Universit£T M£Nster
Identification and profiling of 3,5-dimethyl-isoxazole-4-carboxylic acid [2-methyl-4-((2S,3'S)-2-methyl-[1,3']bipyrrolidinyl-1'-yl)phenyl] amide as histamine H(3) receptor antagonist for the treatment of depression.
Bioorg Med Chem Lett 23: 6269-73 (2013)
Sanofi Us
Discovery of 2-methylpyridine-based biaryl amides as¿-secretase modulators for the treatment of Alzheimer's disease.
Bioorg Med Chem Lett 23: 6447-54 (2013)
Amgen
Discovery and optimization of pyrrolo[1,2-a]pyrazinones leads to novel and selective inhibitors of PIM kinases.
Bioorg Med Chem 21: 7364-80 (2013)
Nerviano Medical Sciences
1,3-Dialkyl-substituted tetrahydropyrimido[1,2-f]purine-2,4-diones as multiple target drugs for the potential treatment of neurodegenerative diseases.
Bioorg Med Chem 21: 7435-52 (2013)
University Of Bonn
Structure-based design and synthesis of potent benzothiazole inhibitors of interleukin-2 inducible T cell kinase (ITK).
Bioorg Med Chem Lett 23: 6331-5 (2013)
Evotec (Uk)
Enhancement of kinase selectivity in a potent class of arylamide FMS inhibitors.
Bioorg Med Chem Lett 23: 6363-9 (2013)
Janssen Research And Development
A structure-activity analysis of biased agonism at the dopamine D2 receptor.
J Med Chem 56: 9199-221 (2013)
Monash University (Parkville Campus)
Azetidines and spiro azetidines as novel P2 units in hepatitis C virus NS3 protease inhibitors.
Bioorg Med Chem Lett 23: 6325-30 (2013)
Emory University
Discovery, design and synthesis of a selective S1P(3) receptor allosteric agonist.
Bioorg Med Chem Lett 23: 6346-9 (2013)
The Scripps Research Institute
Design, synthesis and biological evaluation of 3-benzyloxy-linked pyrimidinylphenylamine derivatives as potent HIV-1 NNRTIs.
Bioorg Med Chem 21: 7398-405 (2013)
Shandong University
Effects of isoform-selective phosphatidylinositol 3-kinase inhibitors on osteoclasts: actions on cytoskeletal organization, survival, and resorption.
J Biol Chem 288: 35346-57 (2013)
Western University
Novel structural and functional insights into M3 muscarinic receptor dimer/oligomer formation.
J Biol Chem 288: 34777-90 (2013)
National Institutes Of Health
Oxidative stress in Alzheimer's disease: are we connecting the dots?
J Med Chem 57: 2821-31 (2014)
University Of Bologna
Design of novel potent inhibitors of human uridine phosphorylase-1: synthesis, inhibition studies, thermodynamics, and in vitro influence on 5-fluorouracil cytotoxicity.
J Med Chem 56: 8892-902 (2013)
Pontifical Catholic University Of Rio Grande Do Sul
Metabolically stable dibenzo[b,e]oxepin-11(6H)-ones as highly selective p38 MAP kinase inhibitors: optimizing anti-cytokine activity in human whole blood.
J Med Chem 56: 8561-78 (2013)
Eberhard-Karls-University T£Bingen
Synthesis, pharmacological and structural characterization, and thermodynamic aspects of GluA2-positive allosteric modulators with a 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide scaffold.
J Med Chem 56: 8736-45 (2013)
University Of Copenhagen
Triazole-dithiocarbamate based selective lysine specific demethylase 1 (LSD1) inactivators inhibit gastric cancer cell growth, invasion, and migration.
J Med Chem 56: 8543-60 (2013)
Zhengzhou University
High accuracy in silico sulfotransferase models.
J Biol Chem 288: 34494-501 (2013)
Albert Einstein College Of Medicine
Design of fluorinated 5-HT(4)R antagonists: influence of the basicity and lipophilicity toward the 5-HT(4)R binding affinities.
Bioorg Med Chem 21: 7529-38 (2013)
University Of Southampton
Ligand modifications to reduce the relative resistance of multi-drug resistant HIV-1 protease.
Bioorg Med Chem 21: 7430-4 (2013)
Wayne State University
Inhibition of cholinesterase and monoamine oxidase-B activity by Tacrine-Homoisoflavonoid hybrids.
Bioorg Med Chem 21: 7406-17 (2013)
Sun Yat-Sen University
Exploring a potential palonosetron allosteric binding site in the 5-HT(3) receptor.
Bioorg Med Chem 21: 7523-8 (2013)
Universit£
Design, synthesis and binding affinity of acetylcholine carbamoyl analogues.
Bioorg Med Chem Lett 23: 6481-5 (2013)
Universit£
Hypoxia-targeting carbonic anhydrase IX inhibitors by a new series of nitroimidazole-sulfonamides/sulfamides/sulfamates.
J Med Chem 56: 8512-20 (2013)
Ecole Nationale Sup£Rieure De Chimie De Montpellier
Targeting botulinum A cellular toxicity: a prodrug approach.
J Med Chem 56: 7870-9 (2013)
The Scripps Research Institute
Molecular characterization of zebrafish Oatp1d1 (Slco1d1), a novel organic anion-transporting polypeptide.
J Biol Chem 288: 33894-911 (2013)
Rudjer Boskovic Institute
Design, synthesis, and bioevaluation of viral 3C and 3C-like protease inhibitors.
Bioorg Med Chem Lett 23: 6317-20 (2013)
Kansas State University
Scaffold hopping approach towards various AFQ-056 analogs as potent metabotropic glutamate receptor 5 negative allosteric modulators.
Bioorg Med Chem Lett 23: 6370-6 (2013)
Merz Pharmaceuticals
Targeting the hydrophobic region of Hsp90's ATP binding pocket with novel 1,3,5-triazines.
Bioorg Med Chem Lett 23: 6427-31 (2013)
Kyungpook National University
Modulators of the Sphingosine 1-phosphate receptor 1.
Bioorg Med Chem Lett 23: 6377-89 (2013)
The Scripps Research Institute
Novel acetamidothiazole derivatives: synthesis and in vitro anticancer evaluation.
Eur J Med Chem 69: 908-19 (2013)
University Of Mansoura
Mastering tricyclic ring systems for desirable functional cannabinoid activity.
Eur J Med Chem 69: 881-907 (2013)
The University Of Montana
6-(1-Benzyl-1H-pyrrol-2-yl)-2,4-dioxo-5-hexenoic acids as dual inhibitors of recombinant HIV-1 integrase and ribonuclease H, synthesized by a parallel synthesis approach.
J Med Chem 56: 8588-98 (2013)
"Sapienza" Universit£
Design, synthesis, and biological evaluation of 2-oxo-3,4-dihydropyrimido[4,5-d]pyrimidinyl derivatives as new irreversible epidermal growth factor receptor inhibitors with improved pharmacokinetic properties.
J Med Chem 56: 8803-13 (2013)
Chinese Academy Of Sciences
Chemotype-selective modes of action of ¿-opioid receptor agonists.
J Biol Chem 288: 34470-83 (2013)
University Of North Carolina
Discovery of a potent dual EGFR/HER-2 inhibitor L-2 (selatinib) for the treatment of cancer.
Eur J Med Chem 69: 833-41 (2013)
Qilu Pharmaceutical
The optimization of aminooxadiazoles as orally active inhibitors of Cdc7.
Bioorg Med Chem Lett 23: 6396-400 (2013)
Amgen
Identification of 2-aminooxazole amides as acyl-CoA: diacylglycerol acyltransferase 1 (DGAT1) inhibitors through scaffold hopping strategy.
Bioorg Med Chem Lett 23: 6410-4 (2013)
Merck Research Laboratories
Novel coumarin-dihydropyrazole thio-ethanone derivatives: design, synthesis and anticancer activity.
Eur J Med Chem 74: 717-25 (2014)
Anhui Medical University
3-[2-(Aminomethyl)-5-[(pyridin-4-yl)carbamoyl]phenyl] benzoates as soft ROCK inhibitors.
Bioorg Med Chem Lett 23: 6442-6 (2013)
Amakem
Design, synthesis and biological evaluation of di-substituted cinnamic hydroxamic acids bearing urea/thiourea unit as potent histone deacetylase inhibitors.
Bioorg Med Chem Lett 23: 6432-5 (2013)
Central South University
GluK1 antagonists from 6-(carboxy)phenyl decahydroisoquinoline derivatives. SAR and evaluation of a prodrug strategy for oral efficacy in pain models.
Bioorg Med Chem Lett 23: 6459-62 (2013)
Centro De Investigaci�N Lilly
Design, synthesis and biological evaluation of N2,N4-disubstituted-1,1,3-trioxo-2H,4H-pyrrolo[1,2-b][1,2,4,6]thiatriazine derivatives as HIV-1 NNRTIs.
Bioorg Med Chem 21: 7091-100 (2013)
Shandong University
Design, synthesis and biological evaluation of pazopanib derivatives as antitumor agents.
Chem Biol Drug Des 83: 306-16 (2014)
Shandong Institute Of Pharmaceutical Industry
Synthesis and evaluation of novel oleanolic acid derivatives as potential antidiabetic agents.
Chem Biol Drug Des 83: 297-305 (2014)
Chengde Medical University
Discovery of tankyrase inhibiting flavones with increased potency and isoenzyme selectivity.
J Med Chem 56: 7880-9 (2013)
University Of Oulu
The antiparasitic clioquinol induces apoptosis in leukemia and myeloma cells by inhibiting histone deacetylase activity.
J Biol Chem 288: 34181-9 (2013)
Soochow University
Acidic biphenyl derivatives: synthesis and biological activity of a new series of potent 5-HT(4) receptor antagonists.
Bioorg Med Chem 21: 7134-45 (2013)
University Of Oslo
5-Deazaflavin derivatives as inhibitors of p53 ubiquitination by HDM2.
Bioorg Med Chem 21: 6868-77 (2013)
University Of Nottingham
Design and synthesis of novel 3,5-bis-N-(aryl/heteroaryl) carbamoyl-4-aryl-1,4-dihydropyridines as small molecule BACE-1 inhibitors.
Bioorg Med Chem 21: 6893-909 (2013)
Shiraz University Of Medical Sciences
Investigation of aryl halides as ketone bioisosteres: refinement of potent and selective inhibitors of human cytochrome P450 19A1 (aromatase).
Bioorg Med Chem Lett 23: 6060-3 (2013)
Mcmaster University
The lignan (-)-hinokinin displays modulatory effects on human monoamine and GABA transporter activities.
J Nat Prod 76: 1889-95 (2013)
Drexel University College Of Medicine
Fragment-based identification of a locus in the Sec7 domain of Arno for the design of protein-protein interaction inhibitors.
J Med Chem 56: 8497-511 (2013)
University Of Montpellier
Tumor-targeting with novel non-benzoyl 6-substituted straight chain pyrrolo[2,3-d]pyrimidine antifolates via cellular uptake by folate receptor a and inhibition of de novo purine nucleotide biosynthesis.
J Med Chem 56: 8684-95 (2013)
Duquesne University
Structural basis for the recognition of mycolic acid precursors by KasA, a condensing enzyme and drug target from Mycobacterium tuberculosis.
J Biol Chem 288: 34190-204 (2013)
University Of Wuerzburg
Synthesis and pharmacological evaluation of aminothiazolomorphinans at the mu and kappa opioid receptors.
J Med Chem 56: 8872-8 (2013)
Harvard Medical School
Methyl-thiazoles: a novel mode of inhibition with the potential to develop novel inhibitors targeting InhA in Mycobacterium tuberculosis.
J Med Chem 56: 8533-42 (2013)
Astrazeneca India
Novel 6?-acylaminomorphinans with analgesic activity.
Eur J Med Chem 69: 786-9 (2013)
Semmelweis University
Inhibition of human carbonic anhydrase isoforms I-XIV with sulfonamides incorporating fluorine and 1,3,5-triazine moieties.
Bioorg Med Chem 21: 6929-36 (2013)
Universit£
Benzenesulfonamides with pyrimidine moiety as inhibitors of human carbonic anhydrases I, II, VI, VII, XII, and XIII.
Bioorg Med Chem 21: 6937-47 (2013)
Vilnius University
Synthesis and biological evaluation of direct thrombin inhibitors bearing 4-(piperidin-1-yl)pyridine at the P1 position with potent anticoagulant activity.
J Med Chem 56: 8696-711 (2013)
University Of Bari &Quot;Aldo Moro&Quot
Design, optimization, and biological evaluation of novel keto-benzimidazoles as potent and selective inhibitors of phosphodiesterase 10A (PDE10A).
J Med Chem 56: 8781-92 (2013)
Amgen
Clicking 3'-azidothymidine into novel potent inhibitors of human immunodeficiency virus.
J Med Chem 56: 8765-80 (2013)
University Of Minnesota
Discovery of an in vivo chemical probe of the lysine methyltransferases G9a and GLP.
J Med Chem 56: 8931-42 (2013)
University Of North Carolina At Chapel Hill
Discovery of NMS-E973 as novel, selective and potent inhibitor of heat shock protein 90 (Hsp90).
Bioorg Med Chem 21: 7047-63 (2013)
Nerviano Medical Sciences
Click chemistry based synthesis of dopamine D4 selective receptor ligands for the selection of potential PET tracers.
Bioorg Med Chem Lett 23: 6079-82 (2013)
Friedrich-Alexander University
Novel highly potent serotonin 5-HT7 receptor ligands: structural modifications to improve pharmacokinetic properties.
Bioorg Med Chem Lett 23: 6083-6 (2013)
Universit£
Novel nonsecosteroidal VDR agonists with phenyl-pyrrolyl pentane skeleton.
Eur J Med Chem 69: 768-78 (2013)
China Pharmaceutical University
Monoamine oxidase inhibitory activity of 3,5-biaryl-4,5-dihydro-1H-pyrazole-1-carboxylate derivatives.
Eur J Med Chem 69: 762-7 (2013)
Birla Institute Of Technology
Discovery of tryptanthrin derivatives as potent inhibitors of indoleamine 2,3-dioxygenase with therapeutic activity in Lewis lung cancer (LLC) tumor-bearing mice.
J Med Chem 56: 8321-31 (2013)
Fudan University
Structure-activity-relationship studies around the 2-amino group and pyridine core of antimalarial 3,5-diarylaminopyridines lead to a novel series of pyrazine analogues with oral in vivo activity.
J Med Chem 56: 8860-71 (2013)
University Of Cape Town
On the histone lysine methyltransferase activity of fungal metabolite chaetocin.
J Med Chem 56: 8616-25 (2013)
Imperial College
Dipeptidyl peptidase IV and its inhibitors: therapeutics for type 2 diabetes and what else?
J Med Chem 57: 2197-212 (2014)
Chuv-Unil
Fragment-to-hit-to-lead discovery of a novel pyridylurea scaffold of ATP competitive dual targeting type II topoisomerase inhibiting antibacterial agents.
Cell Chem Biol 56: 8712-35 (2013)
Astrazeneca R&D Boston
Design, synthesis, and activity of a series of arylpyrid-3-ylmethanones as type I positive allosteric modulators of a7 nicotinic acetylcholine receptors.
J Med Chem 56: 8352-65 (2013)
University Of California Irvine
Synthesis and investigation of dihydroxychalcones as calpain and cathepsin inhibitors.
Bioorg Chem 51: 24-30 (2013)
Ewha Womans University
Design and application of a rigid quinazolone scaffold based on two-face Bima-helix mimicking.
Eur J Med Chem 69: 711-8 (2013)
Dalian University Of Technology
Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
Eur J Med Chem 69: 701-10 (2013)
Medical University Of Gdansk
Design, syntheses, and characterization of pharmacophore based chemokine receptor CCR5 antagonists as anti prostate cancer agents.
Eur J Med Chem 69: 647-58 (2013)
Virginia Commonwealth University
Multifunctional tacrine-flavonoid hybrids with cholinergic,ß-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer's disease.
Eur J Med Chem 69: 632-46 (2013)
China Pharmaceutical University
Design, synthesis and biological activities of some 7-aminocephalosporanic acid derivatives.
Eur J Med Chem 69: 622-31 (2013)
Karadeniz Technical University
New combination of pharmacophoric elements of potents1 ligands: design, synthesis ands receptor affinity of aminoethyl substituted tetrahydrobenzothiophenes.
Eur J Med Chem 69: 490-7 (2013)
Universit£T M£Nster
Synthesis and in vitro evaluation of a novel radioligand foravß3 integrin receptor imaging: [18F]FPPA-c(RGDfK).
Bioorg Med Chem Lett 23: 6068-72 (2013)
University Hospital Of Geneva
The discovery and optimization of novel dual inhibitors of topoisomerase II and histone deacetylase.
Bioorg Med Chem 21: 6981-95 (2013)
East China Normal University
Development of novel ferulic acid derivatives as potent histone deacetylase inhibitors.
Bioorg Med Chem 21: 6973-80 (2013)
Xi'An Jiaotong University
Perindopril and ramipril phosphonate analogues as a new class of angiotensin converting enzyme inhibitors.
Bioorg Med Chem 21: 7216-21 (2013)
Universit£
N-Alkyl dien- and trienamides from the roots of Otanthus maritimus with binding affinity for opioid and cannabinoid receptors.
Bioorg Med Chem 21: 7074-82 (2013)
Uos Of Cagliari
Synthesis and pharmacological evaluation of carboxycoumarins as a new antitumor treatment targeting lactate transport in cancer cells.
Bioorg Med Chem 21: 7107-17 (2013)
Institut De Recherche Exp£Rimentale Et Clinique (Irec)
6-(4-Pyridyl)pyrimidin-4(3H)-ones as CNS penetrant glycogen synthase kinase-3? inhibitors.
Bioorg Med Chem Lett 23: 6928-32 (2013)
Mitsubishi Tanabe Pharma
Hit-to-lead optimization of 2-(1H-pyrazol-1-yl)-thiazole derivatives as a novel class of EP1 receptor antagonists.
Bioorg Med Chem Lett 23: 6064-7 (2013)
Asahi Kasei Pharma
Synthesis and biological evaluation of 5-carbamoyl-2-phenylpyrimidine derivatives as novel and potent PDE4 inhibitors.
Bioorg Med Chem 21: 7025-37 (2013)
Kyushu University
Discovery of 2-aryl-8-hydroxy (or methoxy)-isoquinolin-1(2H)-ones as novel EGFR inhibitor by scaffold hopping.
Bioorg Med Chem 21: 6956-64 (2013)
Xi'An Jiaotong University
Optimization of benzodiazepinones as selective inhibitors of the X-linked inhibitor of apoptosis protein (XIAP) second baculovirus IAP repeat (BIR2) domain.
J Med Chem 56: 7788-803 (2013)
Hoffmann-La Roche
Molecular basis of cannabinoid CB1 receptor coupling to the G protein heterotrimer Gaiß¿: identification of key CB1 contacts with the C-terminal helix a5 of Gai.
J Biol Chem 288: 32449-65 (2013)
North Carolina Central University
Discovery of pyrazolo[1,5-a]pyrimidine-based Pim inhibitors: a template-based approach.
Bioorg Med Chem Lett 23: 6178-82 (2013)
Merck Research Laboratories
Synthesis, docking, and biological studies of phenanthrene ?-diketo acids as novel HIV-1 integrase inhibitors.
Bioorg Med Chem Lett 23: 6146-51 (2013)
University Of Tennessee Health Science Center
Indenoindoles and cyclopentacarbazoles as bioactive compounds: synthesis and biological applications.
Eur J Med Chem 69: 465-79 (2013)
The University Of Oslo
Synthesis and biological evaluation of novel delta (?) opioid receptor ligands with diazatricyclodecane skeletons.
Eur J Med Chem 69: 413-26 (2013)
C.N.R. Istituto Di Farmacologia Traslazionale
Design, synthesis, and biological evaluation of novel 2-ethyl-5-phenylthiazole-4-carboxamide derivatives as protein tyrosine phosphatase 1B inhibitors with improved cellular efficacy.
Eur J Med Chem 69: 399-412 (2013)
Chinese Academy Of Sciences
Structural study of interaction between brinzolamide and dorzolamide inhibition of human carbonic anhydrases.
Bioorg Med Chem 21: 7210-5 (2013)
University Of Florida
Expeditious synthesis, enantiomeric resolution, and enantiomer functional characterization of (4-(4-bromophenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-sulfonamide (4BP-TQS): an allosteric agonist-positive allosteric modulator of α7 nicotinic acetylcholine receptors.
J Med Chem 56: 8943-7 (2013)
Northeastern University
Identification and structure-activity relationship study of carvacrol derivatives as Mycobacterium tuberculosis chorismate mutase inhibitors.
J Enzyme Inhib Med Chem 29: 547-54 (2014)
Birla Institute Of Technology
A systematic quantitative approach to rational drug design and discovery of novel human carbonic anhydrase IX inhibitors.
J Enzyme Inhib Med Chem 29: 571-81 (2014)
Birla Institute Of Technology
Replacement of Thr32 and Gln34 in the C-terminal neuropeptide Y fragment 25-36 by cis-cyclobutane and cis-cyclopentane β-amino acids shifts selectivity toward the Y(4) receptor.
J Med Chem 56: 8422-31 (2013)
University Of Regensburg
Discovery of novel small-molecule inhibitors of BRD4 using structure-based virtual screening.
J Med Chem 56: 8073-88 (2013)
The Institute Of Cancer Research
Design of substituted imidazolidinylpiperidinylbenzoic acids as chemokine receptor 5 antagonists: potent inhibitors of R5 HIV-1 replication.
J Med Chem 56: 8049-65 (2013)
Sanofi
Thiazolopyridine ureas as novel antitubercular agents acting through inhibition of DNA Gyrase B.
Cell Chem Biol 56: 8834-48 (2013)
Astrazeneca India
Molecular basis for the long duration of action and kinetic selectivity of tiotropium for the muscarinic M3 receptor.
J Med Chem 56: 8746-56 (2013)
Boehringer Ingelheim Pharma
Experimental confirmation of new drug-target interactions predicted by Drug Profile Matching.
J Med Chem 56: 8377-88 (2013)
E£Tv£S Lor£Nd University
In vitro structure-activity relationships of aplysinopsin analogs and their in vivo evaluation in the chick anxiety-depression model.
Bioorg Med Chem 21: 7083-90 (2013)
University Of Mississippi
Design and synthesis of novel pyrimidone analogues as HIV-1 integrase inhibitors.
Bioorg Med Chem Lett 23: 6134-7 (2013)
Shandong University
Nonhydrolyzable ATP analogues as selective inhibitors of human NPP1: a combined computational/experimental study.
J Med Chem 56: 8308-20 (2013)
UniversitÉ
Chiral 1,3,4-oxadiazol-2-ones as highly selective FAAH inhibitors.
J Med Chem 56: 8484-96 (2013)
University Of Eastern Finland
Benzazepinones and benzoxazepinones as antagonists of inhibitor of apoptosis proteins (IAPs) selective for the second baculovirus IAP repeat (BIR2) domain.
J Med Chem 56: 7772-87 (2013)
Hoffmann-La Roche
Substrate-based fragment identification for the development of selective, nonpeptidic inhibitors of striatal-enriched protein tyrosine phosphatase.
J Med Chem 56: 7636-50 (2013)
Yale University
Effects of novel human cathepsin S inhibitors on cell migration in human cancer cells.
J Enzyme Inhib Med Chem 29: 538-46 (2014)
National Tsing Hua University
Restraining the flexibility of the central linker in terameprocol results in constrained analogs with improved growth inhibitory activity.
Bioorg Med Chem Lett 23: 6127-33 (2013)
National University Of Singapore
Serendipity in drug-discovery: a new series of 2-(benzyloxy)benzamides as TRPM8 antagonists.
Bioorg Med Chem Lett 23: 6118-22 (2013)
Pfizer
Kinetic and thermodynamic rationale for suberoylanilide hydroxamic acid being a preferential human histone deacetylase 8 inhibitor as compared to the structurally similar ligand, trichostatin a.
Biochemistry 52: 8139-49 (2013)
North Dakota State University
Use of 2'-spirocyclic ethers in HCV nucleoside design.
J Med Chem 57: 1826-35 (2014)
Pharmasset
Rational development of 4-aminopyridyl-based inhibitors targeting Trypanosoma cruzi CYP51 as anti-chagas agents.
J Med Chem 56: 7651-68 (2013)
Scripps Florida
Design, synthesis and efficacy of novel G protein-coupled receptor kinase 2 inhibitors.
Eur J Med Chem 69: 384-92 (2013)
University Of Naples
Squaric acid/4-aminoquinoline conjugates: novel potent antiplasmodial agents.
Eur J Med Chem 69: 365-72 (2013)
University Of Lisbon. Av. Prof. Gama Pinto
Development of 3-phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine derivatives as novel Mycobacterium tuberculosis pantothenate synthetase inhibitors.
Eur J Med Chem 69: 356-64 (2013)
Birla Institute Of Technology
Modulation of A2B adenosine receptor by 1-Benzyl-3-ketoindole derivatives.
Eur J Med Chem 69: 331-7 (2013)
Universit£
Reversible inhibition of human acetylcholinesterase by methoxypyridinium species.
Bioorg Med Chem Lett 23: 5786-9 (2013)
The University Of Iowa
Discovery of a potent, selective, and orally bioavailable histamine H3 receptor antagonist SAR110068 for the treatment of sleep-wake disorders.
Bioorg Med Chem Lett 23: 6141-5 (2013)
Sanofi Us
Discovery of a novel sub-class of ROMK channel inhibitors typified by 5-(2-(4-(2-(4-(1H-Tetrazol-1-yl)phenyl)acetyl)piperazin-1-yl)ethyl)isobenzofuran-1(3H)-one.
Bioorg Med Chem Lett 23: 5829-32 (2013)
Merck Research Laboratories
Structure-based identification of novel PPAR gamma ligands.
Bioorg Med Chem Lett 23: 5795-802 (2013)
Universidade Federal Do Abc
Identification, biological characterization and pharmacophoric analysis of a new potent and selective NK1 receptor antagonist clinical candidate.
Bioorg Med Chem 21: 6264-73 (2013)
Glaxosmithkline
Dimeric argininamide-type neuropeptide Y receptor antagonists: chiral discrimination between Y1 and Y4 receptors.
Bioorg Med Chem 21: 6303-22 (2013)
University Of Regensburg
Synthesis of sterically encumbered 11ß-aminoprogesterone derivatives and evaluation as 11ß-hydroxysteroid dehydrogenase inhibitors and mineralocorticoid receptor antagonists.
Bioorg Med Chem 21: 6274-81 (2013)
University Of Alberta
Identification of novel PARP-1 inhibitors by structure-based virtual screening.
Bioorg Med Chem Lett 23: 5790-4 (2013)
St. John'S University
Discovery of VU0409106: A negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety.
Bioorg Med Chem Lett 23: 5779-85 (2013)
Vanderbilt University Medical Center
Synthesis and bioconversions of formestane.
J Nat Prod 76: 1966-9 (2013)
The University Of Tampa
Probing structural requirements of positive allosteric modulators of the M4 muscarinic receptor.
J Med Chem 56: 8196-200 (2013)
Monash University
Investigating the selectivity of metalloenzyme inhibitors.
J Med Chem 56: 7997-8007 (2013)
University Of California San Diego
Novel selective and potent inhibitors of malaria parasite dihydroorotate dehydrogenase: discovery and optimization of dihydrothiophenone derivatives.
J Med Chem 56: 7911-24 (2013)
State Key Laboratory Of Bioreactor Engineering
The SUMO1-E67 interacting loop peptide is an allosteric inhibitor of the dipeptidyl peptidases 8 and 9.
J Biol Chem 288: 32787-96 (2013)
Georg-August-University Of Goettingen
Crystal structure and pharmacological characterization of a novel N-methyl-D-aspartate (NMDA) receptor antagonist at the GluN1 glycine binding site.
J Biol Chem 288: 33124-35 (2013)
University Of Copenhagen
Structural determinants of Tau aggregation inhibitor potency.
J Biol Chem 288: 32599-611 (2013)
The Ohio State University
Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.
Bioorg Med Chem 21: 6456-65 (2013)
Universit£
Synthesis and structure-activity relationship of 2-phenyliminochromene derivatives as inhibitors for aldo-keto reductase (AKR) 1B10.
Bioorg Med Chem 21: 6378-84 (2013)
Gifu Pharmaceutical University
Design and bio-evaluation of indole derivatives as potent Kv1.5 inhibitors.
Bioorg Med Chem 21: 6466-76 (2013)
China Pharmaceutical University
Synthesis and biological evaluation of novel C-aryl d-glucofuranosides as sodium-dependent glucose co-transporter 2 inhibitors.
Bioorg Med Chem 21: 6282-91 (2013)
National Taiwan University
Discovery of (S,E)-3-(2-fluorophenyl)-N-(1-(3-(pyridin-3-yloxy)phenyl)ethyl)-acrylamide as a potent and efficacious KCNQ2 (Kv7.2) opener for the treatment of neuropathic pain.
Bioorg Med Chem Lett 23: 6188-91 (2013)
Bristol-Myers Squibb
Fluorescence Linked Enzyme Chemoproteomic Strategy for Discovery of a Potent and Selective DAPK1 and ZIPK Inhibitor.
ACS Chem Biol 8: 2715-23 (2013)
Duke University Medical Center
Small molecule probe suitable for in situ profiling and inhibition of protein disulfide isomerase.
ACS Chem Biol 8: 2577-85 (2013)
National University Of Singapore
Discovery of a novel series of potent non-nucleoside inhibitors of hepatitis C virus NS5B.
J Med Chem 56: 8163-82 (2013)
Hoffmann-La Roche
Further SAR studies on bicyclic basic merbarone analogues as potent antiproliferative agents.
Bioorg Med Chem 21: 6328-36 (2013)
Universit£
Structure-activity relationships and discovery of a G protein biased ? opioid receptor ligand, [(3-methoxythiophen-2-yl)methyl]({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro-[4.5]decan-9-yl]ethyl})amine (TRV130), for the treatment of acute severe pain.
J Med Chem 56: 8019-31 (2013)
Trevena
Preparation of asymmetric urea derivatives that target prostate-specific membrane antigen for SPECT imaging.
J Med Chem 56: 7890-901 (2013)
Kyoto University
Design, synthesis, and biological and crystallographic evaluation of novel inhibitors of Plasmodium falciparum enoyl-ACP-reductase (PfFabI).
J Med Chem 56: 7516-26 (2013)
University Of Bologna
Identification of conformationally sensitive residues essential for inhibition of vesicular monoamine transport by the noncompetitive inhibitor tetrabenazine.
J Biol Chem 288: 32160-71 (2013)
Hebrew University Of Jerusalem
Investigation of 3-aryl-pyrimido[5,4-e][1,2,4]triazine-5,7-diones as small molecule antagonists ofß-catenin/TCF transcription.
Bioorg Med Chem Lett 23: 5814-20 (2013)
University Of Michigan
Flavone-based analogues inspired by the natural product simocyclinone D8 as DNA gyrase inhibitors.
Bioorg Med Chem Lett 23: 5874-7 (2013)
Virginia Commonwealth University
Exploring the molecular determinants of substrate-selective inhibition of cyclooxygenase-2 by lumiracoxib.
Bioorg Med Chem Lett 23: 5860-4 (2013)
Vanderbilt University
Discovery of a series of hydroximic acid derivatives as potent histone deacetylase inhibitors.
J Enzyme Inhib Med Chem 29: 582-9 (2014)
Qingdao University
Modulation of global low-frequency motions underlies allosteric regulation: demonstration in CRP/FNR family transcription factors.
PLoS Biol 11: 1-15 (2013)
Durham University
Novel complex crystal structure of prolyl hydroxylase domain-containing protein 2 (PHD2): 2,8-Diazaspiro[4.5]decan-1-ones as potent, orally bioavailable PHD2 inhibitors.
Bioorg Med Chem 21: 6349-58 (2013)
Glaxosmithkline
Synthesis of amino-hydroxy-benzocycloheptenones as potent, selective, non-peptidic dinuclear zinc metalloaminopeptidase inhibitors.
Bioorg Med Chem 21: 6447-55 (2013)
Universit£
Towards new C6-rigid S-DABO HIV-1 reverse transcriptase inhibitors: synthesis, biological investigation and molecular modeling studies.
Bioorg Med Chem 21: 6477-83 (2013)
Fudan University
Binding mode characterization of 6?- and 6?-N-heterocyclic substituted naltrexamine derivatives via docking in opioid receptor crystal structures and site-directed mutagenesis studies: application of the 'message-address' concept in development of mu opioid receptor selective antagonists.
Bioorg Med Chem 21: 6405-13 (2013)
Virginia Commonwealth University
Synthesis and pharmacological evaluation of novel N-aryl-3,4-dihydro-1'H-spiro[chromene-2,4'-piperidine]-1'-carboxamides as TRPM8 antagonists.
Bioorg Med Chem 21: 6542-53 (2013)
Glenmark Pharmaceuticals
Synthesis and biological evaluation of 1,2,4-trisubstituted imidazoles as inhibitors of transforming growth factor-ß type I receptor (ALK5).
Bioorg Med Chem Lett 23: 5850-4 (2013)
Capital Normal University
A small molecule screen identifies selective inhibitors of urea transporter UT-A.
Chem Biol 20: 1235-44 (2013)
University Of California San Francisco
Bacterial neuraminidase inhibitory effects of prenylated isoflavones from roots of Flemingia philippinensis.
Bioorg Med Chem 21: 6398-404 (2013)
Graduate School Of Gyeongsang National University
Synthesis and biological evaluation of a new series of N-ylides as protein farnesyltransferase inhibitors.
Bioorg Med Chem Lett 23: 5887-92 (2013)
'Al. I. Cuza' University Of Iasi
The thermodynamic basis for the use of lipophilic efficiency (LipE) in enthalpic optimizations.
Bioorg Med Chem Lett 23: 5992-6000 (2013)
Novartis Institutes For Biomedical Research
Discovery of pteridin-7(8H)-one-based irreversible inhibitors targeting the epidermal growth factor receptor (EGFR) kinase T790M/L858R mutant.
J Med Chem 56: 7821-37 (2013)
East China University Of Science & Technology
3-aroylmethylene-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-ones as potent Nrf2/ARE inducers in human cancer cells and AOM-DSS treated mice.
J Med Chem 56: 7925-38 (2013)
China Pharmaceutical University
Telomere maintenance as a target for drug discovery.
J Med Chem 57: 521-38 (2014)
University Of North Carolina At Chapel Hill
Conformational restriction approach to ?-secretase (BACE1) inhibitors III: effective investigation of the binding mode by combinational use of X-ray analysis, isothermal titration calorimetry and theoretical calculations.
Bioorg Med Chem 21: 6506-22 (2013)
Hokkaido University
Synthesis and SAR studies of benzimidazolone derivatives as histamine H3-receptor antagonists.
Bioorg Med Chem Lett 23: 6001-3 (2013)
Merck Research Laboratories
Identification of a novel benzoxazolone derivative as a selective, orally active 18 kDa translocator protein (TSPO) ligand.
J Med Chem 56: 8191-5 (2013)
Dainippon Sumitomo Pharma
Exploration of allosteric agonism structure-activity relationships within an acetylene series of metabotropic glutamate receptor 5 (mGlu5) positive allosteric modulators (PAMs): discovery of 5-((3-fluorophenyl)ethynyl)-N-(3-methyloxetan-3-yl)picolinamide (ML254).
J Med Chem 56: 7976-96 (2013)
Vanderbilt University
Derivatives of dibenzothiophene for positron emission tomography imaging ofa7-nicotinic acetylcholine receptors.
J Med Chem 56: 7574-89 (2013)
The Johns Hopkins University School Of Medicine
New serotonin 5-HT1A receptor agonists endowed with antinociceptive activity in vivo.
J Med Chem 56: 7851-61 (2013)
Universidad Complutense De Madrid
Complexes of Trypanosoma cruzi sterol 14a-demethylase (CYP51) with two pyridine-based drug candidates for Chagas disease: structural basis for pathogen selectivity.
J Biol Chem 288: 31602-15 (2013)
Vanderbilt University
Evaluation of licorice flavonoids as protein tyrosine phosphatase 1B inhibitors.
Bioorg Med Chem Lett 23: 5836-9 (2013)
Toho University
Design, synthesis and discovery of picomolar selective α4β2 nicotinic acetylcholine receptor ligands.
J Med Chem 56: 8404-21 (2013)
Georgetown University
Design, synthesis, and biological evaluation of novel investigational nonapeptide KISS1R agonists with testosterone-suppressive activity.
J Med Chem 56: 8298-307 (2013)
Takeda Pharmaceutical
Synthesis and in vitro/in vivo antibacterial activity of oxazolidinones having thiocarbamate at C-5 on the A-ring and an amide- or urea-substituted [1,2,5]triazepane or [1,2,5]oxadiazepane as the C-ring.
Eur J Med Chem 69: 262-77 (2013)
Research Foundation Itsuu Laboratory
Aggrecanase-2 inhibitors based on the acylthiosemicarbazide zinc-binding group.
Eur J Med Chem 69: 244-61 (2013)
University Of Lille
Discovery, synthesis, and characterization of an orally bioavailable, brain penetrant inhibitor of mixed lineage kinase 3.
J Med Chem 56: 8032-48 (2013)
Califia Bio
Synthesis and structure-activity relationship studies of novel dihydropyridones as androgen receptor modulators.
J Med Chem 56: 8280-97 (2013)
National Cancer Institute-Frederick
Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.
J Med Chem 56: 8089-103 (2013)
UniversitÀ
A general method for making peptide therapeutics resistant to serine protease degradation: application to dipeptidyl peptidase IV substrates.
J Med Chem 56: 8339-51 (2013)
Tufts University
Design and evaluation of novel 8-oxo-pyridopyrimidine Jak1/2 inhibitors.
Bioorg Med Chem Lett 23: 5923-30 (2013)
Genentech
[(4-Hydroxyl-benzo[4,5]thieno[3,2-c]pyridine-3-carbonyl)-amino]-acetic acid derivatives; HIF prolyl 4-hydroxylase inhibitors as oral erythropoietin secretagogues.
Bioorg Med Chem Lett 23: 5953-7 (2013)
Sungkyunkwan University
Imidazo[4,5-b]pyridine inhibitors of B-Raf kinase.
Bioorg Med Chem Lett 23: 5896-9 (2013)
Array Biopharma
Synthesis and assessment of catechol diether compounds as inhibitors of trypanosomal phosphodiesterase B1 (TbrPDEB1).
Bioorg Med Chem Lett 23: 5971-4 (2013)
Northeastern University
Peripherally selective diphenyl purine antagonist of the CB1 receptor.
J Med Chem 56: 8066-72 (2013)
Research Triangle Institute
Small-molecule ligands of methyl-lysine binding proteins: optimization of selectivity for L3MBTL3.
J Med Chem 56: 7358-71 (2013)
University Of North Carolina At Chapel Hill
The natural product dihydrotanshinone I provides a prototype for uncharged inhibitors that bind specifically to the acetylcholinesterase peripheral site with nanomolar affinity.
Biochemistry 52: 7486-99 (2013)
Mayo Clinic
Identification of Potent and Selective Diphenylpropanamide ROR? Inhibitors.
ACS Med Chem Lett 4: 79-84 (2013)
New York University School Of Medicine
Role of the two structural domains from the periplasmic Escherichia coli histidine-binding protein HisJ.
J Biol Chem 288: 31409-22 (2013)
University Of Calgary
Novel N-methylsulfonamide and retro-N-methylsulfonamide derivatives as 17ß-hydroxysteroid dehydrogenase type 2 (17ß-HSD2) inhibitors with good ADME-related physicochemical parameters.
Eur J Med Chem 69: 201-15 (2013)
Saarland University
Discovery of 4-amino-2-(thio)phenol derivatives as novel protein kinase and angiogenesis inhibitors for the treatment of cancer: synthesis and biological evaluation. Part II.
Eur J Med Chem 69: 191-200 (2013)
Shandong University
TRPV1 antagonist with high analgesic efficacy: 2-Thio pyridine C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides.
Bioorg Med Chem 21: 6657-64 (2013)
Seoul National University
Bicyclic and tricyclic heterocycle derivatives as histamine H3 receptor antagonists for the treatment of obesity.
Bioorg Med Chem Lett 23: 6004-9 (2013)
Merck Research Laboratories
Synthesis of VS-105: A novel and potent vitamin D receptor agonist with reduced hypercalcemic effects.
Bioorg Med Chem Lett 23: 5949-52 (2013)
Vidasym
Synthesis and HDAC inhibitory activity of isosteric thiazoline-oxazole largazole analogs.
Bioorg Med Chem Lett 23: 6025-8 (2013)
Colorado State University
Discovery of 2,8-diazaspiro[4.5]decane-based trisubstituted urea derivatives as highly potent soluble epoxide hydrolase inhibitors and orally active drug candidates for treating hypertension.
Bioorg Med Chem Lett 23: 5975-9 (2013)
Toray Industries
2-Amino-6-chloro-3,4-dihydroquinazoline: A novel 5-HT3 receptor antagonist with antidepressant character.
Bioorg Med Chem Lett 23: 5945-8 (2013)
Virginia Commonwealth University
Identification of new inhibitors for low molecular weight protein tyrosine phosphatase isoform B.
Bioorg Med Chem Lett 23: 5912-4 (2013)
Saint John'S University
IspC as target for antiinfective drug discovery: synthesis, enantiomeric separation, and structural biology of fosmidomycin thia isosters.
J Med Chem 56: 8151-62 (2013)
Lehrstuhl FÜR Biochemie
Structure-kinetic relationships--an overlooked parameter in hit-to-lead optimization: a case of cyclopentylamines as chemokine receptor 2 antagonists.
J Med Chem 56: 7706-14 (2013)
Leiden University
O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.
J Med Chem 56: 8139-50 (2013)
University Of Notre Dame
Synthesis and biological evaluation of N-(2-fluorophenyl)-2ß-deoxyfuconojirimycin acetamide as a potent inhibitor fora-l-fucosidases.
Bioorg Med Chem 21: 6565-73 (2013)
University Of Toyama
Design, synthesis, and structure-activity relationships of azolylmethylpyrroloquinolines as nonsteroidal aromatase inhibitors.
J Med Chem 56: 7536-51 (2013)
University Of Padova
Inhibiting the HIV integration process: past, present, and the future.
J Med Chem 57: 539-66 (2014)
"Sapienza" Universit£
Structural basis of mycobacterial inhibition by cyclomarin A
J Biol Chem 288: 30883-91 (2013)
Novartis Institute For Tropical Diseases
Discovery and characterization of NVP-QAV680, a potent and selective CRTh2 receptor antagonist suitable for clinical testing in allergic diseases.
Bioorg Med Chem 21: 6582-91 (2013)
Novartis Institutes For Biomedical Research
Selective inhibition of heme oxygenase-2 activity by analogs of 1-(4-chlorobenzyl)-2-(pyrrolidin-1-ylmethyl)-1H-benzimidazole (clemizole): Exploration of the effects of substituents at the N-1 position.
Bioorg Med Chem 21: 6788-95 (2013)
Queen'S University
Identification of amides derived from 1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT).
Bioorg Med Chem Lett 23: 5488-97 (2013)
Forma Therapeutics
Influences of hydrocarbon linkers on the receptor binding affinities of gonadotropin-releasing hormone peptides.
Bioorg Med Chem Lett 23: 5484-7 (2013)
University Of New Mexico
Discovery of epigenetic regulator I-BET762: lead optimization to afford a clinical candidate inhibitor of the BET bromodomains.
J Med Chem 56: 7501-15 (2013)
Glaxosmithkline
Identification of a new class of glucokinase activators through structure-based design.
J Med Chem 56: 7669-78 (2013)
Array Biopharma
Drug discovery for neglected diseases: molecular target-based and phenotypic approaches.
J Med Chem 56: 7719-26 (2013)
University Of Dundee
Development of a chimeric c-Src kinase and HDAC inhibitor.
ACS Med Chem Lett 4: 779-783 (2013)
University Of Michigan
3-(3-Butylamino-2-hydroxy-propoxy)-1-hydroxy-xanthen-9-one acts as a topoisomerase II? catalytic inhibitor with low DNA damage.
Eur J Med Chem 69: 139-45 (2013)
Ewha Womans University
Design, synthesis, and structure-activity relationships of novel 6,7-disubstituted-4-phenoxyquinoline derivatives as potential antitumor agents.
Eur J Med Chem 69: 77-89 (2013)
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University)
Structural study of the location of the phenyl tail of benzene sulfonamides and the effect on human carbonic anhydrase inhibition.
Bioorg Med Chem 21: 6674-80 (2013)
Universit£
Development of a novel fluorine-18 labeled deuterated fluororasagiline ([(18)F]fluororasagiline-D2) radioligand for PET studies of monoamino oxidase B (MAO-B).
Bioorg Med Chem 21: 6634-41 (2013)
Karolinska Institutet
Substrate envelope-designed potent HIV-1 protease inhibitors to avoid drug resistance.
Chem Biol 20: 1116-24 (2013)
University Of Massachusetts
Efforts toward broadening the spectrum of arylomycin antibiotic activity.
Bioorg Med Chem Lett 23: 5654-9 (2013)
The Scripps Research Institute
Identification of 2-amino-5-aryl-pyrazines as inhibitors of human lactate dehydrogenase.
Bioorg Med Chem Lett 23: 5533-9 (2013)
Genentech
Inhibition of monoamine oxidase by 3,4-dihydro-2(1H)-quinolinone derivatives.
Bioorg Med Chem Lett 23: 5498-502 (2013)
North-West University
Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.
Bioorg Med Chem Lett 23: 5515-8 (2013)
Sogang University
Calix[4]arene methylenebisphosphonic acids as inhibitors of protein tyrosine phosphatase 1B.
Bioorg Med Chem Lett 23: 5619-23 (2013)
National Academy Of Sciences Of Ukraine
New chemotypes for wALADin1-like inhibitors of delta-aminolevulinic acid dehydratase from Wolbachia endobacteria.
Bioorg Med Chem Lett 23: 5558-62 (2013)
University Hospital Of Bonn
Synthesis and SAR studies of 5-(pyridin-4-yl)-1,3,4-thiadiazol-2-amine derivatives as potent inhibitors of Bloom helicase.
Bioorg Med Chem Lett 23: 5660-6 (2013)
National Center For Advancing Translational Sciences
Synthesis and binding affinity of new 1,4-disubstituted triazoles as potential dopamine D(3) receptor ligands.
Bioorg Med Chem Lett 23: 5586-91 (2013)
Universidad De Santiago De Compostela
Heterocyclic glucocorticoid receptor modulators with a 2,2-dimethyl-3-phenyl-N-(thiazol or thiadiazol-2-yl)propanamide core.
Bioorg Med Chem Lett 23: 5571-4 (2013)
Bristol-Myers Squibb
A Casein kinase 1/Checkpoint kinase 1 pyrazolo-pyridine protein kinase inhibitor as novel activator of the p53 pathway.
Bioorg Med Chem Lett 23: 5578-85 (2013)
University Of Edinburgh Cancer Research Centre In The Institute Of Genetics And Molecular Medicine
Design, synthesis and biological evaluation of a novel class of potent TGR5 agonists based on a 4-phenyl pyridine scaffold.
Eur J Med Chem 69: 55-68 (2013)
Chinese Academy Of Sciences
Nonpeptidic angiotensin II AT? receptor antagonists derived from 6-substituted aminocarbonyl and acylamino benzimidazoles.
Eur J Med Chem 69: 44-54 (2013)
Beijing Institute Of Technology
Nonpeptidic propargylamines as inhibitors of lysine specific demethylase 1 (LSD1) with cellular activity.
J Med Chem 56: 7334-42 (2013)
University Of Freiburg
Selectively targeting prostate cancer with antiandrogen equipped histone deacetylase inhibitors.
ACS Chem Biol 8: 2550-60 (2013)
Georgia Institute Of Technology
Discovery of inhibitors of Bacillus anthracis primase DnaG.
Biochemistry 52: 6905-10 (2013)
University Of Michigan
Structural, functional, and inhibition studies of a Gcn5-related N-acetyltransferase (GNAT) superfamily protein PA4794: a new C-terminal lysine protein acetyltransferase from pseudomonas aeruginosa.
J Biol Chem 288: 30223-35 (2013)
University Of Virginia
Curated by BindingDB
Curated by ChEMBL